Issues influencing medication adherence in Black women with hypertension by Abel, Willie M. & NC DOCKS at The University of North Carolina at Greensboro
 
ABEL, WILLIE M., Ph.D. Issues Influencing Medication Adherence in Black Women 
with Hypertension. (2011)  
Directed by Dr. Patricia B. Crane. 279 pp. 
 
 
The purposes of this study were to: (a) describe the differences in adherent and 
nonadherent Black women who have hypertension (HTN), (b) examine issues that 
influence medication adherence, and (c) explore the relationship of reactant behaviors 
and medication adherence. Cox‘s interaction model of client health behavior was used to 
guide this study. Client singularity background variables: demographic characteristics 
(age and education), social influence (religion), previous health care experience (family 
history of HTN, comorbidities, number of medications, blood pressure [BP], and body 
mass index), and environmental resources (income and type of health coverage) along 
with client singularity dynamic variables: intrinsic motivation (reactance), cognitive 
appraisal (HTN knowledge, self-care of HTN, trust in health care provider, and coping), 
and affective response (perceived racism and depression) were examined to determine 
their influence on the health outcome, medication adherence. 
A cross-sectional, correlational non-experimental study was conducted with a 
convenience sample of 80 Black women who were taking antihypertensive prescription 
medications for blood pressure control. Over half of the participants (56%) were single, 
divorced, or widowed. Ages ranged from 19 to 60 with a mean age of 47.8 (SD ± 9.2). 
Almost one-third 30% (n=24) of the participants reported household incomes levels at or 
below the federal poverty level. The majority of the sample was employed (67%), 
physically inactive (90%), overweight/obese (88%), and had a history of smoking (54%).  
The study results did not show a difference between those who adhere to 
antihypertensive medications and those who do not. Also, there was no relationship 
between reactant behaviors and medication adherence. However, in the optimal 
predictive model, those aged 40-49 were less likely to be adherent to their 
antihypertensive medications. In contrast, those who took 5 to 7 medications were more 
likely to be adherent. Trust in the health care provider was highly associated with 
adherence to the medication treatment regimen. These results are congruent with the 
expectation that trust in the health care provider promotes better medication adherence. 
Future research should continue to identify factors that influence adherence to the 
treatment regimen among Black women with HTN and develop interventions that 
facilitate their ability to better manage their HTN and thus, maintain BP control. 
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CHAPTER I 
BACKGROUND
 
Introduction 
Cardiovascular disease (CVD) is the leading cause of death for women in the 
United States with a substantially higher death rate in Black women ("Facts about 
women", 2009; "Women's health", 2010; "Women and heart disease", 2010). In fact, 
almost half (49%) of all Black women 18 years of age or older have some form of CVD 
(Roger et al., 2011) positioning them at an increased risk for heart attack, heart failure, 
stroke, and kidney disease. At least one or more of the major risk factors (diabetes, 
smoking, high blood pressure [BP], high blood cholesterol, physical inactivity, 
overweight/obesity, and family history of heart disease) for CVD are common for every 
Black woman ("Love your heart", 2009; Roger et al., 2011). Of all these risk factors, 
hypertension (HTN) is the leading cause of CVD, especially for Black women (Roger et 
al., 2011).  
The prevalence of HTN is vast, affecting approximately one billion adults 
worldwide (Chobanian et al., 2003). In the United States, HTN is present in about 76.4 
million adults representing 33% of the population (Roger et al., 2011). Of particular 
concern are Blacks in the United States, aged 20 years of age and older, who have the 
highest prevalence of HTN in the world. When examining data from 1988-1994 through 
1999-2002,  HTN for Blacks has steadily increased from 35.8% to 41.4% as compared to 
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24.3% to 28.1% for Whites (Roger et al., 2011). When further delineated by sex, HTN is 
greater for Black women (45.7%), followed by Black men (43.0%), then White men 
(33.9%), and is lowest for White women (31.3%) (Roger et al., 2011).   
Aims to decrease HTN can be achieved by modifying risk factors that affect CVD 
such as diet (Douglas et al., 2003; "Leading worldwide cause", 2008; "Women and 
health", 2009) and physical activity, along with antihypertensive drug therapy (Douglas 
et al., 2003). Black women have not readily participated in risk reduction behaviors to 
manage and prevent HTN, such as physical activity and diet. More importantly, the 
reasons for not participating are not fully understood (Benjamin et al., 2005; Smith et al., 
2005; Webb & Gonzalez, 2006). Equally perplexing is the lack of adherence of Black 
women to antihypertensive treatment regimens such as medications that have proven 
efficacy in lowering BP (Chobanian et al., 2004; Fongwa, Evangelista, & Doering, 2006; 
Mabotuwana, Warren, & Kennelly, 2009; Martins, Gor, Teklehaimanot, & Norris, 2001). 
Nonadherence to the HTN health regimen may create an enormous burden to 
Blacks because the chronicity of HTN oftentimes results in morbidity, disability, and 
mortality (Roger et al., 2011). The magnitude of this problem escalates since Blacks 
develop HTN earlier in life with greater severity and more organ damage, when 
compared to Whites (Chobanian et al., 2004; Nesbitt & Victor, 2004; Roger et al., 2011). 
Morbidities associated with CVD include HTN, coronary heart disease, myocardial 
infarction, angina pectoris, heart failure, and stroke. In the majority (75%) of individuals 
with CVD comorbidities, HTN is evident (Roger et al., 2011). 
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Cardiovascular disease is a major cause of disability that negatively influences the 
lives of about 45 million people in the United States, preventing normal lifestyles, 
activities of daily living, and employment. Heart disease, stroke, and HTN are among the 
15 leading causes of disabilities attributed to CVD (Roger et al., 2011). Eventually, 
uncontrolled HTN results in increased mortality rates in Blacks. Death rates from CVD 
were comparable for Blacks (588.7 deaths per 100,000 population) and Whites (586 
deaths per 100,000 population) in the 1950s ("Health, United States", 2010). Between 
1950 to 2007, both racial groups have experienced a decrease in CVD death rates with a 
greater decline for Whites (191.4 deaths per 100,000 population) than Blacks (251.9 
deaths per 100,000 population) (Xu, Kochanek, Murphy, & Tejada-Vera, 2010). Hence, 
Blacks are 1.3 times as likely as Whites to die from CVD (Xu et al., 2010). In 2007, the 
overall death rate for HTN was 17.8 per 100,000. From a race and sex perspective, the 
HTN death rate for White men and women was 15.7 and 14.3 respectively, whereas the 
death rate for Black men and women was 49.2 and 37.0 per 100,000  (Roger et al., 2011). 
In fact, HTN is the leading global risk for mortality in the world and ranks in the top two 
leading risk factors across all income groups ("Global health risks", 2009). Though a 
shorter life expectancy is troubling, morbidity and disability present a unique set of 
problems such as increased health care costs.  
Nonadherence to the HTN treatment regimen may result in frequent CVD 
exacerbations that could create a substantial cost burden to individuals, families, and 
society (Dragomir et al., 2010; Piette, Heisler, Horne, & Alexander, 2006; Rand & 
Sevick, 2000). In 2010, an estimated $503.2 billion was spent on health care related to 
4 
CVD, and of that amount, HTN was estimated to cost $76.6 billion (Lloyd-Jones et al., 
2010). This cost is astounding when considering that a number of the contributing factors 
for CVD are preventable ("Women and health", 2009).  
It is estimated that a surprising 50-70% of those diagnosed with HTN do not 
follow the prescribed medication regimen resulting in a lack of therapeutic effects 
("Adherence to long-term therapies", 2003; Charles, Good, Hanusa, Chang, & Whittle, 
2003; Fongwa et al., 2006; Rolley et al., 2008). Moreover, of the individuals prescribed 
antihypertensive medications, 70% do not achieve a controlled BP less than 140/90 
(Rolley et al., 2008; Wetzels et al., 2006).  Thus, nonadherence to antihypertensive 
medication is a significant issue in controlling HTN, especially in Black women who are 
at increased risk for morbidity and mortality. 
Although not implicit, the factors related to antihypertensive medication 
nonadherence in Black women include the multifaceted nature of historical and 
socioeconomic determinants such as coping with multiple stressors, perceived racism, 
(Webb & Gonzalez, 2006), lower education, divergent health beliefs, inadequate lifestyle 
modifications, poor social support, alcohol and illicit drug use, medication side effects, 
cost factors, lack of health insurance, lack of access to care (Fongwa et al., 2006), distrust 
of healthcare provider (Lukoschek, 2003), and poor communication with health care 
providers (Kressin et al., 2007). Currently, the worldwide prevalence of HTN (Roger et 
al., 2011) is evidence that Black women have had limited success with interventions for 
BP control (Fongwa et al., 2006). With the sophistication of technological advances in 
CVD therapies, HTN disparities among Black women with high prevalence and mortality 
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rates are unacceptable. Undoubtedly, one of the major obstacles to adequate BP 
achievement and the attainment of optimal health for Black women is failure to adhere to 
the health regimen. However, the multifaceted nature of this problem creates a 
complexity that may be more individualistic in nature whereby one intervention strategy 
may not fit the majority of this population. The high prevalence of HTN and the limited 
success of adherence interventions (Douglas et al., 2003) provide evidence of the 
complexity of this disease process, especially in Black women. According to R. A. 
Williams (2009), there is a lack of research on new and improved treatment approaches 
to CVD problems that are unique to Black women. Fongwa et al. (2006) denoted that the 
lack of successful interventions are attributed to the paucity of research on factors 
influencing adherence to treatment for Black women. Thus, research focusing on 
adherence is essential. 
Significance 
Hypertension is an especially dangerous disease because its victims are oftentimes 
asymptomatic ("About high blood pressure", 2010), thus the designation of HTN as the 
silent killer. Over time, damage to arterial walls and diminished blood supply cause 
destructive effects to major body systems such as the heart, kidney, and brain (Chobanian 
et al., 2004; "High blood pressure", 2010). The exact cause of HTN cannot be directly 
ascertained due to the involvement of multiple interactions of body systems, hormones, 
and physiological pathways (Arnett, 2000; Gutierrez & Peterson, 2007). Though HTN is 
often attributed to genetic factors (Roger et al., 2011), the results of most genetic studies 
have had limited success in identifying individual genes that contribute to HTN (Arnett, 
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2000) and remain experimental ("Human genome project", 2007). Because HTN is 
multifactorial (Chobanian et al., 2004; Gutierrez & Peterson, 2007), the treatment process 
is presumed to be multifaceted.  
According to the Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) (Chobanian et al., 
2004), the following classifications of BP are established while an individual is at rest. 
Normal BP is defined as a BP less than 120/80 mm Hg and pre-HTN is a BP 120/80-
139/89 mm Hg. Hypertension has two stages; stage 1 is a BP 140/90-159/99 mm Hg and 
stage 2 is a BP ≥ 160/100 mm Hg. Lifestyle modifications for those with pre-HTN are 
recommended by JNC 7 (Chobanian et al., 2004).  As an exception, antihypertensive 
medications should be prescribed for those individuals with prehypertension and 
diagnosed with diabetes or kidney disease that has a BP greater than 130/80. For all 
individuals with stages 1 and 2 HTN, JNC 7 recommends treatment with antihypertensive 
medications and lifestyle modifications (Chobanian et al., 2004).  
Interestingly, the International Society on Hypertension in Blacks (ISHIB) (Flack 
et al., 2010) recommends lowering target BP from less than 140/90 to less than 135/85 
for clients with uncomplicated HTN (e.g. no target organ damage or CVD) and less than 
130/80 for clients with complicated HTN (e.g. target organ damage and CVD). These BP 
recommendations were made after an extensive review of clinical trials and treatment 
guidelines (Flack et al., 2010). However, Wright et al. (2010) criticized ISHIB 
recommendations claiming insufficient evidence to support the lower BP goals. 
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Nevertheless, to effectively manage HTN in Blacks, guidelines from both JNC 7 and 
ISHIB warrant an aggressive community health focus. 
Because of the critical need to reduce health disparity for Blacks and improve 
cardiovascular health, Healthy People 2010 objectives underwent revisions for Healthy 
People 2020. Objectives that relate to BP were retained as previously written or retained 
with modifications. However, of particular interest is one new objective for Healthy 
People 2020 that focuses on medication adherence. The goal of this objective is to 
increase the number of people with HTN who take their medications as prescribed to 
decrease their BP ("Get to know healthy people", 2010). Thus, medication adherence is 
recognized as a national health care problem. 
A number of different medicine classifications have demonstrated efficacy in BP 
control (Chobanian et al., 2004; Fongwa et al., 2006; Mabotuwana et al., 2009). For 
about 30% of individuals with HTN, adequate BP control is achieved with one 
medication, while over 65% require two or more medications from different medicine 
classifications (Chobanian et al., 2004). Because multiple medications and multiple doses 
have been known to contribute to low adherence rates, fixed-dose combinations (two 
different medicine classifications in one tablet or pill form) were developed to aid 
adherence, maintain BP control, and decrease costs (Chobanian et al., 2004). However 
many third party payers will not pay for combination medications that are not available in 
the generic form because the cost is higher than reimbursing for two generic medications 
(Chobanian et al., 2004; Gradman, Basile, Carter, & Bakris, 2010; Pitt, 2004).  
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Maintaining adherence to the treatment regimen, whether antihypertensive 
medications or lifestyle modifications, has been problematic for Blacks (Fongwa et al., 
2008; Wexler, Elton, Pleister, & Feldman, 2009). One of the most intriguing reasons for 
nonadherence in Blacks stems from their historical beginnings within the United States 
healthcare system. Introduced to this country as slaves, Blacks were marketed as property 
with little to no human rights. They were frequently used in medical experiments by 
White doctors to perfect their technique before attempting procedures on those who were 
White (Gamble, 1997; Spillers, 1987; Washington, 2006). Because of skin color and 
other distinctive features such as hair texture, thick lips, and body shape, the lives of 
Blacks were not valued, and their exploitation by White physicians endured a long 
history (Gamble, 1997; Spillers, 1987; Washington, 2006). As a result, perceived 
stereotypes and prejudices experienced by Blacks in the health care arena have resulted in 
mistrust, refusal of treatment, and/or poor adherence with treatment regimens by Blacks 
(Gamble, 1997; "Unequal treatment", 2002). Today, remnants of their history continue in 
subtle configurations resulting in many Blacks approaching health care with fear, 
skepticism, and caution (Gamble, 1997).   
Historical factors may provide clues to the rationale for disparate rates of HTN for 
Blacks, especially Black women, thus creating a complexity that generates a 
multifactorial nature to the disorder. Disparate rates of HTN may be related to evidence 
of significant differences in healthcare for Blacks at the cultural (e.g. bias in healthcare 
delivery systems, access to care, and geography), socioeconomic (e.g. racial/ethnic bias, 
poverty, and education), physiological (unequal burden of risk factors), and genetic 
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(disease expression from polymorphisms that are DNA sequence variations resulting in 
altered protein function) levels (Yancy, Benjamin, Fabunmi, & Bonow, 2005). Because 
these disparities are complex and multifactorial, interventions to affect HTN in Black 
women must be multifaceted, inclusive of strategies from micro (interpersonal) to macro 
(local, state, and national) levels (Yancy et al., 2005).   
On further exploration of HTN, disparities may be related to either treatment 
approaches or receptiveness to treatment. Treatment approaches to HTN include 
antihypertensive medications and lifestyle modifications. Although these approaches 
have documented effectiveness (Chobanian et al., 2004), about 50% of clients with HTN 
fail to adhere to the treatment regimen ("Adherence to long-term therapies", 2003). 
Medication nonadherence is one reason why treatment regimens may fail to control HTN 
(Bovet, Burnier, Madeleine, Waeber, & Paccaud, 2002; Chobanian et al., 2004; 
Middleton, 2009; Munger, Van Tassell, & LaFleur, 2007; Schroeder, Fahey, & Ebrahim, 
2004; Stanton, 1987; Waeber, 2004). When taken as directed, antihypertensive 
medications are the most effective treatment for HTN control and are particularly 
effective with lifestyle modifications such as weight control (body mass index 
[BMI]18.5-24.9 kg/m2), healthy diet (rich in fruits, vegetables, low-fat dairy products, 
restricted sodium, and reduced fats), physical activity (at least 30 minutes of aerobic 
physical activity such as brisk walking most days of the week), and low alcohol 
consumption (no more than two standard drinks for men and one standard drink for 
women per week) (Chobanian et al., 2004).  Thus, HTN may be managed effectively 
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when treatment approaches such as medication therapy and lifestyle modification are 
employed.  
Conversely, receptiveness to treatment approaches is an area that deserves further 
exploration. It is inconceivable why an individual with HTN may choose not to adhere to 
treatment regimens since nonadherence could result in chronic debilitating effects such as 
heart failure, kidney disease, stroke, and coronary heart disease (Chobanian et al., 2004; 
Munger et al., 2007; Roger et al., 2011; Shea, Misra, Ehrlich, Field, & Francis, 1992; 
Yancy et al., 2005), all of which could contribute to death from HTN complications 
(Roger et al., 2011). Understanding why Black women may choose not to adhere to 
treatment approaches to HTN, such as antihypertensive medication is essential to divert 
the devastating consequences of HTN.  
In an effort to determine effective interventions to manage HTN and avert high 
morbidity, disability, and mortality rates, it is imperative to clearly understand why 
adherence to antihypertensive medication is problematic for some Black women and not 
for others. Although other studies have examined adherence in Blacks with HTN, only 
one qualitative study (Fongwa et al., 2008) specifically addressed adherence factors in 
Black women. Few adherence studies in Blacks have been multifaceted (Douglas et al., 
2003; Resnick et al., 2009) and none were found that examined the influence of historical 
and socioeconomic determinants that may affect adherence, especially in Black women. 
Therefore, research aimed at understanding issues that may positively or negatively 
influence antihypertensive medication adherence in Black women with HTN is 
warranted.  
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Purpose of Study 
The purposes of this study were to: (a) describe the differences in adherent and 
nonadherent Black women who have HTN, (b) examine issues that influence medication 
adherence, and (c) explore the relationship of reactant behaviors and medication 
adherence.  
Conceptual Framework 
In an attempt to integrate the individual nature of each person into a systematic 
and comprehensive framework that examines multiple determinants of health behavior 
and their associated outcome, Cox developed the interaction model of client health 
behavior (IMCHB) (Cox, 1982, 2003; Robinson & Thomas, 2004). The IMCHB 
originated initially during Cox‘s work as a nurse practitioner in small rural communities 
and was composed mostly of Black sharecroppers who did not have many resources 
(Cox, personal communication, August 4, 2010). As the health care provider, Cox spent a 
lot of time thoroughly assessing background variables, establishing rapport, and 
evaluating the client‘s knowledge base. She found that the clients in these communities 
were not motivated by their lack of knowledge; therefore, involving the client as a 
participant in their health care was a key factor. Clients had to have a role in what the 
health problem was and how to make it right, along with knowledge of the risks involved, 
knowledge of how they contributed to the risk, and the role they needed to play with risk 
reduction; thus, ample time was spent clearing up misperceptions, misunderstandings, 
and misknowledge (Cox, personal communication, August 4, 2010).  
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When working on interventions to yield positive outcomes, Cox found that her 
interaction differed from one client to the next in response to the client‘s affective 
response, motivation, or cognitive appraisal. For example, the client‘s affect (fear, 
anxiety) had to be dealt with before getting to their knowledge base. As she influenced 
the client, she also found that the client influenced her; hence, mutual influence occurred 
during the interaction. As a result of their interaction and subsequent interventions, Cox 
expected to see changes in the client‘s affective response, motivation, or cognitive 
appraisal when she saw her clients again in two weeks, and these changes were her cue to 
proceed to the next step. If there was no change, she had to reassess the background and 
dynamic variables and start over (Cox, personal communication, August 4, 2010). Thus, 
interventions were centered on facilitating client health decisions and behaviors to 
promote positive health outcomes (Cox, 1982). 
Cox‘s IMCHB is a deductive synthesis influenced by the work of four non-
nursing health behavior models that were derived primarily from psychological and 
sociological influences (Cox, 1982). The Rosenstock‘s health belief model, from a 
cognitive psychological background, addresses explanations of preventive health and 
illness behaviors whereby threatening health problems cause people to seek care and 
make health decisions (Cox, 1982; Matthews, Secrest, & Muirhead, 2008). The Suchman 
model, derived from a sociological focus, explains client health behaviors based on the 
influence of sociocultural variables and selected individual characteristics (Cox, 1982; 
Matthews et al., 2008). The Andersen and Newman model, built on the Suchman and 
Rosenstock models, adds economic and community resources (Cox, 1982; Matthews et 
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al., 2008). The self-regulation model, also based on cognitive psychology, explains the 
client‘s ability to process information from various sources and how this information 
influences the health care problem and actions to resolve the problem (Cox, 1982). 
Cox (1982) noted several shortcomings in these health belief models. First, these 
models were not responsive to the multidimensionality and variability in client behaviors 
and therefore, were considered to be of little benefit to the clinical practitioner. Second, 
these models lacked practical use because they are discipline specific, thus none of the 
models represented a holistic view of the client‘s health beliefs or behavior. Third, all of 
the models, except the self-regulation model, evolved from the medical model that 
focuses primarily on the physiological and biological aspects of diseases when 
diagnosing and treating illnesses. Fourth, these models offered theoretical speculation on 
the characteristics of noncompliant clients, rather than more guidelines for interventions. 
For some models, the word compliance implied that a client would relinquish their 
freewill and choose only behaviors consistent with the goals established by the health 
care provider, neglecting the individualistic nature of today‘s clients (Cox, 1982).   
The IMCHB is representative of the individualistic nature of the client, while 
responding to the multidimensionality and variability in client behaviors, thus 
encompassing a holistic view of the client. Clearly delineated in the model is the nursing 
process that depicts the nurses‘ role in the provision of nursing care, meeting client needs 
with nursing interventions, and effecting client health outcomes resultant from the 
nursing care experience (Cox, 1982; Cox & Roghmann, 1984). As a result, the IMCHB 
aids in the understanding of ―what nursing is‖ and ―what nursing does‖ (Cox, 1982, p. 
14 
54). However, the comprehensiveness of the model expands beyond the boundaries of 
nursing, making it applicable to professional health care providers in various health care 
settings (Cox & Roghmann, 1984; Matthews et al., 2008). 
The complexity and comprehensiveness of the model allows for the study of 
multiple variables, making it ideal for working with complex contributing factors and 
health behaviors, especially those that obscure the understanding of disorders such as 
HTN. In essence, the IMCHB creates a solid platform for the study of Black women with 
HTN because they have an array of complex physical, psychosocial, and environmental 
factors that further complicate HTN. In fact, HTN is a multifactorial disorder, and this 
model offers support to the multifaceted nature of the treatment process (Gutierrez & 
Peterson, 2007). In addition, the model sheds light on the limited success of adherence 
interventions and gives some credence to the high prevalence of HTN in Black women 
(Douglas et al., 2003). Thus, the complexity of HTN with its multiple contributing factors 
and health behaviors requires a model such as the IMCHB to provide a structure to gain 
insight into the nature of these occurrences. Because Blacks informed the origins of the 
model, the model‘s concepts fit the multifaceted nature of their health behaviors well 
(Cox, personal communication, August 4, 2010). Thus, the IMCHB is relevant to the care 
of Black women with HTN and has implications for both clinical practice and nursing 
research (Cox, 1982; Cox & Roghmann, 1984). 
Major Elements  
Cox‘s IMCHB (1982) was used to guide this study (see Figure 1). The three 
major elements in the IMCHB are: client singularity (background and dynamic variables 
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unique to an individual), client-professional interaction, and health outcome. As the 
primary objective, the IMCHB purports to identify and explain relationships between the 
three major elements (Cox & Roghmann, 1984). The crux of the model is the interaction 
between the interrelationship of the client‘s singularity (background and dynamic 
characteristics) and the health care providers‘ interventions to produce desired health 
outcomes (Cox, 1982).  
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Figure 1. The Interaction Model of Client Health Behavior. 
From ―A model of health behavior to guide studies of childhood cancer survivors‖, by 
Cox, 2003, Oncology Nursing Forum, 30(5), p. E92-E99. Copyright 2003 by Oncology 
Nursing Society. Reprinted with permission.  
 
Basic assumptions. Intrinsic to the IMCHB are several assumptions: (a) the client 
has the ability to make his or her own health care choices and subsequent health 
behaviors (Carter & Kulbok, 1995; Cox, 1982); (b) most client health behaviors are 
voluntary whereby clients choose to engage in positive or negative behaviors based on 
their personal goals (Cox & Wachs, 1985); (c) the responsibility of care remains the 
client‘s responsibility; (d) clients should exert control over determining optimal health for 
themselves and the actions necessary to attain their health status according to their 
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environmental limitations; and (e) the client and health care provider‘s perceptions of 
reality may differ, but the client‘s perception dominates in his or her life (Carter & 
Kulbok, 1995; Cox, 1982).  
Element of client singularity. Client singularity, the first element, defines the 
individuality of the client and reflects holism. Singularity addresses the client‘s 
interaction with his or her background variables that include demographic characteristics 
(e.g. gender, age), client social group influence (e.g. culture, religion, social network), 
previous health care experiences (e.g. health history, objective health data), and 
environmental resources (e.g. finances, access to health care) (Cox, 1982, 1986, 2003). 
These variables are highly predictive of health behaviors because of their interactive 
nature: They do not occur in isolation and remain virtually unchanged during the client-
provider relationship (Cox, 1982).  
The element of client singularity also includes dynamic variables. The dynamic 
variables are amendable to influence during the client-provider relationship and include 
intrinsic motivation, cognitive appraisal, and affective response (Cox, 1982). While 
intrinsic motivation varies for individuals and health situations, it represents free choice 
and the need to be self-determined and competent in health behaviors (Cox, 1982; Cox & 
Wachs, 1985). Intrinsic motivation may explain reasons for nonadherence in individual 
clients and may also predict why some clients adhere to health care interventions while 
others do not (Troumbley & Lenz, 1992). Cognitive appraisal reflects knowledge, beliefs, 
and values that aid in the client‘s perception or interpretation of their current health state. 
Affective response relates to the client‘s emotional arousal, for instance stress, that may 
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have the capacity to affect cognition and behavior (Cox, 1982). The client‘s decision-
making process about health behaviors may be affected by their background variables. 
Thus, it is the resultant choices, not the background variables, that influence health 
outcomes and become goals for nursing interventions (Cox & Wachs, 1985; Marion & 
Cox, 1996). Being able to examine numerous background variables and the choices made 
as a result of the variables will provide insight into nonadherent behaviors in Black 
women with illness such as HTN. 
Element of client professional interaction. The second element, a major 
influence on the client‘s health care behavior and health outcomes, is the client-
professional interaction. Proposed as a prescriptive theory for nursing, the IMCHB was 
designed to prescribe activities to bring about desired outcomes (Carter & Kulbok, 1995; 
Cox, 1982). The four components of the interaction that impact outcomes include 
provision of health information, affective support, decisional control, and professional 
technical competencies. How the client uses health information is dependent on other 
factors such as singularity, relationship with the health care provider, and client perceived 
control. Affective support addresses the affective response to keep emotions intact so a 
cognitive appraisal process of health information can occur. Decisional control relates to 
the client‘s participation in health care decisions and is dependent on adequate cognitive, 
motivational, informational, and affective responses to obtain desirable results from 
decision-making. The last component, the technical skills of the health care provider 
(intravenous therapy, BP monitoring, medication administration), decreases as the client‘ 
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health status improves and the client is able to increase their ability to process 
information and make decisions for themselves (Cox, 1982).  
The model includes a nonrecursive block that ―demonstrates a multidirectional 
causal flow with feedback mechanisms that suggest the mutual influence of one set of 
elements on another‖ (Cox, 1982, p. 47); predominately, the dynamic variables in the 
elements of client singularity and the elements of client-professional interaction (Cox, 
1982). In the model, health outcomes are determined by the reciprocal interactions 
between the client and health care provider related to client health concerns (Cox & 
Roghmann, 1984). 
Element of health outcome. The final element, health outcome, reflects the 
client‘s health results based on behavior. The five outcome variables include utilization 
of health care services, client health status indicators, severity of health care problem, 
adherence to the recommended care regimen, and satisfaction with care. Each outcome 
variable differs in meaning dependent on the objectives of the research study. For 
instance, utilization of the emergency room for a symptomatic BP greater than 180/110 is 
a positive health behavior that maintains or promotes a client‘s health status; conversely, 
failure to adhere to the BP treatment regimen is considered a negative behavior that 
reflects risky activities such as nonadherence to antihypertensive medications. 
Traditionally, while multiple health outcomes are examined in practice, Cox (1982) 
advocates one health outcome variable as the focus of an investigation.  
For this study, client singularity and health outcome elements were the main 
focus. Specifically, this study addressed the extent to which client singularity 
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(background and dynamic variables) predict the health care outcome of medication 
adherence (See Figure 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Conceptual Guide to Predict Black Women‘s Medication Adherence Behaviors. 
Adapted from the interaction model of client health behavior (Cox, 2003).  
 
Included in the background variables were demographic characteristics (age and 
education), social influence (religion), previous health care experience (family history of 
HTN, comorbidities, number of medications, BP, and BMI), and environmental resources 
(income and type of health coverage). Dynamic variables included intrinsic motivation 
(reactance), cognitive appraisal (HTN knowledge, self-care of HTN, trust in health care 
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provider, and coping), and affective response (perceived racism and depression). The 
health outcome, medication adherence, was assessed in relation to these variables. 
Definitions 
1. Demographic characteristics: Demographic characteristics are the variations in 
attributes of the sample population operationalized as age and education. 
a. Age: The age of the participants was self-reported on the demographic form. 
For the sample population, the age range in this study was 18 to 60, and was 
consistent with the rationale of James (1996) when describing active coping. 
Centered on employment and career goals, active coping is thought to increase 
around age 18 and diminish around age 60. 
b. Education: Education is an ongoing process of acquiring formal and informal 
knowledge or skill that occurs throughout the lifespan. 
2. Social influence: Social influence is the effect that thoughts and actions of an 
individual or group have on other people operationalized as religion. 
a. Religion: Religion is the belief, worship, obedience, and reverence to a 
supernatural power such as God. 
3. Previous health care experience: Previous health care experience is an individual‘s 
prior exposure to a health care provider in a health care system operationalized as 
family history of HTN, comorbidities, number of medications, BP and BMI.  
a. Family history of HTN: Family history of HTN is part of a client‘s medical 
history where inherited tendencies from direct blood relatives toward HTN are 
identified. 
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b. Comorbidities: Comorbidities are the presence of two or more diseases at the 
same time.  
c. Number of medications: Number of medications is the quantity of prescribed 
and over-the-counter medications an individual consumes.  
d. Blood pressure: BP greater than or equal to 140/90 is defined as hypertension 
(Chobanian et al., 2004). BP is the calculated mean systolic BP and mean 
diastolic BP determined by averaging the two BP measurements obtained 
during the interview.   
e. Body mass index: BMI is the relation of an individual‘s weight to their height 
to determine underweight, normal weight, and overweight categories and 
disease risk calculated as weight in kilograms divided by height in meters 
squared also expressed as weight (kg) / [height (m)]
2
 
4. Environmental resource: Environmental resource is the study participants‘ personal 
resources (Cox, 1982) and was operationalized as income and type of health 
coverage. 
a. Income: Income is the annual wages and earnings reported by the study 
participant.  
b. Type of health coverage: Type of health coverage refers to the primary entity 
that provides resources for health care services as reported by the study 
participant.  
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5. Intrinsic motivation: Intrinsic motivation is an individual‘s choice, desire, and need 
for competency and self-determinism with respect to the environment (Cox, 1982; 
Cox & Wachs, 1985) operationalized as reactance. 
a. Reactance: Reactance is the motivational arousal to re-establish freedom when 
behavioral freedom is lost, reduced, or threatened with reduction (J. W.  
Brehm, 1966). For this study, reactance was defined by the score on the 28-
item Therapeutic Reactance Scale (Dowd, Milne, & Wise, 1991). 
6. Cognitive appraisal: Cognitive appraisal is an individual‘s knowledge, beliefs, and 
attitudes toward his or her illness and treatment (Cox, 1982, 2003) and was 
operationalized as HTN knowledge, self-care of HTN, trust in health care provider, 
and coping. 
a. Hypertension knowledge: Hypertension knowledge is an individual‘s basic 
understanding of high BP cause and prevention. Knowledge was determined 
as the score on the 12-item High BP Prevention Questionnaire ("Check your 
high blood pressure", 1994).  
b. Self-care of hypertension: Self-care of HTN is an individual‘s naturalistic 
decisions that reflect his or her choice of behaviors in the maintenance and 
management of their BP (Riegel, Lee, Dickson, & Carlson, 2009). In this 
study, self-care of HTN was determined by the score on the 24-item Self-Care 
of Hypertension Index (Riegel et al., 2009).  
c. Trust in health care provider: Trust in health care provider is the belief that a 
health care provider‘s words and actions are trustworthy and can be relied 
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upon. In this study, trust was defined by the score on the 11-item Trust in 
Physician Scale (Anderson & Dedrick, 1990). 
d. Coping: Coping is an individual‘s psychological and physiological responses 
to prolonged exposure working with difficult psychosocial and environmental 
stressors. In this study, coping was measured by the score on the 12-item John 
Henryism Active Coping Scale (James, 1996). 
7. Affective response: Affective response is the emotional arousal in an individual that 
can interfere with cognitive activity and affect behavior (Cox, 1982) operationalized 
as perceived race-related stress and depression. 
a. Perceived race-related stress: Perceived race-related stress is the subjective 
experience of prejudice or discrimination that encompasses beliefs, attitudes, 
institutional arrangements, and acts that tend to denigrate individuals or 
groups because of phenotypic characteristics or ethnic group affiliations (R. 
Clark, Anderson, Clark, & Williams, 1999). For the purpose of this study, 
racial-related stress was determined by the score on the 22-item Index of 
Race-Related Stress-Brief Version. 
b. Depression: Depression is an individual‘s depressed mood exhibiting sadness, 
hopelessness, and discouragement or a loss of interest in previous pleasurable 
activities characterized by changes in appetite, altered sleep pattern, impaired 
thinking, and decreased physical functioning (Diagnostic and statistical 
manual, 2000). In this study, depression was defined as a score of greater than 
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or equal to 5 on the nine-item Patient Health Questionnaire-9 indicating mild 
to severe depressive symptoms (Kroenke, Spitzer, & Williams, 2001). 
8. Health outcome: Health outcome is the health status that results from the client‘s 
health behavior (Cox, 1982) toward the prescribed HTN medication regimen 
operationalized as medication adherence. 
a. Medication adherence: Medication adherence is the self-report of an 
individual‘s medication-taking behavior. For this study, adherence was 
measured by the score on the 14-item Hill-Bone Compliance to High Blood 
Pressure Therapy Scale (M.T. Kim, Hill, Bone, & Levine, 2000). 
Specific Aims and Research Questions 
The specific aims and associated research questions are:  
1. Describe Black women who adhere to antihypertensive medication treatment and 
those who do not adhere.  
Q1: Are there differences in background variables (age, education, religion, 
family history of HTN, comorbidities, number of medications, BP, BMI, income, 
and type of health coverage) in Black women who adhere to antihypertensive 
medication treatment as compared to Black women who do not? 
2. Examine the influence of background variables (age, education, religion, family 
history of HTN, comorbidities, number of medications, BP, BMI, income, and type of 
health coverage), and dynamic variables (HTN knowledge, self-care of HTN, trust in 
health care provider, coping, perceived racism, and depression) on medication 
adherence in Black women with HTN.  
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Q2. Are the background variables (age, education, religion, family history of 
HTN, comorbidities, number of medications, BP, BMI, income, and type of 
health coverage) and dynamic variables (HTN knowledge, self-care of HTN, trust 
in health care provider, coping, perceived racism, and depression) associated with 
medication adherence in Black women with HTN?  
Q3. Do the background variables (age, education, religion, family history of HTN, 
comorbidities, number of medications, BP, BMI, income, and type of health 
coverage), and dynamic variables (HTN knowledge, self-care of HTN, trust in 
health care provider, coping, perceived racism, and depression) predict 
medication adherence in Black women with HTN on an ordinal scale? 
3. Explore the relationship between reactant behaviors and antihypertensive medication 
adherence in Black women. 
Q4. Is there a relationship between reactant behaviors and medication adherence 
in Black women with HTN? 
Assumptions 
Several assumptions support the underpinnings of this study. First, according to 
the IMCHB, choices related to health behavior reflect self-will. Secondly, with the theory 
of psychological reactance, individuals want freedom to make their own choices and any 
interference whether positive or negative, interferes with their freedom to choose. The 
third assumption is that the concepts of reactance, knowledge, self-care of HTN, trust, 
coping, perceived racism, depression, and adherence can be quantified. Finally, the last 
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assumption is that answers to questions on instruments, tools, and scales reflect honest 
and accurate responses from participants and thus, represent reality or truth.   
Summary 
The purpose of this study was to describe the characteristics of Black women who 
are adherent versus nonadherent to antihypertensive medication treatment and examine 
issues that influence medication adherence. In addition, this study explored the 
relationship between reactant behaviors and medication adherence. Cox‘s IMCHB was 
used to guide this study. Results of this study will assist researchers to identify issues that 
influence adherence to antihypertensive medications and determine the impact of reactant 
behaviors on medication adherence in hypertensive Black women. The findings will 
provide important information for health care providers regarding issues and behaviors 
most likely to affect adherence to antihypertensive medications and become the impetus 
for purposefully designed interventions targeted toward those with the greatest burden of 
HTN, Black women.   
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CHAPTER II 
LITERATURE REVIEW
 
Introduction 
Several concepts in the literature have been used to describe the client‘s 
willingness or unwillingness to follow the prescribed treatment regimen, particularly 
medication-taking. Frequently used synonymously, compliance, adherence, and 
concordance are three concepts with different meanings. The historical and current 
interchange of these concepts in health care creates confusion and ambiguity 
(Bissonnette, 2008; Lehane & McCarthy, 2009). Ideally, conceptual frameworks or 
models are used to integrate concepts into a meaningful configuration (Fawcett, 1999). 
However, no conceptual frameworks or models were found that consistently explain or 
predict any of the three concepts, thus contributing to a plethora of confusion surrounding 
these concepts. While scholars and researchers continue to debate and explore these 
concepts, the lack of adherence to medication regimens has become a major crises in the 
United States and worldwide ("Enhancing prescription medicine adherence", 2007). One 
disorder, hypertension (HTN), is adversely affected by medication adherence issues and 
contributes to increased morbidity, disability, and mortality (Roger et al., 2011). 
Therefore, it is imperative that scholars agree on common terminology and address the 
barriers that influence client medication adherence ("Enhancing prescription medicine 
adherence", 2007), especially for those with HTN.  
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This literature review focuses on conceptual views of adherence and provides an 
overview of medication adherence and HTN. In addition, selected components of Cox‘s 
interaction model of client health behavior (IMCHB), elements of client singularity 
(background and dynamic variables) and health outcome, are explored. Cox‘s IMCHB 
provides the conceptual framework for client characteristics that may predict adherence 
to the recommended medication regimen.  
Conceptual Views on Adherence 
Brawley and Culos-Reed (2000) proclaim that no distinct conceptual model exits 
for adherence and that while several health belief models have attempted to predict 
compliance/adherence, including the Pender‘s Health Belief Model (Hwang, 2010), 
results have been inconsistent and do not account for large amounts of variance in health 
outcomes. According to Gearing and Mian (2005), no single model assimilates all the 
constructs underpinning adherence nor is applicable to every client and their specific 
illness and associated contexts. This lack of a model is concerning since adherence is 
viewed as one of the most serious problems facing health care today (Becker, 1985; 
Middleton, 2009). 
Examining three concepts, compliance, adherence, and concordance, assist in 
determining which concept is most suitable for use in nursing research and clinical 
practice. The first concept, compliance, is defined as the extent the client‘s behavior 
matches the health care providers‘ recommendations (Haynes, 1979). Compliance 
implies passive subordination to an order and suggests blame for failure to comply with 
treatment (Haynes, 1979). Further delineated, compliance infers that the client is a 
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passive recipient of paternalistic orders from the health care provider in the same manner 
as when the law commands obedience. According to Evangelista  (1999), use of the 
concept compliance leaves the client little choice or power to make decisions regarding 
his or her health status and sets the stage for a power relationship between the client and 
health care provider, whereby all power rests with the health care provider. Because 
clients should be active participants in his or her health care and more credence should be 
given to the client‘s perspective of his or her health problem (Evangelista, 1999), 
focusing on the client‘s perspective of the costs and benefits of the health regimen is 
essential to implementing a plan the client is willing to follow.  
Adherence, the second concept, is defined as the extent the client‘s behavior 
matches agreed recommendations made by the health care provider (Barofsky, 1978). 
Hearnshaw and Lindenmeyer (2005) conducted a literature review to identify and 
categorize definitions and measurements of adherence in diabetic populations. 
Unfortunately, they noted various definitions of adherence that lacked clarity. The 
chronicity of many diseases require adherence to the recommended health regimen to 
ensure a reasonable quality of life with lifestyle changes and medications. Therefore, a 
clear definition of adherence is imperative to achieve positive health care outcomes in 
chronic diseases such as diabetes and HTN.  
Defining adherence is important and would contribute to a consistent 
measurement of the concept. Based on a review of 26 papers, Hearnshaw and 
Lindenmeyer (2005) assigned five categories of adherence definitions. Three of the 
categories addressed aspects of medication-taking behavior such as the agreement of 
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client behavior with health care provider advice, evaluation of outcome and process 
targets, and taking the medication as prescribed. Client and health care provider 
relationships were the focus of the fourth category. Lastly, the final category addressed 
the interconnection of adherence with client motivation, health beliefs, and perceived 
self-efficacy. These categories captured the complexity of adherence and attest to the fact 
that adherence is difficult to simplify into a single definition. Defining adherence as it 
relates to complex treatment, lifestyle living, and counsel is difficult because of the need 
for: (a) individualization; (b) multiple components such as diet, medication, and exercise; 
(c) varying components over time; (d) adherence difficulties for different components; 
and (e) the necessity to pre-specify the exact aim of the intervention (Hearnshaw & 
Lindenmeyer, 2005). In a concept analysis on adherence, Bissonnette (2008) concluded 
that a definition of adherence that uses a client-centered approach and reflects the 
dynamic nature of adherence behavior remains elusive in the literature. One reason for 
the indefinable aspect of the concept adherence is that its complexity lends itself to a 
multifaceted process that is not confined to a common meaning, thus confusion and 
ambiguity exist reflective of poorly understood health outcomes in nursing research and 
practice.  
After identifying the definition categories of adherence, Hearnshaw and 
Lindenmeyer (2005) categorized the measurements of adherence according to the 
definitions. Because the definition of adherence was oftentimes missing or not explicitly 
defined, adherence was difficult to measure. Thus, defining and measuring adherence was 
complicated because of the multifaceted nature of chronic disease and its treatment as it 
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progresses over time (Hearnshaw & Lindenmeyer, 2005). This review of the literature 
concluded that measurements of adherence are oftentimes not based on a definition, and 
thus, the measurement instruments for adherence in many studies were not validated.  
Because adherence emphasizes the client‘s freedom to decide if they will or will 
not follow the health care provider‘s recommendation, no blame is associated with the 
client‘s decision not to follow recommendations (Barofsky, 1978; Horne, Weinman, 
Barber, Elliott, & Morgan, 2005). With adherence, the clients‘ decision to follow a 
prescribed health regimen becomes a shared responsibility between the client and health 
care provider by eliciting the client‘s cooperation through dialogue to understand the 
client‘s perspective about his or her condition and how it affects their life (DiGiacomo, 
2008). Through open communication, the health care provider and client are able to 
identify reasons for nonadherence that may contribute to solutions that positively impact 
adherence (Lutfey & Wishner, 1999). When successful, adherence is viewed as a method 
that produces long-term lifestyle changes. As an example, long-term weight loss requires 
a lifestyle of adherence, and those who are most successful partner with weight loss 
programs such as weight watchers, that provide lifelong education and support 
(Chiappetta, 2008). Similarly, clients with HTN must collaborate with health care 
providers to obtain education, support, and monitoring of blood pressure (BP), lifestyle 
changes, and antihypertensive medications to ensure positive health outcomes. Thus, 
adherence rather than compliance, would be an appropriate concept for clients with HTN 
(Chobanian et al., 2004), especially Black women. 
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Use of the concept adherence removes some of the accusatory tone inherent in the 
concept compliance. Some may argue that the difference in the two concepts is a matter 
of academic semantics: However, the goal of using adherence instead of compliance is to 
improve the relationship between the client and health care provider, creating a more 
favorable work environment (Singleton, 2008). Adherence and compliance differ because 
the concept compliance suggests a passive client role that hinders the establishment of a 
working relationship with the client. In the literature, researchers have exchanged the 
concept compliance for adherence because it infers a positive connation and working 
relationship between the client and health care provider. In summary, the relationship in 
adherence emphasizes: (a) the necessity of an agreement between the client and health 
care provider, (b) the client‘s freedom to decide whether or not to adhere to the 
recommended health regimen, and (c) no blame if the client fails to adhere the health care 
provider‘s recommendations (Horne et al., 2005). 
The last concept, concordance was coined after a partnership developed between 
the Royal Pharmaceutical Society of Great Britain and Merck & Dohme pharmaceutical 
company (Cushing & Metcalfe, 2007; Marinker, 2004). Concordance is defined as an 
agreement between the client and health care provider that is negotiated based on the 
beliefs and wishes of the client as to how medications are taken with importance given to 
the client‘s decision (Marinker, 1997; Thompson, 2000). The concept concordance 
addresses the extent, cause, and consequences of non-compliance (Marinker, 2004) that 
result in nontherapeutic doses to prescribed medications (Marinker, 1997). Using a 
consultation approach, the client has expertise of his or her body‘s response to illness and 
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treatment, and the health care provider is the scientific expert in medications (Weiss & 
Britten, 2003). An understanding and respect for the client‘s view is the central focus.  
As equal partners of concordance, the health care provider and client negotiate an 
agreed plan of care inclusive of both their views. Ultimately, the client decides if he/she 
will or will not take medications. When disagreements occur, the health care provider 
bears the responsibility of offering future discussions if the client chooses to address the 
issue (Marinker, 2004). Pound and colleagues (2005) assert that because most clients 
self-regulate prescribed medications, it would be safer if health care providers accepted 
this practice and guided them through the process. The authors (Pound et al., 2005) 
advocate concordance as the mechanism to help clients test and modify prescribed 
medications while given sufficient information, feedback, and guidance from healthcare 
providers. With concordance, clients would be partners and make informed decisions 
about prescribed medication regimens. Pounds et al. (2005) recognized that concordance 
may not be ideal for all clients such as those with HIV or poor mental health. In addition, 
concordance may not be best for clients with HTN who need to maintain BP levels within 
an acceptable range to preserve major body organ functioning, especially when lifestyle 
changes have not been effective (Chobanian et al., 2004).  
Implementing adherence closely resembles concordance by the health care 
provider when involving the client through collaboration and dialogue. Yet, one major 
contrast between the two is the ability for negotiation in concordance (Aronson, 2007; 
Lehane & McCarthy, 2009). Physicians argue that a negotiated agreement is not relevant 
in interactions with clients because a definitive diagnosis leaves no room for negotiation 
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(Aronson, 2007). Other concerns center on the lack of clinical evidence of the benefits 
and harms of concordance. To date, there is no specific research study that test the 
benefits of concordance; instead, research describes achieving, promoting, improving, 
and enhancing concordance (Aronson, 2007; Lehane & McCarthy, 2009).   
Another major problem with the term concordance is that it focuses on the 
interaction with the health care provider and the partnership rather than the actual client 
behavior, specifically medication-taking (Horne et al., 2005; Lehane & McCarthy, 2009). 
In contrast, both adherence and compliance describe individual client behavior. In 
essence, the main issue with taking medicine is the client‘s individual behavior and the 
degree to which that behavior does or does not match the prescribed treatment regimen 
(Horne et al., 2005). In fact, the National Health Service in Great Britain who coined the 
term concordance, now advocates adherence as the term of choice to describe the client‘s 
medication-taking behavior (Horne et al., 2005).    
Of the three concepts, Lehane and McCarthy (2009) purport that adherence is the 
most appropriate concept for nursing research and clinical practice. Adherence implies 
the ability of clients to stick to prescribed treatment regimens and follow recommended 
instructions (Bissonnette, 2008; Buchmann, 1997). In addition, adherence refers to a 
steady or faithful attachment or fidelity, implying loyalty, devotion, and commitment 
(Chiappetta, 2008; Evangelista, 1999). The factors that change adherence to 
nonadherence are related to client choice and therefore, not completely understood. As a 
component of human behavior, adherence is complex, multifaceted, challenging, and 
influenced by social, psychological, and environmental contexts (Bissonnette, 2008). 
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Therefore adherence behaviors deserve further research to identify factors that may 
predict adherence and nonadherence while ultimately informing practice interventions. 
Of great concern is the lack of understanding of medication adherence in those with 
HTN, especially since antihypertensive medications have proven efficacy in lowering BP 
(Chobanian et al., 2004; Fongwa et al., 2006; Mabotuwana et al., 2009; Martins et al., 
2001). Therefore, an understanding of medication adherence issues in clients with HTN is 
vital to achieving effective interventions that produce positive health outcomes, 
especially for Black women. 
Medication Adherence in Clients with HTN 
Adherence to medication-taking has been the subject of research in clients with 
HTN for more than 30 years (Hill, Miller, & DeGeest, 2010). Findings reveal that many 
clients with HTN who seek health care do not successfully adhere to prescribed 
antihypertensive medications ("Healthy people 2010"; L. M. Lewis, Askie, Randleman, 
& Shelton-Dunston, 2010; Ndumele, Shaykevich, Williams, & Hicks, 2010), despite 
goals to influence client health behaviors to achieve positive health outcomes (Singleton, 
2008). Surprisingly, only about 50% of those prescribed antihypertensive medications 
continue treatment after one year (Hill et al., 2010). Even with advances in medical 
technology and client centered approaches to health care, the nonadherence problem 
remains unsolved ("Enhancing prescription medicine adherence", 2007; Kaufman & 
Birks, 2009).  
To achieve success in BP control for clients with HTN, many lifestyle changes are 
required including weight control, healthy diet, physical activity, low alcohol 
37 
consumption, and smoking cessation (Chobanian et al., 2004; Flack et al., 2010). 
Adherence to the prescribed antihypertensive medication regimen may be another 
lifestyle alteration. A combination of lifestyle changes along with antihypertensive 
medications taken as directed are the most effective treatment for BP control (Chobanian 
et al., 2004).  
Adherence to the treatment regimen has been positively affected by factors such 
as satisfactory client-provider interactions, social support systems (Chobanian et al., 
2004; Flack et al., 2010), health education with multiple intervention strategies, self-
management of HTN, and support in managing HTN (Connell, Wolfe, & McKevitt, 
2008). Several research studies have further identified that adherence to the 
antihypertensive medication regimen was associated with decreased morbidity and 
mortality for individuals diagnosed with HTN (Dragomir et al., 2010; L. M. Lewis & 
Ogedegbe, 2008). Poor medication adherence, especially in Blacks, may provide an 
explanation for racial disparities in BP control between Blacks and Whites (Dickson & 
Plauschinat, 2008; Gerber, Cho, Arozullah, & Lee, 2010; L. M. Lewis & Ogedegbe, 
2008). Despite adherence research, medication-taking behavior is not well understood 
and no interventions targeting antihypertensive medication adherence have produced 
reliable, long-term results (L. M. Lewis & Ogedegbe, 2008). Therefore, a significant gap 
remains in the science concerning adherence to the treatment regimen in persons with 
HTN, especially medication-taking. 
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Elements of Client Singularity 
Background Variables 
The IMCHB provides a foundation for holistic client care and offers a theoretical 
framework for understanding poor adherence to health treatment regimens for Black 
women with HTN. The IMCHB is operationalized using two of the major elements, 
client singularity and health outcome (Cox, 1986). The elements of client singularity have 
two components, background and dynamic variables. The first component, background 
variables, addresses environmental and sociological determinants of behavior that 
contribute to definitive predictions about health care behaviors (Cox, 1982). Background 
variables encompass multiple external attributes pertinent to the unique nature of 
individuals. The background variables of interest unique to this study included 
demographic characteristics, social influence, previous health care experience, and 
environmental resources.             
Demographic characteristics. Two demographic characteristics significant to 
Black women with HTN are age and education. Typically HTN increases with age 
(Chobanian et al., 2004), but for Blacks, HTN tends to occur earlier in life with greater 
severity and more organ damage when compared to Whites (Chobanian et al., 2004; 
Nesbitt & Victor, 2004; Roger et al., 2011). Thus, morbidity, disability, and mortality are 
frequent consequences of HTN, especially when diagnosed at an early age. In addition, 
HTN is more prevalent in Blacks who have lower educational levels that contribute to the 
likelihood of lower income levels (Roger et al., 2011). Thus, lower socioeconomic status 
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(low educational and income levels) and the daily stressors associated with it may 
predispose individuals to HTN (Chaix et al., 2010; James, 1996; R. B. Williams, 2010).   
Age. Individuals with the highest rate of HTN tend to be middle aged or older 
(Roger et al., 2011). If we are able to predict issues that influence adherence to the 
treatment regimen in younger aged hypertensive clients, then we may impact HTN 
control in the middle aged. The same could hold true in predicting issues that influence 
adherence to the treatment regimen in middle aged hypertensive clients and possible 
HTN control in older clients. This study identified factors that predicted adherence to the 
treatment regimen in younger and middle aged Black women that could improve HTN 
outcomes in middle and older adults and contribute to longer life spans without increased 
morbidity, disability, and mortality.  
In the 18-39 age group, the prevalence of HTN increases with age 7%, as 
compared to 30% in the 40-59 age group and 67% in the 60 and older age group 
(Ostchega, Yoon, Hughes, & Louis, 2008). If risk factors for cardiovascular disease 
(CVD) such as HTN can be prevented or managed, then the probability of survival to 85 
years of age increases without major comorbidities. However, if CVD risk factors are 
present during middle age, the predicted probability of survival to age 85 decreases 
significantly (Terry et al., 2005). According to the United States Census‘ 2010 Statistical 
Report ("Projected life expectancy", 2009), none of the racial ethnic groups in the United 
States experience an average life expectancy of 85 years. Blacks experience the lowest 
average life expectancy (73.8 years overall, 70.2 for males and 77.2 for females) as 
compared to Whites (78.9 years overall, 76.5 for males and 81.3 for females). 
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Surprisingly, Hispanics reported the highest average life expectancy (81.1 years overall, 
78.4 for males and 83.7 for females). Thus, the age range of 18 to 60 in the sample 
population in this study could be an opportune age for identifying HTN adherence issues 
and eventually contribute to the institution of appropriate interventions to ensure positive 
health outcomes in middle and old age.   
Education. Based on data collected from the American Community Survey and 
the Current Population Survey, the 2007 United States Census Bureau (Crissey, 2009) 
reported lower educational attainment for Blacks and Hispanics when compared to 
Whites and Asians on all educational levels.  For instance, lower high school completion 
rates were noted for Blacks (80%) and Hispanics (61%) when compared to Whites (89 
%) and Asians (86%). In addition, completion of a college degree was lower for Blacks 
(17.3%) and Hispanics (12.5%) than Whites (30.5%) and Asians (49.5%). The same 
trend was true with lower percentages of advanced degrees for Blacks (5.8%) and 
Hispanics (3.9%) than Whites (11.3%) and Asians (19.6%) (Crissey, 2009). According to 
Roger et al. (2011), the highest rates of HTN are noted in individuals who are less 
educated. However, this statement does not hold true for Hispanics who have the lowest 
educational attainment, but the prevalence rate of HTN in Hispanic men (25.9%) is lower 
than Black (43%) and White (34.4%) men ("Men and cardiovascular diseases", 2010). 
Similarly, HTN prevalence rates for Hispanic women (31.6%) are lower than Black 
women (44.8%) but about the same as White women (31.1%) ("Women and 
cardiovascular diseases", 2010). Thus, the association between low educational 
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attainment in Blacks and HTN may be coupled with unknown factors not evident in 
Asian, White, or Hispanic populations. 
Social influence. The cultural heritage of Blacks was thought to be lost because 
Africans were brought to the United States from many different parts of West Africa with 
diverse languages, religions, customs, and institutions that were subjugated during 
slavery. Levine (1977, p. 4) writes that the culture Africans possessed was tangible and 
could not be lost because it was their ―style of life.‖ He further described culture as a 
process that is not fixed but interacts with the past and present. For Africans, culture was 
expressed in various methods such as music, song, dance, folktales, spirituality, folk 
medicine, magic, superstition, kinship, and fictive kinship family bonds. Many of these 
cultural expressions continue to be evident in the lives of Blacks today, especially 
spirituality. 
The church is a group of persons with beliefs that influence and inform its 
member‘s lifestyles. Through the historical legacy of slavery and oppression, Blacks have 
found peace and inner strength in the church that has helped them withstand 
insurmountable hardships (Chang, 2004, August). Spirituality became vital to survival of 
Blacks and played a significant role in their ability to transcend and transform horrific 
experiences (L. M. Lewis & Ogedegbe, 2008) of slavery and oppression. Thus, Blacks‘ 
strong affiliation to the church has endured for centuries. As a result, Blacks are regarded 
as the most religiously devout group of all ethnic/racial groups in the United States (Vu, 
2009, February).   
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Religion. Spirituality and religion are separate but related concepts. Spiritually 
denotes an inner freedom to engage in faith, while religion refers to the outward 
adherence to highly prescribed beliefs and rituals. Both concepts relate to the reliance, 
trust, and faith in a higher being, such as God (L. M. Lewis & Ogedegbe, 2008). Lewis 
and Ogedegbe (2008) proposed a conceptual model of spirituality and medication 
adherence to guide the development of spiritually based interventions to improve 
adherence to medication therapy. This model purports that spiritually based interventions 
could be used to eradicate key barriers to medication adherence (L. M. Lewis & 
Ogedegbe, 2008). Yet, no correlation was found between spirituality and medication 
adherence in heart failure clients (Black, Davis, Heathcotte, Mitchell, & Sanderson, 
2006). Black et al. (2006)  assert that many clients are becoming more concerned about 
spiritual issues since they are living longer with chronic diseases such as heart failure and 
HTN. Despite client concerns, spiritual needs are rarely recognized by health care 
providers although they claim to provide holistic health care (Black et al., 2006). Thus, 
religious activity and spirituality are concepts that deserve further exploration in nursing 
research and clinical practice.  
According to Gillum and Griffith (2010), religious activity contributes to positive 
health outcomes in several ways that include providing social support, regulating health 
behaviors, promoting healthy beliefs, and generating positive emotions. Hence, religious 
activity is thought to reduce the emotional impact of stress and depression while 
enhancing coping abilities. Particularly, social support preserves the continuity of 
positive health behavior and is associated with cooperation and self-care that is essential 
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for treatment of chronic diseases such as HTN (Naewbood, Sorajjakool, & Triamchaisri, 
2010, March). Although the health benefits of religious activity are encouraging, 
unfortunately, many Blacks have not experienced positive health outcomes in relation to 
chronic diseases. 
High levels of religiosity have been associated with lower BP. Using data from 
NHANES III, a large data set (N=12,488) was analyzed to compare those who attend 
religions services weekly or more often to those who never attend services. Results 
revealed lower odds of HTN among Whites and Blacks, particularly Black women, while 
no relationship was noted between attendance and HTN for Hispanics (Bell, Bowie, & 
Thorpe, 2010). Similarly, religiosity was found to have a positive association between 
lower BP and better lipid profiles for individuals with Judeo-Christian religious practices 
in a critical review of the literature (Seeman, Dubin, & Seeman, 2003). Although Blacks 
and Hispanics are considered to be more religious than Whites (Bell et al., 2010), this 
relationship between religion and lower odds of HTN has not held constant for Blacks 
who have the highest prevalence of HTN in the United States (Roger et al., 2011). Thus, 
the influence of religiosity on the physiological response of BP is not clear. Although 
these research findings are intriguing, they present a significant gap in the literature that 
warrants further research.     
Culture. Some Blacks engage in behaviors associated with cultural practices that 
have an adverse effect on health. Cultural influences that result in risky health behaviors 
are not fully understood by the larger society. One cultural practice is the ―kinship 
burden‖ whereby many Blacks exhibit a strong commitment to family (Webb & 
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Gonzalez, 2006, p. 260) by sacrificing their health and personal needs to meet the needs 
of family. This commitment or burden is more pronounced in Black women and as a 
result, women tend to report more life stressors (Jones & Shorter-Gooden, 2003). The 
―strong Black woman‖ is a perception embraced by Blacks. This perception is actually a 
myth that creates undue stress and leads women to feel inadequate when the myth does 
not become a realization (Jones & Shorter-Gooden, 2003, pp. 11, 22). Stress affects 
quality of life in Blacks, and there is a strong relationship between stress and HTN 
(Lehman, Taylor, Kiefe, & Seeman, 2009; Schneider et al., 2001). Research suggests that 
chronic environmental stress, negative emotions, and risky health behaviors may 
contribute to allostatic load accumulation (Lehman et al., 2009). Allostatic load refers to 
the increased persistent stress on the body that consumes energy and sustains a 
physiological stress response that eventually results in chronic diseases such as HTN (B. 
S. McEwen, 2003). Research examining HTN in Black women must note the influence of 
culture on HTN and medication adherence. 
In a qualitative study, Peters, Aroian, and Flack (2006) found that it is oftentimes 
difficult to understand Black health behavior without first recognizing that their health 
behavior is entrenched within their culture. The experiences of discrimination, 
oppression, and mistreatment have had a profound effect on Blacks, thus contributing to a 
sense of collective identity that has shaped their attitudes toward health care and 
ultimately influences their health outcomes (R. M.  Peters, K. J. Aroian, & J. M. Flack, 
2006). This finding becomes significant when cultural practices result in non-adherent 
behaviors that impact the health care regimen. In a study of Black adults, Peters et al. 
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(2006) noted that study participants were reluctant to adhere to dietary, weight, and 
activity recommendations for fear that they would be perceived as acting White and 
disregarding their culture. Therefore, to avoid criticism and ostracism from family and 
peers, participants refused to engage in preventive care even to the detriment of their 
health. Peters et al. (2006, p. 840) used the metaphor ―circle of culture‖ to describe these 
boundaries that bind many Black families and communities together while separating 
them from outsiders. This metaphor may provide an explanation of why many health 
behavior programs focusing on adherence are not effective (R. M. Peters et al., 2006). 
Similarly, an online research study found that three out of four (75%) people were aware 
of a family member with HTN, but three out of five (60%) with this knowledge choose 
not to engage in preventive health behaviors before their own diagnosis of HTN ("The 
pressure is on", 2009). While this study did not examine the rationale for lack of health 
promoting behaviors, these alarming ratios lend support to other influences, such as the 
―circle of culture.‖ Other researchers (Wexler et al., 2009) described this behavior as 
fatalistic in nature whereby many Blacks tend to believe that HTN is inevitable, so why 
do anything about it. Although negatively affecting adherence and contributing to 
subsequent health problems for Blacks, clearly, cultural practices in Blacks are poorly 
understood. 
Defeatist behavior is also exemplified in overweight and obese Blacks who 
communicate disinterest in increasing physical activity to control weight (R. M. Peters et 
al., 2006), while others cite physical inactivity to the lack of a convenient, safe 
environment due to poor crime-ridden neighborhoods (Fongwa et al., 2008).  Obesity is 
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prevalent among Black women (51%) as compared to Mexican (43%), and White (33%) 
women (Roger et al., 2011). Another factor that contributes to overweight and obese 
Blacks is the high dietary sodium and fat that remains a cultural practice indigenous to 
slavery for food preservation and making undesirable animal parts palatable (Martins & 
Norris, 2004). Cultural traditions for diet and food preparation unique to slavery are 
attributed to poor eating habits today. Further, the low socioeconomic status and limited 
income of many Blacks may contribute to the purchase of cheaper, nonnutritious, high 
fat, high caloric foods, rather than more costly nutritious foods such as fruits, vegetables, 
and lean meats (Ewing, n.d.; R. M. Peters et al., 2006; Webb & Gonzalez, 2006). 
Likewise, the use of alternative treatments with foodstuff may be practiced to make 
medicinal remedies for various ailments. Alternative treatments may include home 
remedies such as vinegar, ginger, lime, raw onions, and garlic to self-treat high BP 
(Fongwa et al., 2008; Lukoschek, 2003). Many Blacks attribute the use of alternative 
therapies to a lack of finances and to decreased access to health care and appropriate 
medications, thus affecting adherence to the health care regimen. Thus, psychosocial 
stressors, dietary factors, greater weight, and adherence to antihypertensive medications 
are major risk factors for CVD, particularly HTN (Munger et al., 2007; Roger et al., 
2011). 
All Black cultural practices do not have negative health effects. Spirituality has 
probably been the sustaining force that has provided comfort and hope for Blacks during 
years of slavery and oppression. Faith and reliance on God has allowed Blacks to 
persevere and overcome insurmountable odds of slavery and racial injustice (L. M. Lewis 
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& Ogedegbe, 2008). In an effort to combat health disparities for Blacks, researchers have 
begun to focus studies in the heart of the Black community, the church. Several studies 
have shown positive results in the reduction of CVD risk factors in church-related 
exercise and diet programs (DeHaven, Hunter, Wilder, Walton, & Berry, 2004; White, 
Drechsel, & Johnson, 2006; Yanek, Becker, Moy, Gittelsohn, & Koffman, 2001) 
resulting in positive health behaviors that promote spiritual, physical, and psychological 
health. However, strong evaluations, program effectiveness, and outcome measures are 
generally lacking in many of the church-based studies making it difficult to determine the 
contribution of these programs to improved health and quality of life in Black churches 
and communities (Campbell et al., 2007; DeHaven et al., 2004).  
Cultural influences that may result in risky health behaviors for Blacks are poorly 
understood. This is evidenced by the reluctance of many Blacks to practice health 
behaviors that are not costly and can be addressed through lifestyle changes to reverse the 
effects of physical inactivity, alcohol use, overweight/obesity, sedentary lifestyle, and 
smoking; all of these are modifiable risk factors. Jenkins (2009) asserts that 
nonadherence to modifiable risk factors may be attributed to lack of knowledge and effort 
for many Blacks. Conversely, Peters, Aroian, and Flack (2006) contend that individual 
Black behavior, attitudes, and beliefs cannot be understood independent of culture. 
Consequently, some cultural influences have proved detrimental to the health of Blacks, 
especially when resultant behaviors dictate non-participation in preventive care while 
sacrificing healthy behaviors for poor health.  
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Because the rate of HTN is increasing in Black women, there is a need for 
discovery of primary factors that influence adherence and effective HTN management 
that are beneficial to healthy outcomes (Fongwa et al., 2006). One factor, cultural 
practices, presents a challenge to health care providers. Although little is known about 
what accurately predicts adherence to the treatment regimen from a Black cultural 
perspective, what is known is that HTN is a multifaceted disease process, and using 
multiple constructs and multiple interventions are more effective than single constructs 
(Middleton, 2009). Thus, studies are needed to fill the gap in knowledge that exists about 
how culture influences adherence and nonadherence to HTN treatment, particularly in 
Black women.  
Previous health care experience. Previous health experiences are potential 
determinants of health-related behavior and current health state (Troumbley & Lenz, 
1992). Experiences are selected for this study because of their importance to the health 
problem, medication adherence in Black women with HTN. Previous health care 
experiences include family history of HTN, comorbidities, number of medications, BP, 
and body mass index (BMI).  
Family history of HTN. Family history is a non-modifiable risk factor of HTN 
and attributed to genetic factors (Arnett, 2000; Roger et al., 2011). According to Arnett 
(2000), the results of most genetic studies have had limited success in identifying 
individual genes that contribute to HTN. Numerous gene studies (epithelial sodium 
channels, the renin-angiotensin aldosterone system, α- and β-adrenergic receptors, 
endothelin and endothelin receptors, kallikrein, natriuretic peptides and their receptors, 
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increased sodium absorption and salt sensitivity, transforming growth factor 
hyperexpression, and the nitric oxide pathway) have resulted in a dearth of information 
from primarily small case-control studies using nonrandom convenience samples 
(Ferdinand & Welch, 2007). However, a recent research study involving variants located 
on two genes, natriuretic-peptide precursor A (NPPA) and natriuretic-peptide precursor B 
(NPPB) associated with the production of atrial and b-type natriuretic peptides (ANP and 
BNP) have shown promise in reducing BP. Both ANP and BNP lower BP through salt-
wasting and vasodilatory effects. Future treatments may be aimed at establishing normal 
levels of natriuretic-peptide in individuals who are deficient to decrease the risk of HTN 
(Newton-Cheh et al., 2009).   
Another recent discovery in animal research with mice identified corin, a 
transmembrane serine protease enzyme in the heart. Corin converts pro-atrial natriuretic 
peptide (pro-ANP) to active ANP to reduce BP. When corin is deficient, not only does 
BP elevate, but cardiac hypertrophy occurs as well. Although the corin study has been 
limited to animal research, the data indicate that corin deficiency may be responsible for 
HTN in humans and may alter antihypertensive drug performance. These findings may 
prove beneficial for Blacks who have the highest prevalence of HTN in the world (Zhou, 
Jiang, Cui, & Wu, 2009).   
Comorbidities. HTN may co-exist with other medical conditions such as heart 
failure, kidney disease, and diabetes requiring medication therapy. All comorbidities 
must be stabilized and monitored at follow-up visits as prescribed (Chobanian et al., 
2004). One study conducted by Lagu et al. (2009) examined the effect of cardiovascular 
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and noncardiovascular comorbidities on antihypertensive prescription filling in Black 
Medicaid clients with HTN. Results indicated that 25% of prescriptions for 
antihypertensive medication were not filled by clients and those ≤ 50 years of age had 
42% lower odds of filling a prescription. Interestingly, prescriptions for clients with 
cardiovascular comorbidities were not more likely to filled, whereas clients with five or 
more noncardiovascular comorbidities were significantly more likely to fill prescriptions. 
However, clients with stage II HTN were more likely to fill prescriptions than clients 
with controlled BP. Although medication cost was not a factor, these findings indicate the 
need to explore other issues that impact medication adherence and the necessity of 
developing interventions to maximize medication-taking benefits.       
Number of medications. The increased quantity of medications, better known as 
polypharmacy, can create a substantial cost burden, especially to the elderly client. In 
addition, polypharmacy could cause untoward side effects and compromise the health 
status of the client, especially if multiple comorbidities are present. As noted by West, 
Lefler, and Franks (2010), when side effects increase, medication adherence decreases. 
Moss and Crane (2010) investigated polypharmacy in elderly women who had 
experienced a myocardial infarction and found that participants took approximately seven 
medications daily. The study concluded that the elderly could suffer adverse effects from 
polypharmacy; therefore, health care providers should be aware of polypharmacy 
complications and cost considerations.          
Medical management of HTN can be achieved when health care providers and 
clients are persistent in working together to achieve optimal BP control using established 
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medication guidelines. More than 75% of individuals diagnosed with HTN require two or 
more antihypertensive medications from different drug classifications for BP control 
(Chobanian et al., 2004), and many clients with HTN may have one or more 
comorbidities requiring additional medications (Munger et al., 2007). Simplifying the 
medication regimen and using a multifactorial intervention approach may improve 
medication adherence (Chobanian et al., 2004; Munger et al., 2007). Strategies may 
include selecting antihypertensive medications that are tolerated with minimal adverse 
effects, use of long-acting medications to decrease dose frequency, client education 
combined with motivational approaches, and the use of an electronic home BP device to 
actively engage the client in the treatment process (Munger et al., 2007). Polypharmacy 
could have detrimental effects on adherence due to financial issues and difficulty 
organizing medication time frequencies (Chobanian et al., 2004; Munger et al., 2007). 
Thus, examining the number of medications is important when exploring adherence. 
Blood pressure. Hypertension is generally defined as a BP greater than or equal to 
140/90. According to Chobanian, et al. (2004), HTN can be further delineated as systolic 
HTN and diastolic HTN. Systolic HTN is a major risk factor for CVD and increases with 
age throughout the lifespan. In contrast, diastolic HTN predominates by rising before age 
50 and then levels off and remains virtually unchanged in later life, thus, it is a more 
potent CVD risk factor. Most health care providers tend to consider diastolic HTN as 
more important and institute aggressive treatment. However, systolic HTN increases 
CVD mortality, stroke, and heart failure, necessitating that more emphasis be placed on 
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its management, especially in older adults (Chobanian et al., 2004). Yet, to avoid 
untoward CVD events, both systolic and diastolic HTN should be managed appropriately.   
In the 20-year longitudinal community based Coronary Artery Risk Development 
in Young Adults (CARDIA) study (D. A. Levine et al., 2011), a biracial cohort was 
followed from early adulthood to examine if risk factors for HTN are explained by racial 
and geographic variability. When adults aged 18 to 30 were recruited for the CARDIA 
study in 1985-1986, systolic and diastolic BP increases were higher in Black men and 
women than in White men and women. Over the 20-year period, Black women had the 
largest systolic and diastolic BP indicating significantly higher rates of HTN incidence. 
Thus, better monitoring and aggressive management of HTN risk factors, such as obesity 
and physical inactivity, is indicated for Black women (D. A. Levine et al., 2011). 
Body mass index. Overweight and obesity are considered to be an epidemic in the 
United States (Flack et al., 2010). Black women (51%) have the highest prevalence rates 
of obesity when compared to Mexican (43%), and White women (33%) (Roger et al., 
2011). Increased health risks, such as CVD, are significantly higher in women who are 
overweight (20%) and obese (64%) (Roger et al., 2011). As predictors of increased health 
risk, BMI and waist circumference have been used to assess obesity-related diseases. The 
BMI, calculated as weight in kilograms divided by height in meters squared, is 
categorized as underweight (less than 18.5 kg/m
2
), normal weight (18.5 to 24.9 kg/m
2
), 
overweight (25-29.9 kg/m
2
), or obesity (greater than or equal to 30 kg/m
2
) ("BMI 
classification", 2010; "Calculate your body mass index", n.d.). Whereas, a waist 
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circumference greater than or equal to 88 cm in women and 100 cm in men is regarded as 
abdominal obesity (Mosca et al., 2007; Roger et al., 2011).  
Together, BMI and waist circumference have served as predictors of morbidity 
and mortality associated with chronic diseases such as diabetes, CVD, stroke, and 
metabolic syndrome. However, in a study conducted by Janssen, Katzmarzyk and Ross 
(2004), waist circumference was found to be a better predictor of obesity-related diseases 
independently of BMI. In contrast, a study by Benetou et al. (2004) indicated that BMI 
was the dominant predictor of BP for women, but waist circumference was the dominant 
predictor of BP in men. Conversely, another study showed that both obesity variables, 
BMI and waist circumference, contributed to higher BP in the mediating role (Chaix et 
al., 2010). However, BMI is misleading in Asians and waist circumference may be a 
better indicator of CVD risk (Friedewald, Nesbitt, Ram, & Roberts, 2010). Because 
abdominal obesity can be problematic for individuals in the normal weight range, 
assessment of both BMI and waist circumference is recommended ("Abdominal fat", 
2006) and both were anthropometric measures for this study.  
Environmental resources. Adequate environmental resources are relatively static 
and considered a major determining factor for personal health care, barriers to health 
care, and access to health care (Cox, 2003). Lack of environmental resources in Black 
women with HTN may be a factor that negatively impacts adherence to the treatment 
regimen. The variables of interest in this study are income and type of health coverage.  
Income. In 2009, the median income for Blacks ($32,584) was lower than 
Hispanics ($36,039), and Whites ($54,461). The poverty rate in 2009 was higher for 
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Blacks (25.8%) when compared to Hispanics (25.3%) and Whites (9.4%) (DeNavas-
Walt, Proctor, & Smith, 2010). Thus, a wide economic gap continues to exist between 
Blacks and Whites. 
Historical evidence has shown that socioeconomic status is a strong predictor of 
health outcomes with poverty as the leading cause of avoidable morbidity and mortality 
(Bierman & Dunn, 2006). James (1996) noted an inverse correlation between 
socioeconomic status and health; those with lower socioeconomic status are more likely 
to experience illness and premature death than those with higher socioeconomic status, 
thus adversely affecting Blacks, and other minority/ethnic groups. Similarly, Ndumele et 
al. (2010)  write that low income clients, particularly Blacks, have challenges with 
medication adherence contributing to poor BP control. Likewise, another study (Kressin, 
Orner, Manze, Glickman, & Berlowitz, 2010) on racial disparities in BP control revealed 
that Blacks (58%) with household incomes ˂  $20,000 were more likely to have 
uncontrolled BP than Whites (36%) with the same income level. Thus, low income levels 
for Blacks and Whites may not result in the same health outcomes. 
Type of health coverage. In the United States most people had employee-based 
health insurance coverage in 2009 (55.8%). In the same year, 30% were covered by 
government health programs such as Medicaid (15.7%) and Medicare (14.3%). The 
uninsured rate was less for Whites (12%) as compared to Blacks (21%) and greatest for 
Hispanics (32.4%) (DeNavas-Walt et al., 2010). According to a study conducted by 
Kressin et al.(2010) , uncontrolled BP was more likely to occur in clients with Medicaid 
and free care. Because health coverage in some of these programs may require a copay to 
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purchase medications, this is an important variable to measure when examining 
medication adherence, especially in those with low income levels. 
Dynamic Variables 
The second component of client singularity, dynamic variables, addresses 
psychological determinants of behavior that contribute to definitive predictions about 
health care behaviors (Cox, 1982). Subject to change over time, dynamic variables 
encompass internal processes that are formulated with background variables and 
contribute to the individual‘s nature. Dynamic variables of interest that are unique to 
study participants include intrinsic motivation, cognitive appraisal, and affective 
response.              
Intrinsic motivation. An assumption of the IMCHB is that the majority of health 
maintenance and promotion behaviors are dependent on individual choice to adhere or 
not adhere to the prescribed health regimen (Cox & Wachs, 1985). Important to the 
manifestation of overt behavior, intrinsic motivation is dependent on volitional control 
centered on meeting an individual need (DiNapoli, 2003). When prescribed a health care 
regimen, individual needs may be impacted by background variables such as age, sex, 
race, education, religion, family history, income, and insurance type that may contribute 
to how choices are made about subsequent health behaviors. However, Cox and Wachs 
(1985) assert that it is the individual‘s choices that will ultimately impact health 
outcomes and not the background variables. Thus, when individual needs are threatened 
or hindered by the health care regimen, intrinsic motivation may invoke an individual‘s 
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will to choose adherence or nonadherence to resolve conflicts among needs (Cox & 
Wachs, 1985).  
In an exploration of adherence (compliance), Fogarty (1997) concluded that 
diagnosis such as HTN may involve substantial lifestyle changes such as medications, 
diet, and physical activity that could impact a number of highly valued freedoms. These 
health care demands may disrupt personal routines and restrict valued freedoms (Fogarty, 
1997), while triggering the motivation to act to preserve those freedoms. Because the 
asymptomatic nature of HTN makes the treatment regimen seem more troublesome than 
the disease itself, some client‘s react negatively and perceive the prescribed treatment 
plan as a threat instead of a health benefit (Fogarty, 1997). The persistence of 
nonadherence to the treatment regimen led Fogarty (1997) to propose the theory of 
psychological reactance as a means to understanding nonadherent behaviors, particularly 
in Black women with HTN.  
Reactance. J. W. Brehm‘s (1966) theory of psychological reactance was 
developed to depict the behavioral motivation to re-establish lost or threatened freedom. 
An awareness of reactant behaviors may assist healthcare providers in mediating 
adherence with behavioral tasks such as adhering to the medication regimen, ultimately 
affecting healthcare outcomes (Dowd et al., 1991).  
The psychological reactance theory was conceived by J. W. Brehm (1966) when 
he noted that as advice is given to another person, oftentimes the person acts contrary to 
the advice (S. S. Brehm & Brehm, 1981). Rather than exerting a positive influence, the 
advice seems to have a negative influence on the person: people do the opposite of what 
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they are told to do. According to J. W. Brehm (1966), the best description of this 
phenomenon is the desire for freedom to make a decision without outside interference. 
Freedom implies having the power to change a situation or control a potential outcome. 
Thus, people are free to govern their own behavior. When an individual feels their 
freedom is threatened or restricted, they are motivated to preserve that freedom (J. W.  
Brehm, 1966; Christensen, 2004). Thus, reactance is a motivational state to re-establish 
the perceived or actual threatened or eliminated freedom (J. W.  Brehm, 1966). 
Several tenets explain the motivational state of a reactant individual. First, when a 
free behavior is threatened or eliminated, a ―forbidden fruit effect‖ prevails where the 
individual‘s desire for the behavior increases (Christensen, 2004, p. 33). Second, the 
greater the force to restrict or threaten to eliminate a behavior, the more intently the 
individual will engage in the behavior to preserve it. Any attempt to discourage the 
individual‘s behavior creates an opposite reaction known as the ―boomerang effect‖ (J. 
W.  Brehm, 1966, p. 14; Christensen, 2004, p. 33). Lastly, the greater the importance of a 
threatened freedom (implies the loss of other freedoms), the more inclined the individual 
is to restore the freedom and also increase the frequency of the restricted behavior (J. W.  
Brehm, 1966; S. S. Brehm & Brehm, 1981; Christensen, 2004). 
The magnitude of reactance arousal is determined by four principles that may 
threaten, restrict, or eliminate freedom (S. S. Brehm & Brehm, 1981; Christensen, 2004). 
First, the individual must believe they have a certain freedom (e.g. freedom from lifetime 
commitment to medications). Second, the freedom must be important to the individual 
(e.g. importance of the freedom to be medication-free and virtually healthy). Third, the 
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reduction of more than one freedom or total elimination of a freedom is evident (e.g. 
reductions related to diet and physical inactivity or the elimination of a medication-free 
life). Last, the implied reduction of freedom is inferred to other freedoms (e.g. threats to 
freedom of smoking and drinking alcohol) (J. W.  Brehm, 1966; J. W. Brehm, 1976; S. S. 
Brehm & Brehm, 1981).  
As noted by Christensen (2004), threats and oftentimes elimination of personal 
freedoms are commonplace in the medical environment. Clients are expected to renounce 
freedom and surrender control to the health care team. Staff in hospital environments may 
dictate what the client can and cannot do regarding eating, sleeping, medications, diet, 
activity, diagnostic tests, and visitors: The list of restrictions may be endless. The theory 
of psychological reactance becomes operational as the client attempts to regain control 
over the lost freedom and restricted behaviors imposed upon them. Client adherence 
issues began to surface when the perceived freedom is restricted or threatened with 
elimination and the client becomes reactant to treatment regimen. The restriction of free 
choice becomes a control issue for the client whose desire or motivation is to protect their 
sense of freedom. The motivational state of the client yields a response of reactance in an 
attempt to regain control (Christensen, 2004). Although psychological reactance theory 
has rarely been used in nursing, the implication of high reactance levels and loss of 
control to medication adherence warrants further study, especially in Black women.  
Psychological reactance may be relevant to Blacks because of their history of 
slavery and oppression. Because of the lingering effects of their historical legacy, Blacks 
tend to view freedom from a different perspective than other races. Reactance to potential 
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restrictions or threats to eliminate freedoms may contribute to physiological tension and 
psychological pressure with changes in perceptions and judgments (J. W. Brehm, 1976). 
The historical legacy of slavery and its lingering effects places Black clients in a unique 
position to protect and safeguard their personal freedoms. Thus, if health care providers 
could identify and address Black client‘s underlying reactant behaviors initially with the 
IMCHB‘s elements of client singularity, then interventions to control HTN with lifestyle 
changes and medication adherence could be implemented. 
Woller, Buboltz, and Loveland (2007), noted that highly reactant individuals are 
likely to experience anxiety and are distrustful of others. Further, Palmentera (1996) 
stated that reactant individuals demonstrated more stress, hostility, and emotion-focused 
coping styles with feelings of self-deprecation linked to depressive symptoms. Thus, the 
psychological ramifications of highly reactant behaviors may hinder therapeutic 
relationships with health care providers (Seemann, Buboltz, Jenkins, Soper, & Woller, 
2004) and impede adherence to the treatment regimen, especially medication-taking 
(Christensen, 2004).  
Reactance varied with race in a study conducted by Seemann et al. (2004). Blacks 
had higher levels of reactance than Whites on the verbal, behavioral, and total therapeutic 
reactance scale. In another study (Woller et al., 2007), the scores of Blacks and 
Hispanic/Latinos were not significantly different, but were significantly higher than both 
Whites and Native Americans. According to Seemann et al. (2004), minorities may have 
higher reactance levels when compared to Whites because of constantly defending their 
freedoms in a White dominated society plagued with economic, social, and occupational 
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discrimination. Woller, Buboltz, and Lovelace (2007) further stated that differences in 
reactance levels for minority groups may result from disparate environmental 
opportunities related to discrimination that restricts free behavior, especially for Blacks 
and Hispanic/Latinos. Thus, reactance behaviors experienced in society may be 
generalized to relationships with health care providers implementing the treatment 
regimen.  
The vast amount of literature on lack of compliance and adherence attest to the 
continual resistance of individuals to taking medications, even though they may receive 
pertinent information, interventional strategies, and admonishments (Fogarty, 1997; 
Pound et al., 2005). Several authors contend that because varying degrees of resistance 
exist and are usually hidden from health care providers, it is highly unlikely that 
individuals will stop resisting prescribed medications (Fogarty, 1997; Pound et al., 2005). 
Intrinsic motivation as described by Cox and Brehm‘s reactance theory may provide 
insight into factors that promote adherence behaviors. The rationale for reactant 
behaviors and resulting resistance to the treatment regimen, particularly medication-
taking, warrants further exploration.  
Cognitive appraisal. Cognitive appraisal provides insight into the client‘s 
perceptions and interpretation of his or her health status, behavioral choices, and 
interaction with the health care provider (Cox, 1982). Importantly, the client‘s 
perceptions and interpretations are representative of his or her reality and may or may not 
reflect that of the health care professional (Carter & Kulbok, 1995; Cox, 1982). The 
client‘s cognitive appraisal related to HTN knowledge, self-care of HTN, trust in health 
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care provider, and coping are explored in relation to medication adherence in Black 
women with HTN.   
Hypertension knowledge. It seems logical to assume that knowledge of HTN 
diagnosis, medications, and lifestyle modifications are imperative to attain adequate BP 
control. However, Pascucci et al. (2010) assert that the association between knowledge 
and adherence is disconcerted because knowledge in itself is not enough to ensure 
adherence, but it is necessary for adherence to occur (Pascucci, Leasure, Belknap, & 
Kodumthara, 2010). While educational information is usually beneficial for individuals 
who are motivated to adhere to the treatment regimen but unlearned in regimen process, 
individuals unmotivated in adherence and already knowledgeable are unlikely to improve 
with additional educational information (Becker, 1985). Thus, client education is 
essential, although its effectiveness may be questioned, especially when intrinsic 
motivation is lacking.  
Becker (1985) asserts that providing information to clients about diagnosed 
illnesses and prescribed treatments have not increased adherence. In a systematic review 
of randomized controlled trials, Schroeder et al. (2004) concluded that client education 
was not successful. In fact, a recent Cochrane review on intervention effectiveness for BP 
control in clients on prescribed medications concluded that client education alone was not 
associated with large BP reductions (Glynn, Murphy, Smith, Schroeder, & Fahey, 2010). 
In contrast, a study (E.-Y. Kim et al., 2007) examining intentional and unintentional 
nonadherence to antihypertensive medication regimens in middle-aged Korean 
Americans with HTN noted that intentional medication nonadherence was significantly 
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associated with lack of high BP knowledge. However, literacy was not reported as an 
issue in this study even though over 45% of the sample had less than a high school 
education. Authors recommended individualized client education on HTN disease 
management with an emphasis on medication side effects, a frequently cited reason for 
medication nonadherence.  
Several studies of racially mixed adults with HTN indicated that Blacks with less 
than a high school education had insufficient HTN knowledge (Ayotte, Trivedi, & 
Bosworth, 2009; Sanne, Muntner, Kawasaki, Hyre, & DeSalvo, 2008; Viera, Cohen, 
Mitchell, & Sloane, 2008). Similarly, a study conducted by Chaix et al. (2010) found that 
decreased individual educational level and lower average neighborhood educational level 
was strongly associated with HTN. In contrast, Martins et al. (2001) conducted a study on 
HTN knowledge in Blacks living in an urban community and concluded that participants 
with greater HTN knowledge were associated with a higher educational level or a 
personal history of HTN. Thus, deficient HTN knowledge and less than a high school 
education may be related to health literacy issues.  
Literacy issues may be one of the primary reasons for uncertainty of educational 
effectiveness. For almost 50% of U. S. citizens, reading skills are inadequate (M. V. 
Williams, Baker, Parker, & Nurss, 1998), and Flack et al. (2010) contend that 
nonadherence to treatment regimens in Blacks with HTN is likely attributed to an 
inability to read and satisfactorily follow prescription instructions. Low literacy levels 
can result in difficulty understanding health information, accessing health care, following 
instructions from a health care provider, and taking medications correctly; all of which 
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contribute to poor adherence to the treatment regimen, uncontrolled chronic disease, and 
increased health care costs (Safeer & Keenan, 2005).  
Milio (1976) exerts is that it is not enough to make clients knowledgeable about 
healthy lifestyle choices without assuring that clients have ready access to the treatment 
options promoted. If health care providers adequately assess clients prior to implementing 
treatment and allow clients an opportunity to exert control over determining optimal 
health for themselves, then the actions necessary to attain their health status could be 
implemented according to the client‘s environmental limitations (Carter & Kulbok, 1995; 
Cox, 1982). Adequate assessment of the client‘s ability to practice positive health 
behaviors within the environmental resources available may provide a realistic 
expectation for the client to succeed in adhering to the health care regimen and allow the 
health care provider an opportunity to individualize the health care regimen, thus making 
adherence a viable possibility. 
Self-care of HTN. As defined by Riegel, Lee, Dickson, and Carlson (2009), self-
care is a decision-making process that clients naturally use to choose behaviors to 
maintain their physiological status and manage any symptoms that may occur. Created 
after the self-care of heart failure model, the self-care of HTN model includes the same 
two concepts, self-care maintenance and management. Maintenance refers to living a 
healthy lifestyle, adhering to the treatment regimen, and monitoring symptoms that may 
require decision making if a response is needed. Conversely, management is the 
deliberate process of action to recognize symptoms, evaluate the need to act, implement a 
treatment strategy, and evaluate treatment effectiveness (Riegel et al., 2009). As a chronic 
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disease, HTN includes a constellation of lifestyle alterations that require intermittent 
consultation with health care providers. Thus, clients are left to self-manage symptoms 
that arise and engage in decision-making and problem-solving to maintain their 
physiological status (Pascucci et al., 2010). Therefore, clients who are expertly engaged 
in self-care should possess qualities such as knowledge, experience, and skill relevant to 
their disease process (Riegel et al., 2009). 
Involving clients as active participants in self-care is a crucial aspect contributing 
to the success of HTN maintenance and management. As collaborators of care, health 
care providers must be abreast of current research on HTN interventions to assist clients 
toward positive health outcomes. Of all the self-care of HTN interventions, the one with 
the most evidence of effectiveness is simplification of the medication dosing regimen 
(Viera & Jamieson, 2007). Because most clients may require more than one medication 
for BP control, use of combination medications may be desired to improve client 
adherence to the medication-taking regimen (Chobanian et al., 2003; Viera & Jamieson, 
2007). Evidence has shown that education alone is not effective in improving client 
adherence to antihypertensive medications. However, dietary advice has shown modest 
short-term improvements in fat intake and fruit and vegetable consumption. Conversely, 
advice to increase physical activity has not shown effectiveness (Viera & Jamieson, 
2007). According to these evidence-based client self-care interventions for HTN, further 
research is warranted to determine mechanisms to enhance adherence to the treatment 
regimen, especially in Black women.  
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Finkelstein and Cha (2009) proposed an innovative study on HTN 
telemanagement in Blacks. This randomized clinical study used technology to implement 
client self-care, enhance health care provider decision support and care coordination 
using JNC 7 guidelines, improve client-provider communication, provide client 
education, control client adherence to individualized treatment regimens, counsel clients 
on healthy lifestyle, and provide social support. A BP monitoring device and weight scale 
are part of the telemanagement system. The system was designed to initiate alerts if the 
client does not complete scheduled self-testing, did not take medications as prescribed, or 
exceeded specified clinical parameter thresholds. A nurse monitored the system, 
contacted clients to counsel and educate and notified the physician of client events 
monthly and problem areas as needed. Pilot testing on focus groups has generated 
enthusiasm in participants. The potential impact of a multi-component telemanagement 
system could improve BP control in Blacks and provide better methods of monitoring 
client self-care.   
Trust in health care provider. Client trust is an essential element of the client and 
health care provider relationship that directly impacts adherence to the treatment regimen 
(P. A. Clark, 2009). According to Cox (2003), the content of the health care provider‘s 
interaction and sensitivity to the client‘s elements of singularity are evidenced by the 
client‘s satisfaction with care, which is strongly predictive of subsequent adherent 
behavior.  
As cited by several authors (Flack et al., 2010; Greer, 2010; Watkins & Terrell, 
1988), Blacks seem more apt to mistrust White health care providers. However, trust with 
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Black clients differs from White clients because Blacks generally consider health care 
providers as untrustworthy. Therefore, signals of distrust by Blacks may include 
behaviors such as anger (Watkins & Terrell, 1988), assertive behaviors that are 
oftentimes misinterpreted as attitudinal or militant (Fongwa, 2002), and request for the 
services of a Black health care provider (Flack et al., 2010; Greer, 2010; Watkins & 
Terrell, 1988).  
Lack of trust in health care providers hinders the establishment of a trusting 
client-health care provider relationship. Factors that may impede relationship 
development include health care disparities (Greer, 2010; L. M. Lewis & Ogedegbe, 
2008), multiple episodes of real and perceived racism or discrimination (Greer, 2010), 
and lack of health care provider cultural competency (Flack et al., 2010). This lack of 
trust may explain the Black client‘s lack of adherence with treatment, missed follow-up 
appointments (Flack et al., 2010; Greer, 2010; Watkins & Terrell, 1988), hesitance to 
accept referral appointments (Greer, 2010), failure to get prescriptions filled (Greer, 
2010), expectancy of poor treatment from White health care providers (Greer, 2010; 
Watkins & Terrell, 1988), and self-treatment behaviors in lieu of or in conjunction with 
medical treatment (Pound et al., 2005).  
Health care disparities revealed in research findings (B. D. Smedley, Stith, & 
Nelson, 2003) have confirmed suspicions of unequal treatment in healthcare and 
reiterated fear and distrust among many Blacks. Fear and distrust create a powerful 
motivating factor for nonadherent health behaviors. For example, the trust factor was 
illustrated in a qualitative study where one participant voiced concern that the health care 
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provider‘s office would call to remind of appointment times indicating wanting their 
business but would not follow-up to monitor their health status when new treatment was 
prescribed (Wexler et al., 2009). If a trusting relationship were apparent and the client felt 
the healthcare provider cared about their health status, then the study participant may 
have telephoned the health care provider to report any adverse effects from their 
treatment. When the lack of trust is present, it may negatively affect an individual‘s 
health behavior toward the health care provider and the prescribed treatment regimen.  
Disparate health care for Blacks and other racial/ethnic groups is well 
documented ("Unequal treatment", 2002). Because remnants of Black history continue to 
exist in subtle configurations, many Blacks approach health care with fear, skepticism, 
and caution (Gamble, 1997). Several studies cited distrust of the medical community as 
the rationale for nonadherent health behaviors (Lukoschek, 2003; Martins & Norris, 
2004; R. M. Peters et al., 2006). Many study participants were quick to mention the 
Tuskegee experiments and other perceived injustices experienced personally or by family 
members and friends. The reluctance to seek health care due to distrust in the medical 
system is oftentimes pervasive in the Black culture (R. M. Peters et al., 2006) and has 
contributed to significant health problems from nonadherence to treatment regimens 
(Fongwa et al., 2008; Wexler et al., 2009). Therefore, it is important that health care 
providers, along with Black clients, devise mechanisms to transcend the effects of 
history, restore trust in the health system, and overcome barriers to forming relationships 
to foster optimal health care.  
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According to a study conducted by Benkert, Hollie, Nordstrom, Wickson and 
Bins-Emerick (2009), nurse practitioners were found to have better trusting relationships 
with Black clients. However, study participants with higher trust and satisfaction were in 
concordant client-provider relationships. Further study findings revealed that Black men 
reported less satisfaction with care provided by nurse practitioners and were more 
suspicious of the health care system. Reasons for lack of trust in this study were not 
investigated (P. A. Clark, 2009). Consequently, several authors cited (Cooper & Powe, 
2004, July; Greer, 2010; Saha, Komaromy, Koepsell, & Bindman, 1999) that many 
Blacks prefer care and treatment from Black health care providers who they feel can 
identify with their plight in life. However, the shortage of Black health care providers 
leaves clients with little choice for health care providers of the same ethnicity (Cooper & 
Powe, 2004, July; Greer, 2010). 
Black clients who have experiences of perceived racism may mistrust other 
racial/ethnic groups, and this mistrust may filter into their relationship with the health 
care provider. A study conducted by Benkert, Peters, Clark, and Keves-Foster (2006) 
found that the majority of low-income, urban dwelling Blacks were fairly trusting of their 
healthcare providers and satisfied with the health care given. Trust was more likely to be 
higher in nurse practitioners and highest in nurse managed clinics, both of which were 
mostly women, than Asian providers and male physicians. However, negative effects of 
perceived racism on trust and satisfaction were evident. This study confirms that Blacks 
do experience an element of trust in their health care providers, but skepticism continues.  
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An attempt to reestablish trust in health care providers to foster the Black client‘s 
adherence to the health regimen is a major issue. Adherence centers on the ability of 
health care providers to establish a working (trusting) relationship with the client where 
both perspectives are fully understood (DiGiacomo, 2008) and prejudices, stereotypes, 
and other issues that may hinder the establishment of a working relationship are 
addressed. A good working relationship between the healthcare provider and client can 
facilitate medication adherence. According to Rand and Sevick (2000), the health care 
provider should work with the client to meet their needs in coping with issues that may 
interfere with adherence and allow them the autonomy they need to actively participate in 
the treatment process. Thus, an agreement between the client and health care provider 
implies a working relationship that allows a reciprocal exchange of information (Cox, 
1982), and contributes to an understanding of forces that shape client‘s lives.  
Health care providers need to understand the social, political, environmental, and 
economic influences that affect the health of clients and simulate rebellion, conflict, and 
mistrust in relationships with health care providers (Butterfield, 2002). Oftentimes, short-
term health interventions are not successful when ―band-aids‖ are placed on 
psychological or physiological symptoms rather than addressing the socioeconomic 
problem that contributed to client‘s health situation. Hence, times exist when health care 
providers must work to alter the systems that influence the health status of individuals 
and populations and empower groups and individuals to work on their own behalf 
(Butterfield, 2002). Clearly, trust is a major factor in medication adherence in Blacks. 
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Coping. Coping is the way an individual responds to stress or as described by 
Shorter-Gooden (2004), coping is a method of solving problems to reduce stress. 
According to McEwen and Seeman (1999), Black women frequently experience 
recurring stressors that overtax their coping skills. These stressors may include social 
confrontations of racism, poor income, sexism, and lower socioeconomic status. 
Conversely, Carlson and Chamberlain (2005) write that the more powerful predictors that 
activate the stress response are mental representations of individual expectations and 
interpretations of events, unlike previous beliefs that emphasize environmental stressors 
such as racism, sexism, and classism as reasons for variation in health outcomes, 
especially in Black women. Nevertheless, mental representations offer inadequate 
explanations for the realism of negative health outcomes resulting from stress related 
illness such as HTN. 
Coping with excessive stressors may contribute to allostatic load, defined as the 
persistent wear and tear on the body and brain, resulting in the inefficient turning-on or 
shutting-off of the autonomic nervous system. Repeated, unrelieved, or unremitting stress 
that occurs frequently over a long period of time causes illness that could affect almost 
every body system, especially, the cardiovascular system. Hence, constant stress may 
contribute to allostatic load and eventually lead to an allostatic overload that predisposes 
an individual to chronic diseases such as HTN (B. McEwen & Seeman, 1999; B. S. 
McEwen, 2005). Further, McEwen and Lasley (2003) noted that individuals with 
excessive stress tend to show earlier aging, more depression, insulin resistance, 
immunosuppression, cognitive impairment, and premature decline in physical 
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functioning. Researchers agree that stress affects quality life in Blacks with a strong 
relationship to HTN (Lehman et al., 2009; Schneider et al., 2001). Thus, coping with 
stress is important to understand in Blacks with HTN treatment adherence issues.  
According to James (1996), the legend of John Henry may explain how coping 
with difficult psychosocial environmental stressors increases the susceptibility of 
marginalized people to increased morbidity and mortality rates. Based on this folktale, 
there was a contest between a Black man named John Henry and a machine; he defeated 
the machine and suffered mental and physical exhaustion that resulted in death. James 
(1996) purports that John Henry symbolizes the relentless struggles of unskilled laborers 
in their effort to cope with psychosocial, economic, and environmental stressors that 
eventually erodes their health over time contributing to increased morbidity and 
mortality. High John Henryism in unskilled labors and its stress-related risks ignite 
coping mechanisms that interact with low socioeconomic status to increase the risk for 
HTN. Thus, low socioeconomic status is inversely associated with HTN. Because 
individuals with low income may be unable to afford medical care and purchase 
medication(s), nonadherence to the treatment regimen, including medications, may result. 
Thus, this unfortunate spiral of events could further complicate the HTN disease process 
and overtax coping mechanisms needed to deal with the resultant morbidity, disability, 
and eventual mortality that oftentimes occur. 
It is often difficult to explicate the psychological and physiological stressors that 
many Black women cope with in their daily lives. One term, double jeopardy, was first 
conceptualized by Beal (1969) as she addressed the plight of Black women in a capitalist 
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society that birthed racism in an attempt to maintain the oppression of Blacks. Jones and 
Shorter-Gooden (2003) describe the plight of Black women by using the metaphor of a 
childhood game called double dutch jump rope. Just as the game has two ropes, Black 
females have two identities, race and gender. The key to being skillful in the game is to 
focus on both ropes at the same time because focusing on one rope leads to stumbling. 
For Black women, race has been the primary concern, while the dualism of race and 
sexism presents a double jeopardy. Sexism is often unresolved leaving Black women 
with lower pay than coworkers, unreported sexual harassment, and treatment as second 
class citizens when compared to White women (Jones & Shorter-Gooden, 2003). Beal 
(1969) also addressed classism, thus adding a triple jeopardy to the identities assumed by 
Black women. Thus bias, prejudice, and/or discrimination because of one‘s race, sex or 
gender, and social or economic class may impart undue stressors on Black women that 
contribute to chronic diseases such as HTN. 
Affective response. Because health behavior cannot be explained fully with 
rational thought, cognitions should be analyzed together with emotional expression. 
Perceived racism and depression are types of affective responses explored. According to 
Cox (1982), affective responses can interfere with an individual‘s cognitive ability by 
serving as distractions to internal and external cues. Affective response could serve as a 
major deterrent to medication adherence in Black women with HTN.  
Perceived racism/discrimination. Interestingly, the term race originated as a 
means to perpetuate slavery by using physical features to create markers of social 
stratum. By inventing myths to portray Blacks as different, inferior, and less than human 
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savages, laws were enacted in this country to distinguish Black people as property on the 
same level with livestock and beast of burden (A. Smedley, 1997; Spillers, 1987). Thus, 
the race ideology originated as a social invention that lacked scientific support. 
Genetically, the DNA sequence in all people is 99.9% identical, making race 
indistinguishable ("Exploring genetics issues", 2003; A. Smedley, 1997). However, 
despite scientific evidence, remnants of the social stratum that distinguishes groups of 
people as unequal continue to exist (A. Smedley, 1997).  
The race category in the 2010 census questionnaire lists Black, African American, 
and Negro together as one group ("The 2010 census questionnaire", 2010). Oftentimes, 
many use the term Black as synonymous with the term African American. The term 
African American describes people who are descendants of slaves bought to the United 
States from Africa. On the other hand, Black is an inclusive term that describes the 
shared social and political culture of people that share physical traits such as skin color, 
hair texture, and distinct facial features (Barksdale, Farrug, & Harkness, 2009). Thus, 
Blacks may not be African Americans since Blacks include people who originated from 
other countries that may include the Caribbean, Central America, South America, 
Europe, and African. Neither the term African American or Black refers to a 
homogeneous group, but rather includes numerous subgroups with common physical 
traits (Barksdale et al., 2009; E. E. Davis & Huffman, 2007). The category Negro is 
rarely used except in a historical context and considered obsolete. Because this study 
does not specify the origin of descendants, the more inclusive term Blacks was used to 
reference the study population. 
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Since the Civil Rights movement, perceived racism and discrimination continue 
to be a significant source of stress (Pieterse & Carter, 2010) for Blacks. Considerable 
legislation was passed by congress during the Civil Rights movement to legally address 
segregated education, voting rights, employment discrimination, access to public housing 
(Byrd & Clayton, 2002) and segregated public places (Civil Rights Act, n.d.). Racial 
discrimination in all federally assisted programs such as Medicare and Medicaid was 
prohibited, and all hospitals who were recipients of federal funds were obligated to 
comply with civil rights legislation. While Blacks had access to hospitals throughout the 
nation during the 1970s and 1980s, health disparities continued to widen between Whites 
and racial/ethnic minorities, but the gap was more profound for Blacks (Gamble & Stone, 
2006). Still, in the year 2000, laws were enacted because of minority health inequalities. 
A profound statement by Martin Luther King, Jr. in 1966 still resounds with truth: ―Of all 
the forms of inequality, injustice in health care is the most shocking and most inhumane‖ 
(King, 1966, March). Unfortunately, inequalities in healthcare persist today for Blacks 
and other racial/ethnic groups despite the Civil Rights movement and legislative action. 
Research findings confirmed the perceptions of injustices and discrimination 
experienced by many Blacks in various health care situations. An extensive study 
("Unequal treatment", 2002) found that minority groups are less likely than Whites to 
receive needed services, procedures, and routine treatments for common health problems 
and diseases such as cancer, CVD, and diabetes. For example, cardiac care is one area of 
health care that consistently demonstrates disparity in health care access and delivery. 
When compared to Whites with similar clinical manifestations for CVD disease, Blacks 
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are less likely to receive pharmacological therapy (e.g. thrombolytic therapy), diagnostic 
angiography, heart transplantation, cardiac catheterization, and invasive surgical 
treatments (e.g. coronary bypass surgery) even when treatments and procedures are 
judged to be appropriate ("Unequal treatment", 2002). Equally perplexing is the strong 
link related to finances and access to cardiac care (Mayberry, Mili, & Ofili, 2002) that 
oftentimes result in discriminatory practices for poor people. It is also daunting to 
consider that discriminatory practices persist even in Blacks and other minority/ethnic 
groups who have the ability to pay for health care services (Kennedy, Mathis, & Woods, 
2007).    
Recognition of disparities in health care have been the impetus for local, state, 
federal, and private efforts to address this issue (Betancourt, 2009). Disparate health care, 
coupled with fear and distrust, have continued over the course of several centuries 
creating a powerful motivating factor for nonadherence and result in limited use of health 
care services and sicker presentations requiring emergency care (Rand & Sevick, 2000). 
Understanding the historical context of Blacks in this country provides some clues about 
nonadherent behaviors.  
One study with normotensive Black college students examined the relationship of 
BP responses to racially stressful and anger-provoking situations in a laboratory setting 
(Armstead, Lawler, Gorden, Cross, & Gibbons, 1989). Students were shown neutral, 
anger-provoking, and racist video segments and after each scene, their BP was taken and 
data tools were completed. Results revealed that racist stimuli increased BP more than 
anger-provoking stimuli. However, study participants who demonstrated higher anger 
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suppression had higher systolic BPs. Male and female participants differed in that the 
majority of females stated they respond to racism by holding their anger in whereas males 
were more likely to express their anger. Authors concluded that racism in society may 
contribute to the development of HTN (Armstead et al., 1989), especially in Black 
women. 
In a cross-sectional study of diverse middle aged women (Black, Hispanic, White, 
Japanese, and Chinese women), the association between perceived unfair treatment and 
HTN was examined (C. Brown, Matthews, Bromberger, & Chang, 2006). Black women 
reported the highest levels of perceived unfair treatment followed by Chinese women. 
However, results did not indicate a positive correlation between perceived unfair 
treatment and elevated BP. Similarly, findings in several studies (Barksdale et al., 2009; 
Benkert et al., 2006; S. K. Davis & Quarells, 2005; Peters, 2004, 2006) found no 
association between BP and perceived racism.    
The influence of racism on HTN was examined in a subgroup of women enrolled 
in the Black Women‘s Health Study (Cozier et al., 2006). The study indicated that Black 
women born outside the United States and those who grew up in predominantly White 
neighborhoods experienced positive associations between racism and HTN. However, the 
associations between racism and HTN were most evident in Black women born outside 
the United States, especially those from the Caribbean and Central and South America. 
Authors surmised that this observation may reflect cultural differences in encountering 
and responding to racism in the United States.   
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Another study examined the relationship of perceived racism and ambulatory BP 
in Black men and women during a typical work day. In addition to data collection 
instruments, study participant‘s BP was monitored for 24 hours with an ambulatory BP 
device. Perceived racism was related to increases in systolic and diastolic waking BP, 
while anger inhibition was related to increases in diastolic sleep BP (Steffen, McNeilly, 
Anderson, & Sherwood, 2003). Another study was conducted in a sample of Black and 
White men and women to examine everyday discrimination as related to nocturnal BP 
dipping whereby study participants were monitored for 48 hours with an ambulatory BP 
device. Participants in this study who reported more everyday discrimination 
demonstrated less systolic and diastolic BP dipping, a negative health outcome regardless 
of racial identification, and Blacks reported higher levels of everyday discrimination than 
Whites (Tomfohr, Cooper, Mills, Nelesen, & Dimsdale, 2010). In both studies, 
differences between men and women were not significantly different. A cross-sectional 
comparative study on perceived discrimination and HTN in older Black and White adult 
men and women provided support that perceived discrimination was associated with 
higher diastolic BP. Authors concluded that discrimination may cause adverse effects on 
BP levels in Blacks (T. T. Lewis et al., 2009)  
The issues surrounding HTN are complex with multiple causes for the widening 
health disparity that results in disproportionate mortality rates. However, the exact 
mechanism responsible for the negative physiological and psychological health outcomes 
remains unclear. Research studies continue to reveal conflicting results concerning the 
relationship between perceived racism and HTN. Thus, elimination of racial disparities in 
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Blacks with HTN will substantially decrease the number of deaths from CVD. Equitable 
treatment and access to adequate resources could facilitate better control of HTN for 
Blacks and contribute to improved treatment adherence (Fiscella & Holt, 2008; Fongwa 
et al., 2006).  
Depression. There is an old myth that depression is rare for Blacks, especially 
Black women (Fakhruddin, Woolridge, & Khan, 1975; Jones & Shorter-Gooden, 2003). 
Because depression is oftentimes camouflaged in Black women, it may not be physically 
detected due to a confident, tough appearing exterior (Jones & Shorter-Gooden, 2003). In 
addition, depression may not be easily identified on standardized instruments because 
perceptions of depression are different in Black women who often complain of feeling 
tired or stressed out. Jones and Shorter-Gooden (2003) describe depression in Black 
women as the loss of self or loss of one‘s identity whereby self is silenced, as opposed to 
typical depression that is precipitated by an external loss such as death or a job. In a 
qualitative study on depression and violence (Nicolaidis et al., 2010), Black women 
echoed these descriptions of depression. Participants described depression as a mask, 
oppressiveness on the inside, and as a strong Black woman on the outside and breaking 
down on the inside. According to Duckworth (2009), the avoidance of emotions among 
Black women originated during slavery as a survival technique that has now evolved into 
a cultural habit. Traditionally, Blacks have not sought treatment because depression is 
perceived as a personal weakness as opposed to a health problem. When treatment is 
sought, misdiagnosis frequently occurs. Therefore, health care providers may need 
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additional training to appropriately screen Black women for depression (Schoenthaler, 
Ogedegbe, & Allengrante, 2009).  
Similarly, Cooper et al. (2003) conducted a telephone survey that included Whites 
(n=659), Blacks (n=97) and Hispanics (n=73) on the acceptability of depression 
treatment. The study found that Blacks and Hispanics were less likely than Whites to 
think that antidepressant medication was acceptable treatment for depression. The odds of 
finding counseling acceptable as a treatment option were significantly higher for 
Hispanics and lower for Blacks when compared to Whites. In additions, Blacks were 
more likely to believe that prayer may help heal depression and stated a preference for a 
health care provider of the same race. This study supports the premise that Blacks have 
different beliefs about depression and treatment modalities, and that health care providers 
should address sociocultural considerations in Black clients when negotiating the 
depression treatment regimen. 
While the pattern of depression in Black women is not fully understood, there 
appears to be a strong link between depression and HTN (Read & Gorman, 2007). In a 
cross-sectional study conducted by Patten (2001) on the Canadian National Population 
Health Survey data (N=11,859), HTN was associated with an elevated risk of major 
depression in men, but not women. In contrast, a study of Black men with HTN and 
substance abuse revealed that depression was not significantly correlated with BP, but 
those with higher depression scores were not likely to adhere to antihypertensive 
medication and dietary regimens (M. T. Kim, Han, Hill, Rose, & Roary, 2003). In 
another study conducted by Schoenthaler et al. (2009) with Blacks who have HTN, poor 
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medication adherence was associated with depressive symptoms and younger age. More 
importantly, increases in depressive symptoms are associated with lower odds of 
antihypertensive medication adherence (Wang et al., 2002). Similarly, in a qualitative 
study conducted by Fongwa et al. (2008), depressed clients ruminated about things they 
could not change and failed to follow the prescribed treatment regimen. Clearly, these 
studies show that depression is associated with medication adherence. 
A systematic review of studies published from 2002-2009 (Eze-Nliam, Thombs, 
Lima, Smith, & Ziegelstein, 2010) was conducted on eight research studies (44 reviewed) 
that met the inclusion criteria to assess the association between depression and adherence 
to antihypertensive medications. Study results found varied adherence rates ranging from 
29% to 91%. Although all studies reported statistically significant relationships between 
depression and nonadherence to antihypertensive medications, six studies also reported at 
least one statistically insignificant result dependent on the statistical analysis (bivariate 
versus multivariate) and the type adherence or depression measure (such as dichotomous 
or continuous) used in the specific analysis. Heterogeneity between studies was related to 
various assessments of depression, how adherence was defined and measured, and 
methods employed to assess the relationship between depression and adherence. Another 
concern was the range of study participants (167 to 496 and one study had 40,492). These 
inconsistencies within and between studies resulted in the inability to draw definitive 
conclusions. Even though the link between depression and antihypertensive medication 
nonadherence is probable, the limitations of existing evidence in this review could not 
conclude the degree to which depression is associated with antihypertensive medication 
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nonadherence. Therefore, further research is warranted to objectively assess and clarify 
the relationship between depression and medication nonadherence.  
Interaction of Background and Dynamic Variables 
The elements of client singularity (background and dynamic variables) reflect 
holism and individuality of the client‘s interaction within their own social, physical, and 
psychological environment (Cox, 1986). In the IMCHB, explanatory relationships are 
postulated between client singularity and resultant health behaviors of clients. 
Background variables are relatively static and interact cumulatively, simultaneously, and 
oftentimes interdependently with each other to create behaviors that impact health 
outcomes (Cox, 1982, 1986). For example, a client‘s lower educational status 
(demographic characteristics) along with established cultural practices (social influence) 
and lack of financial resources for health care (environmental resources) will likely 
predict a different set of health outcome behaviors than one variable alone (Cox, 1982).  
Unlike background variables, dynamic variables are not static and therefore, are 
more readily affected by interventions (Cox, 2003). Hence, background variables serve as 
precursors for dynamic variables (Cox & Roghmann, 1984). For example, a client with 
limited income, no health insurance (environmental resources), and ongoing edema in the 
lower extremities secondary to HTN (previous health care experience), may decide 
(intrinsic motivation) to self-treat (cognitive appraisal) because of perceived 
racism/discrimination (affective response), thus contributing to distrust in the health care 
provider (cognitive appraisal) and forgoing follow-up medical evaluation and treatment 
(Cox, 2003). Like background variables, dynamic variables may exert an influence on 
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one another. For example, a client with longstanding HTN diagnosed with acute renal 
failure may experience intense fear of permanent kidney failure with hemodialysis 
(affective response). This fear may cause the client to increase his or her knowledge base 
of acute renal failure (cognitive appraisal) and lead to a self-determination to seek 
evaluation and abide by the treatment regimen in an effort to stay well (intrinsic 
motivation), thus reducing the client‘s anxiety (affective response).  
The elements of client singularity represent a holistic view of the client‘s internal 
and external self. Without an assessment of these elements, health care providers literally 
operate without the essential knowledge necessary to establish therapeutic relationships 
and successfully evaluate client behavioral and health outcomes. Thus, research including 
background and dynamic variables are essential in explaining health behaviors and could 
be strong determinants of heath behaviors, such as medication adherence, and subsequent 
health outcomes.   
Element of Health Outcome 
Adherence to the Recommended Health Regimen 
The health outcome of interest in this study is adherence to the recommended 
health regimen, specifically medication adherence in Black women with HTN. The health 
outcome is a reflection of the client‘s behavior and results in either positive or negative 
health outcomes.  
Medication adherence. According to Cox (2003), adherence describes the extent 
to which a client engages in behaviors or treatments necessary for optimal health 
outcomes. Although many variables may contribute to a client‘s health care outcome, 
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Cox and Wachs (1985) state that it is not the contributing variables, but the client‘s free 
choice, that impact health outcomes. This study examined selected client singularity 
variables that contribute to client behaviors that may influence medication adherence in 
Black women with HTN. 
Medication adherence in Blacks with HTN. One study (N=60) found a method 
to maximize medication adherence by providing free medication and comprehensive 
HTN care to low-income clients, and included 77% Black, 71% female, and mean age of 
47 years, with known barriers such as poor accessibility, expensive follow-up care, costly 
medications, poor client education, and complex medication regimens (Applegate et al., 
2000). Three physicians, internal medicine residents, pharmacist, pre-doctoral clinical 
psychology graduate students, registered nurse, and BP technician staffed a clinic that 
operated two afternoons weekly. During the initial clinic visit, a chart review and 
physical examination were conducted. In addition, laboratory work or procedures were 
done to rule out secondary HTN. All clients were treated or referred as necessary to 
specialty clinics, but only primary HTN clients were included in the data analysis. 
Treatment included antihypertensive medications according to JNC 7 guidelines that 
were individualized according to the client‘s response to treatment, side effects, and 
tolerability. Follow-up for each client was bi-weekly for the first four months to stabilize 
the BP, monitor side effects, establish health care provider-client relationship, and stress 
the importance of monitoring BP control. Clients were seen within one week if perceived 
or real problems occurred from medications and between four to six weeks after 
stabilization of BP. At each visit, BP checks, medication education, medication-taking 
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strategies, physical examination by same health care provider, assessment of 
nonadherence to the medication regimen and corrective action, and encouragement was 
provided. To foster follow-up appointments, only enough medication was dispensed to 
last to the next appointment, thus free medication was contingent on appointment 
keeping. Although appointment keeping was high (83%), those who missed appointments 
were telephoned the next day and scheduled for the next clinic. Study results revealed 
significant drops in systolic (mean of 25mm Hg) and diastolic BP (mean of 13 mm Hg) 
from baseline to six-month post-enrollment. Study participants meeting the criteria for 
JNC 7 controlled HTN increased from 12% to 63% during the study period. Individual 
client needs were addressed through intensive management with the provision of free 
medications, consistency in health care providers, relationships with providers, and HTN 
medication education. The results of this study prompted health care providers at this 
clinic to establish broader free-medication programs for other chronic illnesses. Although 
this study did not have a control group for comparison, it provides strong evidence that a 
multidisciplinary, multifaceted approach to successful medication adherence may be 
warranted.   
Another research study on medication adherence and appointment-keeping 
behavior was conducted in a sample of Blacks with HTN (N=153), 87% women and a 
mean age of 52 years  (G. Ogedegbe, Schoenthaler, & Fernandez, 2007). Although 
appointment-keeping may be used as a signal of medication adherence, the study results 
were not significant, thus concluding that medication adherence should not be equated 
with appointment-keeping. One reason why study participants did not keep appointments 
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could relate to the high unemployment rates in the majority of participants (77%) that 
may have resulted in an inability to afford transportation. Of the participants who missed 
scheduled appointments, one-third continued to take their medications according to 
participant self-report which may be indicative of an overestimation of adherence. 
In a study conducted by Fernandez, Chaplin, Schoenthaler, and Ogedegbe (2008), 
the Medication Adherence Self-Efficacy Scale (MASES) was tested and revised in 
Blacks with HTN (N=168), 86% female, and a mean age of 54 years, along with the 
Morisky self-report medication adherence scale at baseline and at three months; and the 
electronic medication event monitoring system (MEMS) at three months. Results 
revealed that MASES scores were higher for participants who self-rated as adherent when 
compared to those who self-rated as nonadherent. In addition, the MASES and MEMS 
were positively correlated with statistical significance. Preliminary data from this study 
support the validity and reliability of the MASES tool for use in similar samples.   
Several research studies investigated medication nonadherence. Shea, Misra, 
Ehrlich, Field and Francis (1992) found in a sample of Hispanic and Black subjects 
(N=202), 44% male, and average age of around 57, that there was an association between 
medication nonadherence and use of the emergency room for HTN care and lack of a 
primary care physician. In addition, younger age was significantly associated with 
nonadherence. Stanton (1987) purports that when the BP remains inadequately controlled 
over the course of treatment, nonadherence is the problem and not the therapeutic 
regimen. Fongwa, Evangelista, and Doering (2006) concurred that HTN can be controlled 
with current advances in medical treatment.  However, access to health care, health 
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behaviors (smoking, alcohol, diet, overweight/obesity, and inactivity), lack of social 
support, knowledge, and clinical management may influence adherence behaviors 
(Fiscella & Holt, 2008; Fongwa et al., 2006; Stanton, 1987). Interestingly, Munger, 
Tassell, and LaFleur (2007) contend that medication nonadherence could be recognized 
as a cardiovascular risk factor. 
Research presented at the 2008 American Heart Association Scientific Sessions 
suggests that caring behaviors of health care providers influence adherence to prescribed 
treatment and therapy. A 12-month randomized controlled trial was conducted on 
hypertensive Blacks (N=256), 80% women, with mean age of 58, who were taking at 
least one antihypertensive medication and had uncontrolled BP. The study evaluated 
whether a client education intervention with a workbook enhanced with positive affect 
and self-affirmation inductions with bi-monthly telephone calls was more effective than a 
control group with client education in improving medication adherence assessed by 
electronic pill monitors and BP control. Significantly greater BP control was noted in the 
positive affect and self-affirmation inductions group (59%), as compared to the client 
education group (34%) (G. O. Ogedegbe et al., 2008). This study was effective in helping 
clients to affirm positive feelings while reducing negativity surrounding their health 
through self-affirmation and the caring phone calls of health care providers. 
Medication adherence in Black women. There is a paucity of literature that 
primarily addresses medication adherence issues in Black women with HTN. In a 
literature review, one qualitative study (Fongwa et al., 2008) and one scholarly article 
(Fongwa et al., 2006) focused exclusively on adherence treatment factors in Black 
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women with HTN. Because Black women have the highest prevalence of HTN in the 
world (Roger et al., 2011), this lack of research is daunting. Undoubtedly, a dearth of 
information on medication adherence in Black women with HTN represents a significant 
gap in the literature that warrants further research (Fiscella & Holt, 2008; Fongwa et al., 
2006; Fongwa et al., 2008).  
Of the medication adherence studies found, men, older adults, or mixed samples 
of both men and women and diverse racial/ethnic groups with various disease processes 
such as HTN, CVD, stroke, heart failure, cancer, and HIV were noted. Because heart 
disease is the leading cause of death for women > 65 years of age (Roger et al., 2011), a 
concentrated amount of literature was found on older adult women with heart disease. In 
contrast, the literature does not produce the same volume for Black women who suffer a 
disproportionate burden of mortality, disability, and morbidity from HTN related 
complications (Roger et al., 2011).  
A number of qualitative studies (Fongwa et al., 2006; Fongwa et al., 2008; L. M. 
Lewis et al., 2010; Lukoschek, 2003; G. Ogedegbe, Harrison, Robbins, Mancuso, & 
Allegrante, 2004; R. M. Peters et al., 2006; Webb & Gonzalez, 2006; Wexler et al., 2009) 
were found in the literature on medication adherence/compliance issues in Blacks, but 
these studies did not address the specific concerns of Black women. However, these 
qualitative studies do shed light on the many reasons for nonadherence to the prescribed 
treatment regimen, such as low income, lack of health insurance, low educational level, 
perceived racism, and lack of trust in the health care provider. The primary reason for 
qualitative research is to listen to those who ―may be in despair, who may have given up, 
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or who do not have access‖ (Munhall, 2007, p. 20). Further, qualitative studies solicit the 
attention of health care providers, researchers, and policy makers to hear the cry of 
individuals who want to tell their story and give understanding to their world by 
―revealing what had been concealed‖ (Munhall, 2007, p. 11).  
The current qualitative literature provide a holistic view of major issues that may 
impact medication adherence issues in Blacks with HTN, and one qualitative study was 
exclusively centered on Black women and HTN treatment factors. Although national data 
have revealed alarming statistics on the high prevalence rates of HTN in Black women 
(Roger et al., 2011), no quantitative studies were found that focused exclusively on Black 
women with HTN and problems with medication adherence. Undoubtedly this paucity of 
research on medication adherence in Black women with HTN denotes a significant gap in 
the literature that warrants further study (Fiscella & Holt, 2008; Fongwa et al., 2006; 
Fongwa et al., 2008).  
Summary 
Primarily, this study focused on the extent to which client singularity (background 
and dynamic variables) predicted medication adherence outcomes in Black women with 
HTN. To understand health outcomes, it is imperative that health care providers have 
insight into the individual client‘s background (age, education, religion, family history of 
HTN, comorbidities, number of medications, BP, BMI, income, and type of health 
coverage) and dynamic variables (HTN knowledge, self-care of HTN, trust in health care 
provider, coping, perceived racism, and depression) and their influence on client health 
care behaviors, such as medication adherence. The interplay of these variables provide 
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understanding and insight into the processes necessary for development of appropriate 
nursing and other discipline specific interventions (Cox, 1986). Thus, the IMCHB is a 
valuable framework to explain the need for health care providers to address the client‘s 
unique background and dynamic variables in an effort to achieve positive health 
behaviors, such as medication adherence, especially in Black women. 
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CHAPTER III 
METHODS
 
Introduction 
Chapter three described the methodology used to study medication adherence in 
Black women with hypertension (HTN). Included is a description of the research design, 
setting, sample, protection of human subjects, instruments, procedures, and the plan for 
data analysis. Lastly, the limitations of the study are addressed.  
Design 
A cross-sectional, correlational design was used for this non-experimental 
research study. In a cross-sectional design, data are measured on one occasion with the 
goal of describing variables or examining associations among variables (Newman, 
Browner, Cummings, & Hulley, 2007). For instance, a cross-sectional design allows the 
collection of all measurements from participants at one time point to describe their health 
status and examine pertinent issues that may influence medication adherence. Because 
this study does not examine changes in medication adherence over time, a cross-sectional 
design was deemed appropriate. 
With correlational design, this study examined the relationship or association 
between variables that are not manipulated (Gliner & Morgan, 2000; Vogt, 2005). 
Because none of the independent variables (perceived racism, trust in health care 
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provider, HTN knowledge, coping, and reactance) could be ethically manipulated, the 
correlational design was acceptable for this study. 
Setting 
Participants were recruited from various settings with a majority of Black 
members or clients, such as churches, hair salons, and community events in the Piedmont 
region of North Carolina. Using a variety of settings assisted in obtaining an adequate 
and heterogeneous sample of adult Black women ages 18-60 who are taking 
antihypertensive medications. After volunteers contacted the principal investigator (PI) 
indicating their willingness to participate in the study, informed consent was obtained, 
and data were collected in a quiet private setting agreeable to the participant that included 
their home or another preferred location.  
Sample 
A non-probability convenience sample of community dwelling Black women 
were recruited for this study. Inclusion criteria included: (a) ages ranging from 18 to 60 
years, (b) taking one or more prescription medication(s) for HTN, and (c) English 
speaking. Exclusion criteria included self-report of: (a) mental illness that interferes with 
daily functioning, (b) current pregnancy, and (c) concurrent participation in another 
research study.   
Recruitment methods included flyers (see Appendix A) posted on bulletin boards, 
publicized at meetings, distributed directly to potential participants, and circulated to 
targeted community members or leaders in various Black churches, businesses such as 
hair salons, and community events. Follow-up telephone calls and face-to-face meetings 
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with business owners, pastors and community leaders occurred as needed to aid 
recruitment efforts (Ellish, Scott, Royak-Schaler, & Higginbotham, 2009; Watson & 
Torgerson, 2006). In addition, study participants were obtained by snowball sampling and 
social nomination.  
Flyers contained a brief description of the study, the PI‘s name, and local 
telephone number. If interested in participating in the research study, potential 
participants contacted the PI and if they are unable to access a cellular or landline 
telephone, contact information was sent to the PI through the referral person. After an 
explanation of the study and providing answers to any questions, eligibility requirements 
were determined. Arrangements were made to individually meet with study participants 
in a quiet location for written consent (see Appendix B) and completion of data collection 
tools.  
Using an adaptive algorithm to compute power (Efird, 2007), a priori power 
analysis was conducted to determine the sample size needed to answer the research 
questions for this research study. Using the exact discrete-event (proportional odds 
model), a sample size of 80 was required to detect a minimal relative importance score 
(RIS) of 4.5 (alpha of 0.05) with a power of 80% (Efird, 2007).  
Human Subjects Protection 
The approval for this study (see Appendix C) was obtained from The University 
of North Carolina at Greensboro Institutional Review Board (IRB). No other permissions 
were obtained except from individual study participants.   
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The purpose of this study was fully explained to all participants. To avoid issues 
related to literacy, the consent form, written at a fifth grade reading level and all forms 
were read to participants by the PI unless participants choose to self-administer. After all 
questions were addressed, the consent form was signed indicating voluntary participation 
prior to collecting data. Study participants received a copy of the consent form with a 
verbal and written statement of their right to withdraw from the study at any time without 
negative consequences. 
Precautions were taken to eliminate risks to confidentiality on all data collection 
forms and computer files by using non-identifiable or random number codes to identify 
participants instead of names or other identifiable information. The master key of study 
participant‘s names and identification numbers were kept separately from the data 
collection forms and securely locked in a file cabinet accessible only to the PI and faculty 
sponsor. The data collection forms were also kept in a separate locked file cabinet in the 
PI‘s office.       
Instruments 
Data were collected using 10 self-report instruments: (a) the investigator 
developed Demographic Data Tool, (b) Hill-Bone Compliance to High Blood Pressure 
Therapy Scale, (c) Therapeutic Reactance Scale, (d) High Blood Pressure Prevention IQ, 
(e) Self-Care of Hypertension Index, (f) Trust in Physician Scale, (g) John Henryism 
Active Coping Scale, (h) Index of Race-Related Stress-Brief Version, (i) Patient Health 
Questionnaire-9, and (j) the Marlowe-Crowe Social Desirability Scale. 
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Demographic Data Tool  
The Demographic Data Tool (see Appendix D) was developed by the PI to collect 
information not addressed on the other instruments and important in describing the 
sample. The tool included information such as socioeconomic status (education, income, 
and occupation), medical history, health care coverage, housing/living arrangements, and 
transportation. In addition, measured data recorded on this tool included blood pressure 
(BP), height, weight, and waist circumference. 
The Hill-Bone Compliance to High Blood Pressure Therapy Scale  
The Hill-Bone Compliance to High Blood Pressure Therapy Scale (Hill-Bone 
CHBPTS) (see Appendix E) was designed to assess medication compliance. Because 
adherence reflects the conceptual basis for this study, the term adherence was 
interchanged with the term compliance throughout this study. The Hill-Bone CHBPTS is 
a 14 item assessment tool with three subscales: (a) reduced sodium intake, 3-items; (b) 
appointment keeping, 3-items; and (c) medication taking, 8-items. Responses are scored 
on a 4-point Likert scale (1=none of the time, 2=some of the time; 3=most of the time, 
and 4=all the time). According to the authors (M.T. Kim et al., 2000), one or more of the 
subscales may be used for research. For this study, the medication taking subscale was 
chosen to assess medication taking behavior plus one item that addressed prescription 
refills. Adding this one question is consistent with the use of this tool in the literature 
(Hill et al., 1999; M. T. Kim et al., 2003; M.T. Kim et al., 2000; Krousel-Wood et al., 
2008). The minimal medication taking score is 9 and the maximum score is 36. Lower 
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scores reflect medication adherence behaviors and higher scores reflect nonadherence. 
Item #6 was reverse scored before analysis.  
Included in the Hill-Bone CHBPTS is the four-item Medication Adherence Scale 
(MMAS) developed by Morisky et al. (Hill et al., 1999; Morisky, Green, & Levine, 
1986). In the initial Morisky et al. (1986) study, the Cronbach‘s alpha for the MMAS 
(0.61), and concurrent validity between the MMAS and controlled BP were established (r 
= 0.58; p < 0.01). Data from the study indicated that 33% of the variance in BP was 
accounted for by medication adherence (R² = 0.33; p = <0.01). According to Morisky 
(1986), the MMAS is reliable, valid, and has reasonable predictive ability with BP. The 
sample in the original study was 91% Black, 70% female, with a median age of 54 years 
and a median 8
th
 grade educational level (Morisky et al., 1986).       
In a study conducted by M. T. Kim, Han, Hill, Rose, & Roary (2003) with Black 
males, ages 18-55 years, the Cronbach‘s alpha for the Hill-Bone CHBPTS for medication 
compliance subscale was acceptable at 0.77, and for the total scale was 0.75. Using five 
nurses and two physicians who specialized in BP clinical research and practice as a panel 
of experts, content validity was established (M.T. Kim et al., 2000).   
The Therapeutic Reactance Scale  
The Therapeutic Reactance Scale (TRS) (see Appendix F) is a is a 28-item self-
reported inventory designed to measure the psychological trait, reactance (Dowd et al., 
1991). Responses are scored on a 4-point Likert scale (1=strongly disagree, 2=disagree, 
3=agree, and 4=strongly agree). In the initial study conducted by Dowd (1991), a sample 
of 130 undergraduate college students in their early 20s and composed of mostly women 
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(75%) were participants in a test-retest design using 112 items in each session. A total of 
28-items out of 112 remained after item-total correlations and factor analysis. A two 
factor solution (labeled verbal and behavioral) accounted for 26% of the total variance 
with a correlation of 0.37 between the factors. Over three weeks, test-retest reliability 
ranged from 0.57 to 0.60. Cronbach‘s alpha ranged from 0.75 to 0.84 on the initial testing 
and were acceptable levels (Dowd et al., 1991). The minimum score is 28 and the 
maximum score is 112 with higher scores reflecting greater reactance. Eight items are 
reversed scored. 
The High Blood Pressure Prevention IQ  
The High Blood Pressure Prevention IQ (HBPPIQ) (see Appendix G) is a 12-item 
questionnaire designed to measure BP knowledge for laypersons ("Check your high 
blood pressure", 1994). The HBPPIQ uses true-false questions to assess comprehension 
of HTN. In a study conducted by Martins, Gor, Teklehaimanot, and Norris (2001), 397 
Blacks and over half female (63%), aged 18 to 73 years, were surveyed. The total score 
on the HBPPIQ was calculated from the percentage of correct responses and the mean 
score for this sample was 83% indicating a high level of HTN knowledge. No 
psychometric properties were found for this measure. To evaluate this test, validity (face 
and content) and reliability (Cronbach‘s alpha) methods were employed. 
The Self-Care of Hypertension Index  
The Self-Care of Hypertension Index (SCHI) (see Appendix H) is a new 24-item 
tool designed to measure naturalistic decision-making that reflects an individual‘s choice 
of behaviors in the maintenance and management of their BP. The SCHI is adapted from 
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the self-care of heart failure model and consists of three subscales: self-care maintenance, 
management, and confidence. Each subscale stands alone to describe the study sample. 
Therefore, no total score exists and each subscale is standardized to a score of 100 for 
comparability purposes. Responses are scored on a 4-point Likert scale (never or 
rarely=1, sometimes=2, frequently=3, and always or daily=4). The self-care maintenance 
scale of the SCHI has 12 items, and both the management and confidence scales have six 
items. The SCHFI has a cut-point score of 70 or greater indicating self-care adequacy on 
the maintenance and management scales. Although confidence influences self-care, it is 
not part of the self-care process (Riegel et al., 2009).  
According to V. V. Dickson (personal communication, December 5, 2010), 
preliminary Cronbach‘s alphas for the SCHI three subscales were good to acceptable 
(maintenance, 0.78; management, 0.56; and confidence, 0.85), but more data are needed 
to determine validity. In addition, the correlation of the maintenance scale with the 
medical outcomes study (MOS) specific adherence survey was 0.71 (p = .0000). Data 
from this study will contribute to the psychometrics of the SCHI.  
The Trust in Physician Scale  
The Trust in Physician Scale (TPS) (see Appendix I) is an 11-item instrument 
designed to measure client‘s interpersonal trust in their primary health care provider 
(Anderson & Dedrick, 1990). Responses are scored on a 5-point Likert scale (1=strongly 
disagree, 2=disagree, 3=neutral, 4=agree, and 5=strongly agree). ―Neural‖ was not used 
as a response item. The minimal score is 11 and the maximal score is 55 with higher 
scores reflecting greater trust. Four items are reverse scored.  
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Two studies were conducted initially to generate and analyze items and to 
examine the validity and reliability of the TPS. The TPS was tested first in a male sample 
of 160 veterans who were 56% White, with a mean age of 55 years. A second study 
followed with 106 veterans, 62% White, with a mean age of 61 years. In the initial two 
studies, Cronbach‘s alpha for the TPS ranged from 0.85 to 0.90 (Anderson & Dedrick, 
1990). The scale has demonstrated construct validity as evidenced by positive 
correlations with the Multidimensional Health Locus of Control indicating the client‘s 
desire of control and satisfaction in clinical interactions (Anderson & Dedrick, 1990). In 
a study conducted by Freburger, Callahan, Currey, and Andersen (2003), the TPS was 
tested with a majority female sample (77%), 86% White, and a mean age of 60 years. The 
Cronbach‘s alpha was 0.87 in this study with mostly women indicating comparable 
reliability with previous studies of all male samples.       
The John Henryism Active Coping Scale  
The John Henryism Active Coping Scale (JHACS) (see Appendix J) is a 12-item 
assessment tool designed to measure three mutually reinforcing themes of efficacious 
mental and physical vitality, strong commitment to hard work, and determination to 
achieve goals in life (James, Strogatz, Wing, & Ramsey, 1987). Responses are scored on 
a 5-point Likert scale (1=completely false, 2=somewhat false, 3=don‘t know, 
4=somewhat true, and 5=completely true). ―Don‘t know‖ was not used as a response 
item. The minimum score is 12 and the maximum score is 60. High and low JHACS 
scores are determined by a median split of total scale scores. Scores are recorded as high 
(above the median) or low (below the median) to reflect coping characteristics of the 
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study group (James, 1996; James et al., 1987). In a study conducted on Black and White 
men and women (James et al., 1987), the Cronbach‘s alpha for all participants was 0.72, 
and the Cronbach‘s alpha for Black women was 0.71.  
According to James (1996), JHACS is most appropriate for individuals aged 18 to 
60 because at age 18, active coping increases in intensity as employment and career goals 
become more defined. However, by age 60 active coping begins to taper as employment 
and career goals decrease in intensity. Because this tool is important in answering the 
research questions, the age group of 18 to 60 was included in this study.  
The Index of Race-Related Stress-Brief Version  
The Index of Race-Related Stress-Brief Version-B (IRRS-B) (see Appendix K) is 
a multidimensional questionnaire designed to measure stress experienced by Blacks who 
have racist encounters (Utsey, 1999). The IRRS-B was adapted from the original 46-item 
IRRS in an effort to address time constraints and geographically specific questions. 
Supported by exploratory and confirmatory factor analysis, the IRRS-B was reduced to 
22-items and three subscales: (a) cultural racism, 10-items; (b) institutional racism, 6-
items; and (c) individual racism, 6-items, omitting the collective racism subscale. 
Responses are scored on a 5-point Likert scale (0=this has never happened to me, 
1=event happened but did not bother me, 2=event happened and I was slightly upset, 
3=event happened and I was upset, and 4=event happened and I was extremely upset). 
Scores of global racism or total scale result by converting each subscale score to z scores 
before summing the scores of each subscale. The Z scores are necessary because the 
IRRS-B has an unequal number of items in each subscale and weighting the subscales 
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allows an equal distribution of each subscale to the Global Racism score. Higher scores 
indicate greater perceived racism than lower scores (Utsey, 1999).  
In a study conducted by Utsey (1999), the 22-item questionnaire was tested on a 
sample of 239 Black male (n=78) and female (n=138) college students, substance abuse 
program clients, and an area community along with a subsample of Whites (n=25). 
Gender data were missing for 23 study participants. Using multivariate analysis of 
variance, successful discrimination of the IRRS-B was noted between Blacks and Whites 
with significantly higher scores by Blacks on all subscales indicating criterion-related 
validity. Convergent validity was supported by moderate correlations (r = 0.33-0.59) 
between the IRRS-B subscales and the Racism and Life Experience Scale-Revised 
subscales. The IRRS-B Cronbach‘s alpha was reported for cultural (0.78), institutional 
(0.69), and individual racism (0.78) subscales.  
The Patient Health Questionnaire-9  
The Patient Health Questionnaire-9 (PHQ-9) (see Appendix L) is a nine-item tool 
to identify depressive symptoms and the severity of depressive symptoms in the previous 
2-week period. As part of the PHQ designed to screen for five of the most common 
mental disorders, the PHQ-9 reflects the DSM-IV criteria for depressive disorders. 
Responses are scored on a 4-point Likert scale (not at all=0, several days=1, more than 
half the days=2, and nearly every day=3). The minimal score is 0 and the maximal score 
is 27 (Kroenke et al., 2001). A score of 0-4 represents no depressive symptoms, 5-9 
represents minimal depressive symptoms, 10-14 represents minor depressive symptoms, 
15-19 represents moderately severe depressive symptoms, and 20-27 represents severe 
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depression symptoms. Any person scoring 5 to 9 were classified as having minimal 
symptoms of depression, while scores of 10 to 14 were classified as possibly clinically 
significant, and scores of 15 to 19 and 20 to 27 were classified as warranting active 
treatment (Spitzer, Williams, & Kroenke, n.d.). An additional item at the end of the tool 
addressed problem areas checked on the questionnaire: ―How difficult have these 
problems made it for you to do your work, take care of things at home, or get along with 
other people‖ (Kroenke et al., 2001; Spitzer, Kroenke, & Williams, 1999)? 
In a study conducted at eight primary care sites, the PHQ-9 was used to screen 
3000 clients for depressive symptoms and other mental disorders. Clients had a mean age 
of 46 (range 18-99) and the majority were White (79%) and female (66%) with HTN 
(25%) as the most common physical disorder. With 585 of the 3000 participants, criterion 
validity was demonstrated by agreement between the PHQ-9 and the diagnosis of a 
mental health professional (MHP) who was blinded to the PHQ-9 results. The correlation 
between the PHQ-9 and the MHP was 0.84. The sensitivity of the PHQ-9 was 73% and 
specificity 98% with and overall accuracy of 93% (Kroenke et al., 2001).  
In another study (Spitzer et al., 1999), 3000 clients from five general internal 
medicine and three family medicine clinics and 3000 clients from seven obstetrical-
gynecology sites completed the PHQ-9 and the 20-item Short-Form General Health 
Survey (SF-20), a measure of functional status in six domains. Study participants in the 
medicine clinics had a mean age of 46 (±17), and the majority were White (79%) women 
(66%), while the obstetrical-gynecology participants were all women (100%) with a 
mean age of 31 (±11), and the majority were White (39%) and Hispanic (39%). The 
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PHQ-9 Cronbach‘s alpha was 0.86 in the medicine clinic participants and 0.89 in the 
obstetrical-gynecology participants. Likelihood ratio increased as PHQ-9 scores 
increased indicating an association between higher PHQ-9 scores and the likelihood of 
major depression symptoms. The PHQ-9 correlated strongest with the mental health 
domain of the SF-20 at 0.73.  
The Social Desirability Scale  
The Marlowe-Crowe Social Desirability Scale (M-C 1[10] SDS) (see Appendix 
M), short form, is a 10-item instrument designed to measure socially appropriate 
responses to self-report measures or an individual‘s need for approval by responding in a 
manner they perceive the investigator desires (Crowne & Marlowe, 1960; Strahan & 
Gerbasi, 1972). The M-C 1(10) SDS was adapted from the 33-item Marlowe-Crowe 
Social Desirability Scale (M-C SDS) in an effort to reduce respondent burden. This scale 
uses true-false questions whereby higher scores reveal the tendency to provide socially 
desirable answers.  
According to Crowne (1960), the initial study revealed a Kuder-Richardson 
formula 20 (K-R 20) reliability coefficient of 0.88 in a sample of 10 male and 29 female 
undergraduate students who were 19-46 years of age. In a study conducted by Strahan 
and Gerbasi (1972) to form a new scale with fewer items, a sample of 176 non-college 
and college males and 185 college and university females were tested. Three new shorter 
versions of the M-C SDS were developed, the M-C 1(10), M-C 2(10), and the M-C (20). 
The number of items in each scale is listed in parenthesis. Of the shorter scales, the M-C 
1(10) was deemed slightly superior because reliability coefficients were similar across 
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diverse samples when compared to the M-C 2(10), thus, the M-C 1(10) was used for this 
study. Correlations between each new scale and the M-C SDS were in the 0.80s and 
0.90s. For the M-C 1(10), the K-R 20 reliability coefficient ranged from 0.59 and 0.70 for 
non-college and college males and was 0.61 and 0.66 for college and university females 
(Strahan & Gerbasi, 1972). 
Procedures 
All potential participants were informed of the study through one or more 
mechanisms that included flyers, announcements, or social nomination. Those interested 
provided their contact information to the PI by telephone message, electronic mail, or 
referrals indicating interest in the research study. The PI responded by contacting the 
individual via telephone or other means such as electronic mail, and face-to-face 
meetings to provide more information about the study and ensure they meet the inclusion 
criteria. All questions regarding the study were answered, and if the individual met the 
inclusion criteria and agreed to participate in the study, an appointment was made to 
conduct an interview for data collection. On the day before the interview, the PI made 
contact with each individual to confirm the interview time and place. The PI individually 
met with each study participant to get informed consent and to collect data in a quiet 
location chosen by the participant, either their home or another preferred location.  
At the interview, the PI briefly explained the purpose of the research and the data 
collection process. The PI read the entire consent form while asking individuals to read 
along with the researcher. Reading the consent form prevented any issues of illiteracy 
that may affect participation and cause embarrassment (Waltz, Strickland, & Lenz, 2005). 
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After all questions were answered, each participant was asked to sign the consent form 
indicating their voluntary consent to participate in the research study. The signed copy 
was retained by the PI and an unsigned copy was given to the participant for their 
personal records.   
After the informed consent was obtained, each participant was assigned an 
identification number with a designated folder for their data tools. The study participant‘s 
BP, height, weight, and waist circumference were measured. Using a standard 
sphygmomanometer on participants who had been seated for at least five minutes, two 
consecutive BP readings were taken in their dominant arm with one minute between 
measurements (Pickering et al., 2005). Both BP readings were recorded and analyzed as 
BP 1, BP 2, and the average of the two measurements (Chobanian et al., 2003). 
According to JNC 7 (Chobanian et al., 2003), the PI adhered to the following protocol if 
the BP was elevated: (a) stage 1 HTN (BP 140/90-159/99 mm Hg), suggest follow-up 
with health care provider within 2 months; (b) stage 2 HTN (BP greater than or equal to 
160/100 mm Hg), suggest follow-up with primary health care provider within one month; 
and (c) hypertensive emergency (BP greater than or equal 180/110), call 911 or have 
someone transport the participant to the nearest emergency department for immediate 
treatment (Chobanian et al., 2003). Each study participant was given their BP reading 
verbally and in writing along with BP educational materials (American Heart 
Association, 2009; Preventive Cardiovascular Nurses, 2010)  at the completion of data 
collection. 
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A portable platform Seca 813 electronic scale was used to measure weight with 
measurements to the nearest 0.1 kilogram. Height was measured using a portable Seca 
217 stadiometer with measurements to the nearest 0.1 centimeter and was converted to 
height in meters by dividing height in centimeters by 100. Weight and height data were 
used to calculate the body mass index (BMI) using the metric system formula, weight in 
kilograms divided by height in meters squared also express as weight (kg) / [height (m)]
2
. 
The BMI parameters were categorized as underweight (<18.5 kg/m
2
), normal weight 
(18.5 to 24.9 kg/m
2
), overweight (25-29.9 kg/m
2
), and obesity (greater than or equal to 30 
kg/m
2
) ("BMI classification", 2010; "Calculate your body mass index", n.d.). With a 
Gulick tape measure (which included a mechanism to ensure consistent tension when 
measuring), waist circumference was measured to the nearest 0.1 cm by circling a soft 
tape measure around the waist at the top of the iliac crest and slightly above the level of 
the umbilicus from the ―0‖ end of the tape to the intersection of the waist measurement 
number. The participant stood in an upright position without sucking in the abdomen 
while the tape was pulled taut without squeezing into the skin. Waist circumference body 
fat of more than 35 inches (89 cm) for women and more than 40 inches (102 cm) for men 
increases the risk of heart disease (Heaner, n.d.; Rhoads & Kim, 2009). 
After anthropometric measures, the PI inspected all prescribed and over-the-
counter medications the participant had used during the past two weeks preceding the 
interview. Direct visualization of all medications allowed for accurate documentation of 
medication names, dosages, and time frequencies for administration. In addition, direct 
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visualization minimized embarrassment if names of medications were not known or 
pronounced correctly.  
Depression is often unrecognized and therefore not treated, especially in Black 
women (Artinian, Washington, Flack, Hockman, & Jen, 2006). The treatment 
recommendations for the PHQ-9, a screening tool for depression, include: (a) scores of 5 
to 9=minimal symptoms of depression, suggesting support; (b) scores of 10 to 14=minor 
depression symptoms and is possibly clinically significant, suggesting support, watchful 
waiting, and/or active treatment (antidepressant or psychotherapy) if dysthymia or mild 
major depression; (c) scores of 15 to 19=moderately severe major depression symptoms, 
suggesting active treatment; (d) scores of 20 to 27=severe major depression symptoms, 
suggesting active treatment of both antidepressant and psychotherapy ("The patient 
health questionnaire", 2009); and (e) if suicide ideations are detected, call 911 or have 
someone transport the participant to the nearest emergency department for immediate 
treatment (Spitzer et al., n.d.).  
Participants were asked to answer questions on the 10 self-report instruments: (a) 
the investigator developed Demographic Data Tool, (b) Hill-Bone Compliance to High 
Blood Pressure Therapy Scale, (c) Therapeutic Reactance Scale, (d) High Blood Pressure 
Prevention IQ, (e) Self-Care of Hypertension Index, (f) Trust in Physician Scale, (g) John 
Henryism Active Coping Scale, (h) Index of Race-Related Stress-Brief Version, (i) 
Patient Health Questionnaire-9, and (j) the Marlowe-Crowe Social Desirability Scale. 
There was a strong possibility that some study participants may not be able to 
read because of illiteracy or low literacy skills (Flack et al., 2010; Waltz et al., 2005). In 
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an effort to be sensitive to participants with illiteracy or low literacy skills and ensure 
consistency of data collection, the PI read all instruments to each participant in an 
interview style unless the participant chose to self-administer. This process helped to 
prevent embarrassment and ensure clarity and understanding of the questions. Directives 
were given prior to the administration of each tool. When instruments had Likert scale 
responses, the scale was provided to participants as a visual aid during the interview. 
Respondent fatigue was addressed by alternating the various types of scales, keeping the 
participant‘s interest by rotating between dull and interesting questions, and controlling 
the number of questions. In addition, participants were offered a break to prevent fatigue 
during data collection. No known burdens were place on participants. Each data 
collection session lasted approximately 45 to 60 minutes.  
After completion of the data collection tools, the PI thanked participants for their 
time and effort. Participants were given $15 cash as a token of appreciation for their time 
and effort along with their BP reading and BP education materials from the American 
Heart Association and Preventive Cardiovascular Nurses Association. Overall results of 
the research study will be shared with participants upon request while ensuring 
confidentiality of individual responses.  
Data Analyses  
Descriptive statistics were used to describe the demographic characteristics of the 
sample population. The Shapiro-Wilk test was used to assess normality of all independent 
variables (Norusis, 2008). In addition, all continuous data had calculated means, ranges, 
standard deviations, frequencies, skewness, kurtosis, and graphic plots to examine the 
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distribution and cause of nonnormal data. Differences in adherent and non-adherent 
participants‘ demographic characteristics were analyzed using the t-test for normally 
distributed continuous variables (age, mean systolic and mean diastolic BP, and BMI). 
The Mann-Whitney U test was used for non-normally distributed continuous variables 
(number of medications), and cross-tabulations with Chi-Square test was used for 
categorical variables (education and type of health coverage). Cronbach‘ alpha was 
calculated for each instrument. All descriptive statistics were analyzed with SPSS 
(version 19.0.0) software. 
The Fisher‘s exact test was used to examine the significance of association 
(contingency) between background and dynamic variables on medication adherence in 
place of a phi correlation coefficient because data were sparse. A semi-parametric 
regression procedure, exact discrete-event (proportional-odds) model, was used to 
examine the association between a set of predictor variables and an ordinal scale outcome 
variable. Statistical analysis for the Fisher‘s exact test and the exact discrete-event 
(proportional-odds) model was conducted with SAS (version 9.1.3) software.  
Spearman rank-order correlation (Spearman rho) was used to describe the linear 
relationship between reactance and the outcome variable, medication adherence that was 
measured on an ordinal scale. Statistical analysis for Spearman rho was conducted with 
SPSS (version 19.0.0) software. 
Data Analysis for Specific Aims 
The specific aims and associated questions were outlined for data analysis.  
 
109 
1. Describe Black women who adhere to antihypertensive medication treatment and 
those who do not adhere.  
Q1: Are there differences in background variables (age, education, religion, 
family history of HTN, comorbidities, number of medications, BP, BMI, income, 
and type of health coverage) in Black women who adhere to antihypertensive 
medication treatment as compared to Black women who do not? 
Basic descriptive statistics were used to answer this research question. Descriptive 
statistics included the mean, standard deviation, and range to summarize background 
variables. Percentage frequency distributions described nominal and categorical data 
variables. The t-test was used to investigate differences in background variables between 
sub-groups in the sample, such as adherent and nonadherent participants. 
2. Examine the influence of background variables (age, education, religion, family 
history of HTN, comorbidities, number of medications, BP, BMI, income, and type of 
health coverage), and dynamic variables (HTN knowledge, self-care of HTN, trust in 
health care provider, coping, perceived racism, and depression) on medication 
adherence in Black women with HTN.  
Q2. Are the background variables (age, education, religion, family history of 
HTN, comorbidities, number of medications, BP, BMI, income, and type of 
health coverage) and dynamic variables (HTN knowledge, self-care of HTN, trust 
in health care provider, coping, perceived racism, and depression) associated with 
medication adherence in Black women with HTN?  
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Q3. Do the background variables (age, education, religion, family history of HTN, 
comorbidities, number of medications, BP, BMI, income, and type of health 
coverage), and dynamic variables (HTN knowledge, self-care of HTN, trust in 
health care provider, coping, perceived racism, and depression) predict 
medication adherence in Black women with HTN on an ordinal scale? 
The Fisher‘s exact test was used to answer research question 2. The Fisher‘s exact 
test examines the significance of association (contingency) between background and 
dynamic variables on medication adherence. The procedure follows a hypergeometric 
distribution under the null hypothesis of independence with fixed margins and is 
frequently used in place of a phi correlation coefficient when data are sparse (Bower, 
2003; Huck, 2008). Fisher‘s exact test does not rely on normality assumptions and uses 
the exact distribution instead of a normal approximation (Polit, 1996).  
Exact discrete-event (proportion odds model) was used to answer research 
question 3. A semi-parametric regression procedure, exact discrete-event (proportional-
odds) model, was used to examine the association between a set of predictor variables 
and an ordinal scale outcome variable. Similar to a log-binomial or Poisson regression 
model, the adjusted relative effect size of association, referred to as the relative 
importance score (RIS), was computed by exponentiating the regression beta-coefficient 
for the variable of interest (Breslow & Day, 1980). The adjusted RISs determine the 
contribution each independent variable makes in combination with other independent 
variables in predicting the value of the dependent variable. The higher scores represent 
the importance of the dimension (LeBreton & Tonidandel, 2008; Sachdev & Verma, 
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2004). The ordinal outcome for this study, medication adherence, used a four-point Likert 
scale with ordered categories (1=never, 2=some of the time, 3=most of the time, and 
4=all of the time). This study built a model to describe the relationship between the 
outcome variable medication adherence and the predictors, background variables (age, 
education, religion, family history of HTN, comorbidities, number of medications, BP, 
BMI, income, and type of health coverage), and dynamic variables (HTN knowledge, 
self-care of HTN, trust in health care provider, coping, perceived racism, and depression).  
3. Explore the relationship between reactant behaviors and antihypertensive medication 
adherence and in Black women. 
Q4. Is there a relationship between reactant behaviors and medication adherence 
in Black women with HTN? 
Spearman rho was used to answer this research question. The correlation between 
reactance and medication adherence was examined to determine the strength and 
direction of the relationship. Both variables were rank ordered to compute the 
Spearman‘s correlation coefficient (Polit, 1996). If a relationship existed between the two 
variables, reactance and medication adherence, Spearman rho, determined the strength of 
that relationship. The Spearman rho correlation coefficient ranged from -1.00 to +1.00. A 
positive or negative correlation indicates a linear relationship between two variables and 
zero shows no relationship between the variables (Polit, 1996). 
Limitations 
The limitations of this study deserve recognition. Study participants were in the 
18-60 age group, thus restricting the ability to study medication adherence issues in older 
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adults with HTN. A convenience sample from various settings with a majority of Black 
members or clients such as churches, hair salons, and community events provided a self-
selected group who volunteered in response to recruitment efforts. Instrumentation is a 
limitation because using self-report measures can introduce personal bias into the study. 
Hence, the subjective nature of the instruments may not accurately reflect client 
behaviors. In addition, those who agreed to be study participants may differ from those 
who declined as well as differ from those in other parts of the country. Thus, the results 
of this study may only be generalized to this study sample because random sampling was 
not used. Lastly, changes over time cannot be assessed since this is a cross-sectional 
study that examines one point in time using a nonprobability sample of Black women 
with HTN (Vogt, 2005).    
Summary 
This study was conducted to examine medication adherence in Black women with 
HTN and the relationship of HTN knowledge, self-care of HTN, trust in health care 
provider, coping, perceived racism, and depression using a cross-sectional, correlational, 
non-experimental design. This study also described the differences within the sample 
population studied and explored the relationship between reactant behaviors and 
medication adherence. Black women with a diagnosis of HTN were recruited from 
various communities in the Piedmont region of North Carolina. Approval from individual 
participants and the IRB of The University of North Carolina at Greensboro was 
obtained. The PI collected and analyzed all data for this research study.  
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CHAPTER IV 
RESULTS 
 
Introduction 
Chapter four includes the results of the statistical analyses. First, the final sample 
is described in detail. Then the outcomes of study data, instrument testing, and an 
analysis of each research question are examined. Lastly, several different models are 
explored based on initial study findings. 
Sample 
Participants were recruited by distributing flyers in settings with a majority of 
Black members or clients, such as churches, hair salons, and community events in the 
Piedmont region of North Carolina. In addition, snowball sampling or social nominations 
were employed. The principal investigator (PI) provided potential participants with 
detailed information regarding the study via telephone or face-to-face. A total of 87 
persons were contacted by the PI, and three did not meet the eligibility requirement 
because two did not take antihypertensive medications, and one was over the age of 60. 
Four people did not return the PI‘s telephone call when contact was made from 
information provided by social nomination. Thus, 80 persons comprised the sample. All 
data were collected by the PI in one session lasting approximately 45 to 60 minutes. The 
majority of participants completed the interview at their private residence (n=52), while 
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others completed the interview at the home of a family member (n=11), friend (n=7), 
their place of employment (n=5), the PI‘s home (n=3), or their church (n=2).      
Preliminary Examination of Data 
Data for research questions 1 and 5 were analyzed by using the International 
Business Machines Statistical Package for the Social Sciences (IBM SPSS) software, 
version 19.0.0 and research questions 2, 3, and 4 were analyzed by using the Statistical 
Analysis Software (SAS) version 9.1.3. Nine instruments required scores to be 
calculated. Each instrument‘s author provided scoring guidelines to calculate scale totals. 
To check for internal reliability, Cronbach‘s alpha statistic was computed for each 
instrument and selected subscales. Cronbach‘s alpha values are an indication of scale 
reliability, whereby values of .70 or higher are considered to be acceptable, and values of 
.60 or higher are marginally acceptable (Gliner & Morgan, 2000). Only those scales with 
alpha values of .60 or higher were retained for further analysis. Scores were unacceptable 
to excellent and ranged from .026 - .920 (see Table 1).  
The reliability of all subscales was reported. Both the Hill-Bone sodium intake 
and appointment-keeping subscales had low Cronbach‘s alphas, but neither was used in 
data analysis. Only the outcome variable, represented by the Hill-Bone medication 
subscale was used in data analysis, and the Cronbach‘s alpha was good (.843). The High 
BP Prevention IQ Scale had the second lowest Cronbach‘s alpha of .067. The 
questionnaire measured different types of knowledge (heredity, symptoms, stress, weight, 
physical activity, diet, and alcohol) relative to high blood pressure, and the response 
pattern was inconsistent indicating that while participants knew some things about HTN, 
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knowledge was limited in other areas. The Self-Care of Hypertension Index management 
subscale also had a low Cronbach‘s alpha of .491. This subscale was applicable to 34 of 
the 80 participants who reported trouble controlling their blood pressure in the past 
month. Again, the response pattern was inconsistent as participants did not answer 
similarly in how they managed their blood pressure. Lastly, the Therapeutic Reactance 
total scale and behavioral subscale had acceptable Cronbach‘s alphas, while the verbal 
subscale had low Cronbach‘s alpha related to a variance in participants‘ response pattern 
consistency. 
All data were checked for accuracy. Frequencies were run on all variables to 
check for missing data and extreme values. There were no missing data, however, outliers 
were consistently found in most of the variables of study. The majority of the variables in 
this study were discrete with the exception of age, blood pressure (BP), and body mass 
index (BMI). Income was coded as a categorical valuable. Outliers were noted in each of 
the continuous variables except the mean diastolic BP. To limit outlier influence, 
variables not previously categorized were divided into quartiles prior to statistical 
analysis (Mertler & Vannatta, 2010; Vogt, 2005). Because outliers do not follow the 
normal distribution, statistical models that do not require distribution assumptions, such 
as nonparametric and semiparametric models, were used for data analyses. Although 
nonparametric models avoid restrictive assumptions of normality, they may yield difficult 
interpretations and inaccurate estimates for a large number of regressors. However, 
semiparametric models combine components of both parametric and nonparametric 
models while retaining the flexibility of nonparametric models and providing the easy 
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interpretation of parametric models (Hardle, Muller, Sperlich, & Werwatz, 2004). Thus, 
nonparametric and semiparametric models were ideal statistical models for data analyses. 
 
Table 1  
 
Internal Reliability of Instruments 
 
 Instrument  Cronbach‘s Alpha 
 
Hill-Bone Compliance to High BP Pressure Therapy 
Scale (14 items) 
     Medication taking subscale (9 items) 
     Reducing sodium intake subscale (3 items) 
     Appointment keeping subscale (2 items) 
 
 
.740 
.843 
.598 
.026 
John Henryism Active Coping Scale (12 items) 
 
.645 
Patient Health Questionnarie-9 (9 items) 
 
.845 
Index of Race-Related Stress-Brief Version (22 items) 
     Cultural racism subscale (10 items) 
     Institutional racism subscale (6 items) 
     Individual racism subscale (6 items) 
 
.920 
.886 
.749 
.809 
Trust in Physician Scale (11 items) 
 
.835 
High BP Prevention IQ (12 items) 
 
.067 
Self-Care of HTN Index (No total score) 
     Maintenance subscale (12 items) 
     Management subscale (6 items) 
     Confidence subscale (6 items) 
 
NA 
.694 
.491 
.790 
Therapeutic Reactance Scale (28 items) 
     Behavioral subscale (17 items) 
     Verbal subscale (11 items) 
 
.724 
.685 
.550 
Marlowe-Crowne Social Desirability Scale (10 items) .641 
 
Note. HTN=hypertension; BP=blood pressure. 
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Sample Demographics 
The sample was comprised of 80 Black women who were taking antihypertensive 
prescription medications. Over half of the participants were not married (56%) and had a 
single, divorced, or widowed status. Ages ranged from 19 to 60 with a mean age of 47.8 
(SD ± 9.2). The majority of the sample was employed (67%), physically inactive (89%), 
overweight/obese (88%), and had a history of smoking (54%). Table 2 provides 
categorization of demographic data and risk factors.  
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Table 2 
 
Sample Demographic Statistics and Risk Factors (N=80) 
 
Background variables N (%)* 
Marital Status 
     Single (Never Married)  
     Married  
     Separated  
     Divorced 
     Widowed  
 
 
22 
26 
  9 
16 
  7 
 
 
(27) 
(33) 
(11) 
(20) 
  (9) 
 
Employment Status 
     Employed 
     Unemployed/Disabled 
     Retired 
 
54 
24 
  2 
 
 
(67) 
(30) 
  (3) 
Family History of HTN  75 (94) 
 
Physically Inactive
a
 
      
71 
 
(89) 
 
Overweight/Obese
b
 
     Overweight
b
 
     Obese
b
 
 
70 
10 
60 
(88) 
(13) 
(75) 
Smoker (current or past) 43 (54) 
 
Drink Alcohol 
  
23 (29) 
 
Note. *percentages rounded. 
HTN=hypertension. 
a
Less than recommended levels of moderate intensity physical activity for 30 minutes at 
least 5 times per week.  
b
BMI for: Overweight = 25-29.9 kg/m
2
; Obese = ≥ 30 kg/m
2
. 
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Cox’s Interaction Model of Client Health Behavior Variables 
The adapted Cox interaction model of client health behavior (IMCHB) consisted 
of two major elements, client singularity (background and dynamic variables) and health 
outcome (See Figure 3). Descriptive statistics in the form of percentages or means and 
standard deviations are displayed for the background variables (see Table 3), dynamic 
variables (see Table 4), and the health outcome, medication adherence (see Table 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Conceptual Guide to Predict Black Women‘s Medication Adherence Behaviors. 
Adapted from the interaction model of client health behavior (Cox, 2003).  
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Table 3 
Cox Interaction Model of Client Health Behavior: Background Variables (N=80) 
Background Variables Mean (±SD) or N (%) Median Possible Range 
Age   47.8 (± 9.2)   50.0 19 - 60 
Comorbidities     2.8 (± 1.6)     2.0   1 - 9 
Number of Medications     5.1 (± 3.6)     4.0   1 - 18 
BP 
     SBP Mean 
     DBP Mean 
 
135.2 (±19.8) 
  81.3 (±12.6) 
 
134.5 
  81.5 
 
99 - 209 
51 - 114 
 
BMI 
     Subscales: 
         Underweight  
            (<18.5 kg/m
2
) 
         Normal Weight 
            (18.5-24.9 kg/m
2
) 
         Overweight  
            (25-29.9 kg/m
2
) 
         Obesity  
            (≥ 30 kg/m
2
) 
 
  36.8 (±10.4) 
 
       1 (1) 
 
       9 (11) 
 
     10 (13) 
 
     60 (75) 
 
  35.8 17 - 69 
Weight  
     Kilograms 
     Pounds 
 
  
  97.7 (±27.7) 
214.9 (±60.9) 
 
  96.0 
211.2 
 
43 - 165 
95 - 363 
Waist Circumference 
     Centimeters 
     Inches 
     <89 cm 
     >89cm 
 
107.5 (±18.5) 
  42.3 (±  7.3) 
     14 (18) 
     66 (83) 
 
 
106.0 
  41.7 
 
71 - 152 
28 - 60 
 
(continued)
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Table 3 (continued)  
 
Cox Interaction Model of Client Health Behavior: Background Variables (N=80) 
 
Background Variables N (%)* 
Education 
     Less than 12
th
 Grade 
     High School Graduate   
     GED or Equivalent 
     Some Community College  
     Graduated Community College 
     Some 4-year College 
     Graduated 4-year College 
     Some Graduate School 
     Completed Graduate School 
     Completed Trade or Vocational 
        School 
 
13 
16 
  1 
11 
  6 
  5 
10 
  2 
  6 
10 
 
 
(16) 
(20) 
  (1) 
(14) 
  (8) 
  (6) 
(12) 
  (3) 
  (8) 
(12) 
 
Religion 
     Baptist 
     Christian 
     Non-denominational 
     African-Methodist Episcopal Zion 
     Other 
 
57 
  7 
  6 
  5 
  5 
 
(71) 
  (9) 
  (8) 
  (6) 
  (6) 
Family History of HTN 
     Yes 
     Unsure 
 
75 
  5 
 
(94) 
  (6) 
Income 
     Less than $10,000 
     $10,000 to $14,999 
     $15,000 to $19,999 
     $20,000 to $24,999 
     $25,000 to $34,999 
     $35,000 to $44,999 
     $45,000 to $54,999 
     $55,000 to $64,999 
     $65,000 to $74,999 
     $75,000 to $99,999 
     $100,000 and Over 
     Refused 
 
15 
  4 
10 
  8 
10 
12 
  6 
  6 
  3 
  3 
  2 
  1 
 
(18) 
  (5) 
(12) 
(10) 
(12) 
(15) 
  (8) 
  (8) 
  (4) 
  (4) 
  (3) 
  (1) 
Type of health coverage 
     Through Work 
     Medicaid/Medicare/Veteran 
     Uninsured 
 
 
46 
20 
14 
 
(57) 
(25) 
(18) 
Note. *percentages rounded 
BP=blood pressure; SBP=systolic blood pressure; DBP=diastolic blood pressure; 
BMI=body mass index; HTN=hypertension.
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Table 4 
Cox Interaction Model of Client Health Behavior: Dynamic Variables (N=80) 
Dynamic Variables Mean (±SD) Median Range 
 
Possible 
Range 
 
Therapeutic Reactance Scale    
 
     Subscales: 
         Verbal 
         Behavioral 
66.8 (±  7.0) 
 
 
29.7 (±  3.3) 
37.1 (±  5.1) 
67.0 
 
 
30.0 
37.0 
    46 - 85 
     
 
    20 - 38 
    21 - 47 
 
28 - 112 
 
 
11 - 44 
17 - 68 
High BP Prevention IQ 65.2 (±10.2) 
   
66.7 
 
    33 - 92  
 
 0 - 100 
Self-Care of HTN Index    
 
     Subscales: 
         Maintenance 
         Management*  
         Confidence 
 
 
 
45.9 (±14.7) 
42.3 (±20.6) 
60.7 (±19.0) 
 
 
 
47.2 
41.7 
61.1 
 
 
 
    14 - 78 
      6 - 89 
    17 - 100 
 
 
 
 
  0 - 100 
  0 - 100 
  0 - 100 
 
Trust in Physician Scale  
 
43.9 (±  6.3) 45.0     20 - 55 11 - 55 
John Henryism Active 
Coping Scale  
 
50.4 (±  5.1) 
 
 
51.0 
 
    31 - 59 
 
12 - 60 
Index of Race-Related 
Stress-Brief Version  
Global (Z-scores) 
 
     Subscales: 
         Cultural  
         Institutional  
         Individual 
 
     
   
      0 (± 2.6) 
 
 
23.4 (±  9.7) 
  7.7 (±  5.9) 
12.6 (±  6.0) 
 
   
0.21 
 
 
25.0 
  6.0 
13.0 
 
 
-4.93 - 6.04 
   
   
      2 - 40 
      0 - 23 
      1 - 24 
 
      
     - 
 
 
  0 - 40 
  0 - 24 
  0 - 24 
Patient Health 
Questionnarie-9  
 
 6.9 (±   5.4) 
 
 6.0 
 
      0 - 27 
 
  0 – 27 
 
Note. * n=34. 
BP=blood pressure; HTN=hypertension. 
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Table 5 
Cox Interaction Model of Client Health Behavior: Health Outcome Elements (N=80) 
Health Outcome Element Mean (±SD) Median Range Possible 
Range 
 
Hill-Bone Compliance to High 
BP Therapy Scale  
     Subscale: 
        Medication 
           Taking (Adherence) 
        Reducing  
           Sodium Intake  
        Appointment 
           Keeping  
 
  22.7 (±5.0) 
 
 
  13.1 (±4.2) 
 
    6.5 (±1.9) 
 
    3.1 (±1.2) 
 
  23.0 
 
 
  12.5 
 
    6.0 
 
    3.0 
 
15 - 43 
   
 
  9 - 33 
 
  4 - 12 
 
  2 - 6 
 
14 - 56 
    
 
  9 - 36 
 
  3 - 12 
 
  2 - 8 
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Research Question #1  
Are there differences in background variables (age, education, religion, family 
history of HTN, comorbidities, number of medications, BP, BMI, income, and type of 
health coverage) in Black women who adhere to antihypertensive medication treatment 
as compared to Black women who do not? 
The medication subscale of the Hill-Bone Compliance to High Blood Pressure 
Therapy Scale (Hill-Bone CHBPTS) has a 4-point Likert scale ranging from a minimal of 
9 (perfect adherence) to a maximum of 36 (perfect nonadherence). Medication subscale 
scores were used to determine adherent and nonadherent groups. The adherent group 
consisted of 20 (25%) participants (score of 9) and the nonadherent group consisted of 60 
(75%) participants (score 10-36).  
Both groups were analyzed in relation to antihypertensive medication adherence 
or nonadherence and background variables associated with adherence. The Shapiro-Wilk 
test was used to assess normality (Norusis, 2008) of independent variables. In addition, 
calculated means, ranges, standard deviations, frequencies, skewness, kurtosis, and 
graphic plots were analyzed on all continuous data to assess distributions. The results of 
the Shapiro-Wilk test indicated that there were no significant differences in the DBP (p = 
.495) and BMI (p = .215). This was suggestive of a normal distribution allowing use of 
the independent sample t-test (Gliner & Morgan, 2000; Polit, 1996) to determine if there 
was a significant difference between the adherent and nonadherent antihypertensive 
medication groups. Because the sample size was not equal, Levene‘s test (Polit, 1996) for 
homogeneity of variance was conducted, and there was no significant difference in the 
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variance of the adherent group and the nonadherent group for the mean DBP (F = .405, p 
= .526) and BMI (F = .061, p = .806). The independent samples t-test failed to reveal a 
statistically reliable difference between the groups for the DBP and BMI (see Table 6).   
The distribution of the variables age, SBP, comorbidities, and number of 
medications were not normal. Because there was evidence of nonnormality, a two-tailed 
Mann-Whitney U-test (Gliner & Morgan, 2000) was used to investigate differences 
between the adherent and nonadherent groups. The Mann-Whitney U-test revealed no 
significant differences between the adherent and nonadherent groups for age, SBP, 
comorbidities, and number of medications (see Table 6). 
To assess whether there were differences in the adherent and nonadherent 
antihypertensive medication groups on the background variables (education, religion, 
family history of HTN, income, and type of health coverage), a Chi-squared analysis was 
conducted to compare the groups (Huck, 2008) and no significant difference was noted in 
the adherent and nonadherent antihypertensive medication groups.  
In summary, there were no significant differences in the background variables 
(age, education, religion, family history of HTN, comorbidities, number of medications, 
BP, BMI, income, and type of health coverage) of Black women who adhered to 
antihypertensive medication treatment as compared to Black women who did not adhere 
(see Table 6).  
 
 
 
 
126 
Table 6 
 
Group Differences in Background Variables  
 
Variable Mean ±SD or N(%) 
 
P value of difference 
Adherent 
(n=20) 
Nonadherent 
(n=60) 
 
Age 51.15 ± 7.38 46.70 ± 9.51 .072
b 
 
Education 
   High School or less 
 
 5 (25) 
 
25 (41.7) 
 
 
 
   More than High  
   School   
 
15 (75) 
 
35 (58.3) 
 
.182
c
 
 
Religion 
   Baptist 
 
15 (75) 
 
 
42 (70) 
 
   All Other   5 (25) 
 
18 (30) .669
c
 
Family History of HTN 
   Yes 
 
18 (90) 
 
57 (95) 
 
 
 
   No   2 (10) 3 (5) .424
c 
 
Comorbidities 2.75 ± 1.33 2.82 ± 1.75 .788
b 
 
Number of Medications  
5.45 ± 3.59 
 
4.97 ± 3.59 
 
.564
b 
 
SBP1 and SBP2     132.55 ± 14.44 136.02 ± 21.32 
 
.714
b
 
DBP1 and DBP2 78.70 ± 11.73 82.15 ± 12.83 .291
a 
 
HTN during study 7 (35) 27 (45)  
   ↑ SBP1 and SBP2 7 (35) 23 (38)  
   ↑ DBP1 and DBP2 4 (20) 19 (32) 
 
 
 
(continued) 
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Table 6 (continued).  
 
Group Differences in Background Variables 
 
Variable Mean ± SD or N(%) 
 
P value of difference 
 Adherent 
(n=20) 
Nonadherent 
(n=60) 
 
 
BMI 
 
37.95 ± 11.31 36.38 ± 10.21 
 
.564
a 
 
Income 
   <20,000 
 
8 (40) 
 
21 (35) 
 
   ≥20,000 - <35,000 3 (15) 15 (25)  
   ≥35,000 - <55,000 6 (30) 12 (20)  
   ≥55,000 2 (10) 12 (20)  
   Refused               1 (5) 0 (0) 
 
.258
c
 
Type of Health 
Coverage  
    Through Work 
 
 
 
            13 (65) 
 
 
      33 (55) 
 
    Medicare,  
    Medicaid, or  
    VAMC 
 
 
 
3 (15) 
 
 
17 (28.3) 
 
   Uninsured 
 
4 (20) 10 (16.7) .491
c
 
Note. p-values were obtained by different tests.  
a
t tests for continuous normally distributed variables. 
b
Mann-Whitney U-test for continuous nonnormally distributed variables.  
c
chi-square tests for discontinuous variables. 
HTN=hypertension; SBP=systolic blood pressure; DBP=diastolic blood pressure; 
BMI=body mass index; VAMC=Veterans Affairs Medical Center. 
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Research Question #2 
Are the background variables (age, education, religion, family history of HTN, 
comorbidities, number of medications, BP, BMI, income, and type of health coverage) 
and dynamic variables (HTN knowledge, self-care of HTN, trust in health care provider, 
coping, perceived racism, and depression) associated with medication adherence in Black 
women with HTN?  
The Fisher‘s exact test was used to examine the significance of association 
(contingency) between background and dynamic variables on medication adherence. The 
procedure follows a hypergeometric distribution under the null hypothesis of 
independence with fixed margins and is frequently used in place of a phi correlation 
coefficient when data are sparse (Bower, 2003; Huck, 2008). Fisher‘s exact test does not 
rely on normality assumptions and uses the exact distribution instead of a normal 
approximation (Polit, 1996). Variables not previously categorized were divided into 
quartiles (Q) prior to statistical analysis. Quartile derivations is advantageous because it 
limits outlier influence (Mertler & Vannatta, 2010; Vogt, 2005). In addition, Fisher‘s 
exact test could test the significance of the difference in proportions of background and 
dynamic variables on medication adherence when some of the expected cell frequencies 
fell below 5 (Polit, 1996). 
All background variables were examined except family history of HTN and mean 
systolic and diastolic BP. Family history of HTN was excluded from analysis because 
nearly all of the participants (94%) had a family history of HTN leaving no variability. In 
addition, the BP variable was considered to be on the causal pathway because 
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nonadherence to antihypertensive medications may cause increases in BP. Exclusion of 
this variable was related to the strong association of controlled BP to medication 
adherence outcomes. All other dynamic variables were examined.  
The results displayed in Table 7 show counts and frequencies of all variables as 
related to the outcome variable medication adherence and provide results of the Fisher‘s 
exact test. In summary, no background variables (age, education, religion, family history 
of HTN, comorbidities, number of medications, BP, BMI, income, and type of health 
coverage) or dynamic variables (HTN knowledge, self-care of HTN, trust in health care 
provider, coping, perceived racism, and depression) were associated with medication 
adherence in Black women with HTN (see Table 7). However, the lack of a statistically 
significant association in a simple contingency table analysis does not rule out ordinal 
effects or trends that may predict outcome. All results pertaining to this research question 
are listed in Table 7. 
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Table 7 
 
Influence of Background and Dynamic Variables on Medication Adherence 
  
 
 
Characteristics 
Compliant 
None of 
the time 
  (>14)                                  
 
   n(%) 
Compliant 
Some of the 
time  
(13-14) 
 
   n(%) 
Compliant 
Most of 
the time 
(10-12) 
 
  n(%) 
Compliant 
All of 
the time 
    (9) 
 
  n(%) 
 
 
 
 
Fisher‘s 
Exact 
Test 
 
Age 
     Q1 <40 
 
  3 (16) 
 
  6 (29)   
 
  4 (20) 
 
  2 (10) 
 
     Q2 40-49   9 (47)   5 (24)   3 (15)   6 (30)  
     Q3 50-55   6 (32)   6 (29)   8 (40)   4 (20)  
     Q4 >55   1   (5)   4 (19)   5 (25)   8 (40) 0.20 
 
Education  
     ≥ High school                             
 
14 (74) 
 
12 (57) 
 
  9 (45) 
 
15 (75) 
 
     < High school    5 (26)   9 (43) 11 (55)   5 (25) 0.17 
 
Religion 
     Other     
 
  6 (32) 
 
  5 (24) 
 
  7 (35) 
 
  5 (25) 
 
     Baptist 13 (68) 16 (76) 13 (65) 15 (75) 0.86 
 
# of Comorbidities 
     Q1 1 
 
  2 (11) 
 
  5 (24) 
 
  6 (30) 
 
  4 (20) 
 
     Q2 2   9 (47)   5 (24)   6 (30)   6 (30)  
     Q3 3-4   4 (21)   8 (38)   5 (25)   8 (40)  
     Q4 5-9   4 (21)   3 (14)   3 (15)   2 (10) 0.75 
 
# of Medications 
     Q1 1-2 
 
  7 (37) 
 
  6 (29) 
 
  4 (20) 
 
  4 (20) 
 
     Q2 3-4   7 (37)   5 (24)   4 (20)   7 (35)  
     Q3 5-7   1   (5)   6 (29)   6 (30)   5 (25)  
     Q4 8-18   4 (21)   4 (19)   6 (30)   4 (20) 0.61 
 
BMI (WHO) 
     Q1 <18.5  
 
  0   (0) 
 
  1   (5) 
 
  0   (0) 
 
  0   (0) 
 
     Q2 18.5-24.99   3 (16)   1   (5)   3 (15)   2 (10)  
     Q3 25.0-29.99   2 (11)   4 (19)   2 (10)   2 (10)  
     Q4 ≥30 14 (74) 15 (71) 15 (75) 16 (80) 0.92 
 
 
(continued) 
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Table 7 (continued). 
 
Influence of Background and Dynamic Variables on Medication Adherence 
 
 
 
Characteristics 
Compliant 
None of 
the time 
 (>14)   
 
  n(%) 
Compliant 
Some of 
the time 
(13-14) 
 
   n(%) 
Compliant 
Most of  
the time  
(10-12) 
 
   n(%) 
Compliant 
All of  
the time  
    (9) 
 
   n(%) 
 
 
 
 
Fisher‘s 
Exact Test 
 
Income 
     Q1 <20,000 
 
  7 (37) 
 
  7 (33) 
 
  7 (35) 
 
  8 (40) 
 
     Q2 ≥20,000- <35,000   1   (5)   7 (33)   7 (35)   3 (15)  
     Q3 ≥35,000- <55,000   6 (32)   4 (19)   2 (10)   6 (30)  
     Q4 ≥55,000   5 (26)   3 (14)   4 (20)   3 (15) 0.39 
 
Insurance 
     Through work 
 
11 (58) 
 
13 (62) 
 
  9 (45) 
 
13 (65) 
 
     Medicaid/Medicare   3 (16)   8 (38)   6 (30)   3 (15)  
     Uninsured   5 (26)   0   (0)   5 (25)   4 (20) 0.10 
 
HTN Knowledge 
(HBPPIQ) 
     Q1 (58.3) 
 
   
  2 (11) 
 
    
   1  (5) 
 
 
 1   (5) 
 
 
  2 (10) 
 
     Q2 (58.3-<66.6)   4 (21)     9 (43)  7 (35)   8 (40)  
     Q3 (66.6-<75) 12 (63)   9 (43)  9 (45) 10 (50)  
     Q4 (≥75)    1  (5)   2 (10)  3 (15)   0   (0) 0.70 
 
Self-Care of HTN Index 
     Maintenance (SCHI) 
          Q1 (<36.1) 
 
 
  6 (32) 
 
   
  5 (24) 
 
 
  6 (30) 
 
 
  1   (5) 
 
          Q2 (36.1-<47.2)   8 (42)   9 (43)   4 (20)   7 (35)  
          Q3 (47.2-<56.9)   3 (16)   4 (19)   3 (15)   4 (20)  
          Q4 (≥56.9)   2 (11)   3 (14)   7 (35)   8 (40) 0.21 
     Management        
          Q1 (<27.8)   2 (15)   3 (38)   1 (14)  1 (17)  
          Q2 (27.8-<41.7)   3 (23)   4 (50)   1 (14)  2 (33)  
          Q3 (41.7-<50.0)   2 (15)   0   (0)   2 (29)  0   (0)  
          Q4 (≥50.0)   6 (46)   1 (13)   3 (43)  3 (50) 0.56 
               Missing   6 13     13  14  
     Confidence 
          Q1 (<50.0) 
 
  6 (32) 
 
  9 (43) 
 
  6 (30) 
 
  1   (5) 
 
          Q2 (50.0-<61.1)   8 (42)   4 (19)   5 (25)   7 (35)  
          Q3 (61.1-<72.2)   3 (16)   2 (10)   5 (25)   6 (30)  
          Q4 (≥72.2)   2 (11)   6 (29)   4 (20)   6 (30) 0.14 
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Table 7 (continued) 
 
Influence of Background and Dynamic Variables on Medication Adherence 
 
 
 
Characteristics 
Compliant 
None of 
the time 
  (>14)  
 
  n(%) 
Compliant 
Some of 
the time 
(13-14) 
 
   n(%) 
Compliant 
Most of  
the time  
(10-12) 
 
   n(%) 
Compliant 
All of  
the time  
    (9) 
 
   n(%) 
 
 
 
 
Fisher‘s 
Exact 
Test 
 
Trust (TPS) 
     Q1 (<41) (Low) 
 
  5 (26) 
 
  5 (24) 
 
  3 (15) 
 
  4 (20) 
 
     Q2 (41-45)   9 (47) 10 (48)   8 (40)   5 (25)  
     Q3 (46-52)   5 (26)   6 (29)   8 (40)   7 (35)  
     Q4 (>52) (High)   0   (0)   0   (0)   1   (5)   4 (20) 0.30 
 
Coping (JHACS)  
     Q1 (32-46) 
 
  3 (16) 
 
  7 (33) 
 
  5 (25) 
 
  3 (15) 
 
     Q2 (47-50)   7 (37)   5 (24)   1   (5)   6 (30)  
     Q3 (51-53)   5 (26)   2 (10)   9 (45)   3 (15)  
     Q4 (54-59)   4 (21)   7 (33)   5 (25)   8 (40) 0.11 
 
Perceived Racism  
(IRRS-B) 
     Q1 (<2.9) 
 
 
  3 (16) 
 
 
  5 (24) 
 
 
  8 (40) 
 
 
  4 (20) 
 
     Q2 (2.9-<5.1)   5 (26)   8 (38)   3 (15)   4 (20)  
     Q3 (5.1-<6.8)   8 (42)   3 (14)   1   (5)   8 (40)  
     Q4 (≥6.8)   3 (16)   5 (24)   8 (40)   4 (20) 0.074 
 
Depression (PHQ-9) 
     No depression (0-4) 
 
  5 (26) 
 
  7 (33) 
 
11 (55) 
 
10 (50) 
 
     Minimal/Minor (5-14) 11 (58) 12 (57)   7 (35)   9 (45)  
     Major (>14)    3 (16)   2 (10)   2 (10)   1   (5) 0.52 
 
Note. BMI=body mass index; WHO=World Health Organization; HTN=hypertension; 
Q=Quartile; HBPPIQ=High Blood Pressure Prevention IQ; SCHI=Self-Care of 
Hypertension Index; TPS=Trust in Physician Scale; JHACS=John Henryism Active 
Coping Scale; IRRS-B=Index of Race-Related Stress-Brief Version; PHQ-9=Patient 
Health Questionnaire-9. 
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Research Question #3 
Do the background variables (age, education, religion, family history of HTN, 
comorbidities, number of medications, BP, BMI, income, and type of health coverage), 
and dynamic variables (HTN knowledge, self-care of HTN, trust in health care provider, 
coping, perceived racism, and depression) predict medication adherence in Black women 
with HTN on an ordinal scale? 
The data were analyzed using an exact discrete-event (proportional-odds) model. 
This is a semi-parametric regression procedure that examines the association between a 
set of predictor variables and an ordinal scale outcome variable. Similar to a log-binomial 
or Poisson regression model, the adjusted relative effect size of association [herein 
referred to as the relative importance score (RIS)], was computed by exponentiating the 
regression beta-coefficient for the variable of interest (Breslow & Day, 1980). The 
adjusted RISs determine the contribution each independent variable makes in 
combination with other independent variables in predicting the value of the dependent 
variable. The higher scores represent the importance of the dimension (LeBreton & 
Tonidandel, 2008; Sachdev & Verma, 2004). Conditional maximum likelihood parameter 
estimates were determined iteratively using an integral approximation (Gail, Lubin, & 
Rubinstein, 1981).  Model fit was assessed using standard regression deviance-based 
diagnostic plots (Pregibon, 1981).  Normal theory was used to compute test-based 
confidence intervals (CIs) for estimated relative importance scores (RISs). Continuous 
variables were categorized into quartiles based on the distribution among referent 
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participants. An ―optimal predictive model‖ was identified by retaining variables in a 
multivariable analysis only if, for at least for one level, p<0.025 and RIS>2.5 or RIS<0.4. 
The univariable background variables that predicted medication adherence were 
participant age and number of medications (see Table 8). All age groups were less likely 
to be adherent but participants in the 40-49 age group (Q3) had the highest RIS score and 
were 3.6 fold less likely to be adherent to antihypertensive medications than baseline 
(Q1) (P for trend=0.028). In contrast participants who reported taking five to seven 
medications (Q3) were 3.8 fold more likely to be adherent than baseline (Q1) (p=0.001). 
However, a significant linear trend was not observed for ―number of medications.‖   
The univariable dynamic variables that predicted medication adherence were self-
care of HTN maintenance and confidence, trust in health care provider, and depression 
(see Table 8). Participants who scored in the self-care of HTN maintenance Q4 (≥56.9) 
were 2.7 fold likely to be adherent to antihypertensive medications (P for trend=0.0046) 
and those who scored in the self-care of HTN confidence Q3 (61.1-<72.2) were 2.2 fold 
likely to be adherent to antihypertensive medications (P for trend=0.045). Participants 
who scored in the highest trust group Q4 (>52) were 16.7 fold more likely to be adherent 
than baseline (Q1) (P for trend=0.010). However, participants who manifested major 
depressive symptoms were less likely to be adherent to antihypertensive medications as 
observed by a significant linear trend (P for trend=0.046).     
Variables retained in the ―optimal predictive model‖ included participant age, 
number of medications, and trust in health care provider (see Table 8). Again all age 
groups were less likely to be adherent , but participants in the 40-49 age group (Q3) had 
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the highest RIS score and were 3.7 fold less likely to be adherent to antihypertensive 
medications than baseline (Q1) (P for trend=0.0036). Whereas participants who reported 
taking five to seven medications (Q3) were 3.6 fold more likely to be adherent than 
baseline (Q1) (p=0.0048). However, similar to the univariable case, a significant linear 
trend was not observed for ―number of medications.‖ Participants who scored in the 
highest trust group Q4 (>52) were 33.3 fold more likely to be adherent than baseline (Q1) 
(P for trend=0.015).  
In summary, participant age was the only background variable that independently 
predicted nonadherence to antihypertensive medications in our ―optimal predictive 
model.‖ While the only dynamic variable that independently predicted adherence to 
antihypertensive medications in the ―optimal predictive model‖ was trust. Univariable 
predictors and the optimal predictive model for medication adherence are listed in Table 
8.   
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Table 8 
 
Exact Discrete-Event Model (Proportional Odds) for Compliance Scale from High (33) to  
Low (9) 
 
 Univariable Predictors Optimal Predictive Model
† 
 
Characteristics RIS 95% CI RIS 95% CI  
 
Age 
     Q1 >55 
 
1.0 
 
Referent 
 
1.0  
 
 Referent 
     Q2 50-55 2.3 1.1  -4.9    (p=0.029) * 2.9
†
 1.3-6.5    (p=0.011)
 † 
 
     Q3 40-49 3.6 1.6  -8.0    (p=0.001) * 3.7
†
 1.6-8.6    (p=0.0028)
 †
 
     Q4 <40 2.4 1.02-5.4    (p=0.044) * 3.2
†
 1.3-8.2    (p=0.013)
 †
 
  P for trend=0.028
§
*   P for trend =0.0036
§† 
 
Education  
     ≥ High school                             
 
1.0
 
Referent 
 
 --- 
 
             --- 
     < High school    .94 0.56-1.6     (p=0.83)  ---              --- 
 
Religion 
     Other  
 
1.0 
 
Referent 
 
 --- 
 
             --- 
     Baptist 0.98 0.57-17      (p=0.98)  ---              --- 
                   
# of Comorbidities 
     Q1 1 
 
1.0  
 
Referent 
  
 --- 
            
             --- 
     Q2 2 1.9 0.90-4.0     (p=0.092)  ---              --- 
     Q3 3-4 1.1 0.51-2.2     (p=0.87)  ---              --- 
     Q4 5-9 2.0 0.83-4.7     (p=0.12)  ---              --- 
  P for trend =0.49
§ 
 
  
# of Medications 
     Q1 1-2 
 
1.0 
 
Referent 
 
1.0 
 
Referent 
     Q2 3-4 0.56 0.28-1.1      (p=0.11) 0.47 0.22-0.99  (p=0.047) 
     Q3 5-7 0.26 0.12-0.59    (p=0.001) *  0.28
†
 0.12-0.68  (p=0.0048)
 †
 
     Q4 8-18 0.65 0.31-1.4      (p=0.25) 0.73 0.34-1.6    (p=0.45) 
  P for trend =0.11
§
   P for trend =0.35
§ 
 
BMI (WHO) 
     Q1 <18.5  
 
1.0 
 
Referent 
 
 --- 
 
             --- 
     Q2 18.5-24.99 1.2 0.12-13       (p=0.87)  ---              --- 
     Q3 25.0-29.99 1.1 0.10-11       (p=0.95)  ---              --- 
     Q4 ≥30 1.3 0.13-12       (p=0.84)  ---              --- 
  P for trend =0.77
§
  ---              --- 
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Table 8 (continued) 
 
Exact Discrete-Event Model (Proportional Odds) for Compliance Scale from High (33) to  
Low (9) 
 
 Univariable Predictors Optimal Predictive Model
† 
 
Characteristics RIS 95% CI RIS 95% CI  
 
Income 
     Q1 <20K 
 
1.0  
 
Referent 
 
 --- 
 
             --- 
     Q2 ≥20K - <35K 0.64 0.31-1.3      (p=0.21)  ---              --- 
     Q3 ≥35K - <55K 1.2 0.62-2.4      (p=0.56)  ---              --- 
     Q4 ≥55K 0.94 0.46-1.9      (p=0.87)  ---              --- 
  P for trend =0.79
§
  ---  
Insurance 
     Through work 
 
1.0 
 
Referent 
 
 --- 
 
             --- 
     Medicaid/Medicare 0.83 0.45-1.5      (p=0.56)  ---              --- 
     Uninsured 0.99 0.49-2.0      (p=0.97)  ---              --- 
 
HTN Knowledge (HBPPIQ) 
     Q1 (<58.3) 
 
1.0  
 
Referent 
 
 --- 
              
             --- 
     Q2 (58.3-<66.6)      0.95 0.34-2.6      (p=0.92)  ---              --- 
     Q3 (66.6-<75) 1.1 0.40-2.9      (p=0.90)  ---              --- 
     Q4 (≥75) 1.8 0.46-6.8      (p=0.41)  ---              --- 
  P for trend =0.38
§
  ---              --- 
Self-Care of HTN Index 
(SCHI) 
     Maintenance 
          Q1 (<36.1) 
 
 
1.0 
 
 
Referent 
 
 
 --- 
 
 
             --- 
          Q2 (36.1-<47.2) 0.78 0.40-1.5      (p=0.48)  ---              --- 
          Q3 (47.2-<56.9) 0.48 0.21-1.1      (p=0.079)  ---              --- 
          Q4 (≥56.9) 0.37 0.17-0.79    (p=0.010) *  ---              --- 
  P for trend =0.0046
§
*  ---              ---  
     Management 
          Q1 (<27.8) 
 
1.0  
  
Referent 
 
 --- 
 
             --- 
          Q2 (27.8-<41.7) 0.53 0.17-1.7      (p=0.28)  ---              --- 
          Q3 (41.7-<50.0) 0.95 0.24-3.8      (p=0.95)  ---              --- 
          Q4 (≥50.0) 0.87 0.29-2.6      (p=0.80)  ---              --- 
  P for trend =0.84
§
  ---              --- 
     Confidence 
          Q1 (<50) 
 
1.0 
 
Referent 
 
 --- 
 
             --- 
          Q2 (50-<61.1) 0.74 0.39-1.4      (p=0.38)  ---              --- 
          Q3 (61.1-<72.2) 0.45 0.21-0.97    (p=0.042) *  ---              --- 
          Q4 (≥72.2) 0.54 0.26-1.1      (p=0.098)  ---              --- 
  P for trend =0.045
§
*  ---              --- 
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Table 8 (continued) 
 
Exact Discrete-Event Model (Proportional Odds) for Compliance Scale from High (33) to  
Low (9) 
 
 Univariable Predictors Optimal Predictive Model
† 
 
Characteristics RIS 95% CI RIS 95% CI  
 
Trust (TPS) 
     Q1 (<41) (Low) 
 
1.0 
 
Referent 
 
1.0 
 
Referent 
     Q2 (41-45) 0.86 0.44-1.7    (p=0.66) 0.84 0.40-1.8       (p=0.65) 
     Q3 (46-52) 0.57 0.28-1.2    (p=0.12) 0.64 0.29-1.4       (p=0.26) 
     Q4 (>52) (High) 0.06 0.01-0.39  (p=0.003)* 0.03
†
 0.004-0.23   (p=0.0006)
 †
 
  P for trend =0.010
§
*  P for trend =0.015
§† 
 
Coping (JHACS)  
     Q1 (32-46) 
 
1.0 
 
Referent 
 
 --- 
 
             --- 
     Q2 (47-50) 1.6 0.73-3.3     (p=0.25)  ---              --- 
     Q3 (51-53) 0.93 0.44-1.9     (p=0.84)  ---              --- 
     Q4 (54-59) 1.0 0.51-2.1     (p=0.92  ---              --- 
  P for trend =0.66
§
  ---              --- 
 
Perceived Racism Stress 
(IRRS-B) 
     Q1 (<2.9) 
 
 
1.0 
 
  
Referent 
 
 
 --- 
 
 
             --- 
     Q2 (2.9-<5.1) 1.6 0.78-3.3    (p=0.20)  ---              --- 
     Q3 (5.1-<6.8) 1.6 0.79-3.4    (p=0.18)  ---              --- 
     Q4 (≥6.8) 1.0 0.49-2.1    (p=0.96)  ---              --- 
  P for trend =0.96
§
  ---              --- 
 
Depression (PHQ-9) 
     No depression (0-4) 
 
1.0 
 
Referent 
 
 --- 
 
             --- 
     Minimal/Minor (5-14) 1.5 0.89-2.6    (p=0.12)  ---              --- 
     Major (>14)  2.2 0.89-5.3    (p=0.088)  ---              --- 
  P for trend =0.046
§
*  ---              --- 
 
Note. 
†
Variable retained in model if, for at least for one level, p<0.025 and RIS>2.5 or 
RIS<0.4.                
§
Likelihood ratio trend test.  
*p<0.05, Univariable predictors. 
RIS=Relative Importance Scores; CI=Confidence Intervals.  
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Research Question #4 
Is there a relationship between reactant behaviors and medication adherence in 
Black women with HTN? 
Spearman‘s rho was used to determine the correlation between therapeutic 
reactance and medication adherence. Results produced a Spearman‘s rho of .186, and this 
statistic was not significant (p=.098) indicating that there was no relationship between 
total therapeutic reactance score and medication adherence. In addition, the Spearman‘s 
rho for the reactance verbal subscale (.176) and the behavioral subscale (.122) were not 
significant (p=.118 and p=.283 respectively). Based on the results of the Shapiro-Wilk 
test, there was no significant difference in the verbal subscale (p=.599) and the total scale 
score (p=.108) of the therapeutic reactance scale suggestive of a normal distribution 
allowing use of the independent sample t-test (Gliner & Morgan, 2000; Polit, 1996) to 
compare reactance in adherent and nonadherent antihypertensive medication groups. 
Because the sample size was not equal, Levene‘s test (Polit, 1996) for homogeneity of 
variance was conducted, and there was no significant difference in the variance of the 
adherent group and the nonadherent group for the mean verbal subscale (F=.471, p=.495) 
and the total scale score (F= 2.86, p=.095) of the therapeutic reactance scale. The 
independent sample t-test revealed no significant difference in the verbal subscale for the 
adherent (M=29.35, SD=3.69) and nonadherent (M=29.83, SD=3.21) groups: t (78)=  
-.562, p=.576) and there was no significant difference in the total reactance score for the 
adherent (M=66.25, SD=4.80) and nonadherent (M=66.98, SD=7.63) groups: t (78)=  
-.403, p=.688).       
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Additional Analyses 
Because all data were collected using self-report measures, participants completed 
the 10-item Marlowe-Crowne Social Desirability (M-C 1[10] scale to assess the degree of 
socially desirable answers. The basic assumption of the M-C 1[10] is that participants 
who answer in a socially desirable manner are highly likely to answer in a similar manner 
on all self-report measures. Low scores on the M-C 1[10] scale reflect socially 
undesirable or honest answers, high scores reflect socially desirable or dishonest answers, 
and middle scores reflect a combination of both ("Social desirability scale"). Scores on 
the M-C 1[10] ranged from 0-10 with a mean of 5.5 (± 2.1) and a median of 6.0. Of all 
the participants, 63% (n=51) scored in the middle range (4-7) while 19% (n=15) scored in 
the low range (0-3), and 18% (n=14) scored in the high range (8-10). Participants who 
engaged in significant amounts of socially desirable responding were not discarded from 
the study. These data were used to provide a measure to gauge the likelihood that 
participants were providing honest responses to the self-report measure.   
Marlowe-Crowne Social Desirability (M-C 1[10] scale was significantly 
associated with three of the instruments used in this study (see Table 9). A weak negative 
association was noted with the verbal subscale and total scale of the Therapeutic 
Reactance Scale. This correlation implies that participants who demonstrated higher 
verbal and total scale reactance scores tend to be honest. A weak negative association 
was also noted with the Hill-Bone Compliance to High BP Pressure Therapy medication-
taking subscale and the Patient Health Questionnarie-9 depression instrument. These data 
imply that participants who reported nonadherence to medication-taking and those who 
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reported depressive symptoms were truthful. No relationship was noted between the (M-
C 1[10] and the other instruments. 
 
Table 9 
 
Correlations between Instruments and Social Desirability Scale 
 
Instruments Marlowe-Crowne Social Desirability 
Scale (N=80) 
 
Spearman‘s rho Correlation P-value 
 
Hill-Bone Compliance to High BP Pressure Therapy 
Scale 
     Medication taking subscale (adherence outcome) 
      
 
-.307 
 
.006* 
 
John Henryism Active Coping Scale  
 
 .194 .085 
Patient Health Questionnarie-9  
 
-.296 .008* 
Index of Race-Related Stress-Brief Version  
     Cultural racism subscale  
     Institutional racism subscale  
     Individual racism subscale  
 
-.138 
-.097 
-.132 
-.072 
.222 
.391 
.244 
.525 
Trust in Physician Scale  
 
 .103 .363 
High BP Prevention IQ) 
 
-.200 .075 
Self-Care of HTN Index  
     Maintenance subscale  
     Management subscale  
     Confidence subscale  
 
 
 .178 
 .251 
 .119 
 
.114 
.151 
.294 
Therapeutic Reactance Scale  
     Behavioral subscale  
     Verbal subscale  
 
-.287 
-.183 
-.349 
.010* 
.104 
.002* 
Note. *p<0.05  
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Summary 
Eighty Black women who were taking antihypertensive prescription medications 
were interviewed to determine factors that influence medication adherence. Participants 
were mostly single or married, with a mean age of 48 years and employed full-time. 
Cardiovascular disease risk factors such as physical inactivity, overweight/obese, and a 
history of smoking were prevalent in the sample. Univariable predictors of medication 
adherence included age, number of medications, self-care of HTN maintenance and 
confidence, trust in health care provider, and depression. In the optimal predictive model, 
only age and trust in health care provider significantly predicted medication adherence.
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CHAPTER V 
DISCUSSION
 
Introduction 
The purposes of this study were to describe the differences in adherent and 
nonadherent Black women who have hypertension (HTN) and examine issues that 
influence medication adherence. In addition, this study explored the relationship between 
reactant behaviors and medication adherence. This chapter provides an interpretation of 
the findings and implications for nursing practice. Also, recommendations for future 
research are discussed. 
Interpretation of Findings 
Cox‘s Interaction Model of Client Health Behavior (IMCHB) includes three 
major elements, of which, two were used to guide this study: client singularity 
(background and dynamic variables) and health outcome. Included in the background 
variables are demographic characteristics (age and education), social influence (religion), 
previous health care experience (family history of HTN, comorbidities, number of 
medications, blood pressure [BP], and body mass index [BMI]), and environmental 
resources (income and type of health coverage). Dynamic variables included intrinsic 
motivation (reactance), cognitive appraisal (HTN knowledge, self-care of HTN, trust in 
health care provider, and coping), and affective response (perceived racism and 
depression). All data collected were a good fit for this model. The comprehensiveness of 
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the IMCHB allowed for the examination of multiple determinants of health behavior 
pertinent to Black women with HTN that aided in explaining and/or predicting the 
outcome variable, medication adherence. Discussion was organized around the IMCHB 
beginning with the outcome variable, medication adherence, and concluding with client 
singularity (background and dynamic variables). 
Element of Health Outcome: Adherence to the Recommended Health Regimen 
Medication adherence. Black women have the highest prevalence rate of HTN in 
the world (Roger et al., 2011). Several studies found that factors contributing to HTN in 
Blacks were multifaceted and rooted in historical and socioeconomic determinants, such 
as racism (Webb & Gonzalez, 2006), experimental exploitation (Washington, 2006), 
unequal treatment (B. D. Smedley et al., 2003), lower education, poor social support, cost 
factors, lack of health insurance (Fongwa et al., 2006), distrust of health care providers 
(Lukoschek, 2003), and poor communication with health care providers (Kressin et al., 
2007). In several qualitative studies (Fongwa et al., 2008; L. M. Lewis et al., 2010; 
Lukoschek, 2003), another factor contributing to HTN was medication nonadherence. Of 
all the identified qualitative studies on HTN in Blacks (Fongwa et al., 2008; L. M. Lewis 
et al., 2010; Lukoschek, 2003; Webb & Gonzalez, 2006), only one study (Fongwa et al., 
2008) dealt specifically with adherence treatment factors in Black women with HTN. 
However, no quantitative studies were found on Black women with HTN that examined 
factors influencing adherence to antihypertensive medications. Although it is well 
documented that antihypertensive medications have proven efficacy in lowering BP when 
clients adhere to the treatment regimen (Chobanian et al., 2004; Fongwa et al., 2006; 
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Mabotuwana et al., 2009; Martins et al., 2001), the rationale for medication nonadherence 
in Black women is not fully understood (Benjamin et al., 2005; Smith et al., 2005; Webb 
& Gonzalez, 2006). Thus, Black women suffer a disproportionate burden of HTN with 
resultant morbidity, disability and mortality (Roger et al., 2011), along with a substantial 
cost burden to individuals, families, and society (Dragomir et al., 2010; Piette et al., 
2006; Rand & Sevick, 2000). This paucity of research is daunting considering the high 
prevalence rate and health consequences of HTN in Black women. This study sought to 
identify factors that influenced medication adherence. Describing factors that contribute 
to medication adherence is an essential precursor to developing and implementing 
successful treatment approaches to HTN that are unique to Black women.  
In the current study, one-fourth of the sample reported total adherence to their 
antihypertensive medication regimen as indicated by a perfect adherence score (9) on the 
medication subscale of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. 
Of the study participants who claimed total adherence to their antihypertensive 
medications, over one-third had BPs indicative of HTN according to the Seventh Report 
of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of 
High Blood Pressure (JNC 7) guidelines (Chobanian et al., 2004). Although these women 
professed they were following the health care providers instructions precisely in taking 
their medications, unknown factors may have been responsible for their uncontrolled BP, 
such as white coat syndrome, time of BP measurement, or self-neglect (Chobanian et al., 
2004). In comparison, almost half of the nonadherent group reported they were not 
faithful in taking their antihypertensive medications consistently. High rates of 
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uncontrolled BP in both the adherent and nonadherent groups is astounding and warrants 
further attention. In addition to adherence issues, the appropriateness of pharmacological 
management should be evaluated. Hence, more studies are needed that target BP control 
in Black women. 
There was no significant difference between the totally adherent and nonadherent 
group‘s mean systolic and diastolic BP in this study. These results are similar to a study 
of older (M=63.6) adults with HTN after Hurricane Katrina that found no significant 
difference in uncontrolled BP for those who reported perfect adherence as compared to 
those with less than perfect adherence to antihypertensive medications (Krousel-Wood et 
al., 2008).  Similarly, in a five year randomized clinical trial with Black men with HTN, 
there was no significant difference in BP improvements between the treatment (more 
intensive educational, behavioral, and pharmacologic intervention) and control (less 
intensive information and referral intervention) groups (Dennison et al., 2007). These 
findings may indicate that individuals engage in varying levels of adherence because 
there are no differences noted in the BP readings of adherent and nonadherent groups.  
Univariable predictors of medication adherence in this study were age, number of 
medications, self-care of HTN maintenance and confidence, trust in health care provider, 
and depression. However, in the optimal predictive model, only age and trust in health 
care provider significantly predicted medication adherence. Each of these predictors is 
discussed in more detail under the elements of client singularity. 
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Elements of Client Singularity: Background Variables 
Demographic characteristics. 
Age. As age, a nonmodifiable risk factor for HTN, increases, the risk for HTN 
increases. The pattern of HTN differs in men and women as they age. According to 
American Heart Association statistics (Roger et al., 2011), men tend to have a greater risk 
for HTN than women until age 45, and then from age 45 to 64, the risk of HTN is similar 
for both men and women. After age 64 and the onset of menopause, women tend to 
develop a higher risk for HTN than men. More importantly, in Blacks HTN is more 
severe and noted earlier in life. The American Heart Association statistics and JNC 7 
guidelines do not clearly define age recommendations that are specific for Blacks. Black 
men tend to develop HTN around age 45. If we use these guidelines for Black women, 
almost one-third of the participants in this study would meet this criterion. The current 
guideline that HTN risk for women increases after age 55 may not be acceptable for 
Black women. Thus, research is needed to determine specific guidelines that address the 
early age risk for Blacks with HTN.       
Research findings regarding age and medication adherence are diverse. Results of 
this study found that age was both a univariable predictor of medication adherence and a 
predictor in the final model. Though all age groups were less likely to be adherent to their 
antihypertensive medications, the greatest predictor was participants aged 40 to 49. These 
findings differed from other studies. Schoenthaler et al. (2009) reported that younger 
aged Blacks (range 25-98 years) exhibited more nonadherent medication behaviors. In 
contrast, Weingarten & Cannon (1988) reported that lower adherence to antihypertensive 
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medications was associated with younger clients up to age 55 and older clients over age 
65. In the current study, one explanation for less adherence to antihypertensive 
medications among those aged 40 to 49 could be related to the fact that these women 
were more likely to be married or separated, work full- or part-time, and live in 
households with more people (1 to 8) than those in the other age groups. The stressors of 
marriage, working, and family responsibilities may be all consuming to the point where 
women in this age group may overlook their own self-care needs, thus contributing to 
nonadherence to the treatment regimen. Other reasons for these varied findings are the 
measurements of medication adherence. While the gold standard for measurement of 
adherence is the medication event monitoring system (MEMS), even the gold standard 
may not reflect reality when medications are provided to participants. Thus multiple 
factors may be associated with varied results when looking at age and adherence. Several 
studies show that clients self-reporting high medication adherence may not be reflective 
of their actual medication-taking (Choo et al., 1999; Choo et al., 2001; Zeller, Ramseier, 
Teagtmeyer, & Battegay, 2008). Methods of measuring medication adherence, such as 
the MEMS, indicate that clients are usually adherent while being monitored, and 
adherence is not sustained once the monitoring period increases or has ended (Braverman 
& Dedier, 2009).       
Education. The high school completion rate for this sample was slightly higher 
than the national average of 80% for Blacks (Crissey, 2009), and more than half of this 
sample had greater than a high school education. Though the highest rates of HTN are 
 
149 
usually noted in clients who are less educated (Roger et al., 2011), other factors may be 
associated with higher educational attainment and nonadherence in clients with HTN.  
In the current study, there was no statistically significant association between 
education and medication adherence. Results of this study suggest that educational level 
does not necessarily have an effect on antihypertensive medication adherence. In 
contrast, a study on medication adherence to antihypertensive medication in a Nigerian 
population found that higher education predicted medication adherence (Ikechuwku, 
Obinna, & Ogochukwu, 2010). The relationship between education and medication 
adherence may also vary by sex. In a study of Blacks with HTN (Braverman & Dedier, 
2009), men with less than a high school education were more adherent than men with 
higher education. In contrast, women with less than a high school education were less 
adherent than women with higher education. These results suggest that there may be a 
disconnect between educational obtainment and adherence. Increased levels of education 
may not necessarily provide an assurance of adherence. In fact, Braverman and Dedier 
(2009) reported that clients with higher education may better understand content only to 
become argumentative and resistive to the information provided. This perspective closely 
resembles reactance behaviors whereby if a client is told what to do; he/she is likely to do 
the opposite (J. W.  Brehm, 1966). However, no studies were found that examined the 
association of reactance behaviors to higher educational levels.      
One issue that may help to explain medication nonadherence is illiteracy and 
education, in those with less than and greater than a high school education. Flack et al. 
(2010) maintain that the inability to read and amply follow health care directions and 
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prescription instructions results in nonadherence to the treatment regimen, especially 
among Blacks with HTN. With the advent of inflated grades in the educational system, 
illiteracy may be problematic for clients with low educational levels as well as those with 
higher education. Thus, educational level may not be a good surrogate model of a client‘s 
intelligence and ability to learn, apply knowledge, and choose appropriate lifestyle 
modifications. Therefore, other models of educational attainment may be necessary to 
assess literacy, especially as it pertains to a client‘s basic medical knowledge.  
Social influence. 
Religion. The current study examined the relationship between medication 
adherence and religion. Religion and spirituality are frequently used interchangeably but 
are different terms. Whereby religion is overtly expressed in adherence behaviors to 
prescribed religious beliefs, spirituality is inwardly expressed but not tangible (L. M. 
Lewis & Ogedegbe, 2008). Just as God allows people to freely choose to adhere or not 
adhere to His laws, the same freedom to adhere or not adhere to the treatment regimen is 
available. While nonadherence to God‘s laws has consequences, the same holds true for 
nonadherence to the health care regimen. Both religion and health promoting behaviors 
employ similar characteristics in that both require people to be doers of prescribed beliefs 
or the prescribed treatment regimen to achieve optimal benefits. 
In the current study, there was no statistically significant association between 
religion and medication adherence. These results suggest that religion does not 
necessarily have an effect on antihypertensive medication adherence. The majority of the 
sample was recruited by snowball or social nomination from church members. Therefore, 
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all participants reported affiliation with a religious denomination even though a small 
percentage of the sample did not identify membership in a church or place of worship. 
According to two studies (Gillum & Griffith, 2010; Naewbood et al., 2010, March) 
religious activity and social support from the church resulted in positive health behaviors. 
Other studies found that religiosity was associated with lower BP (Bell et al., 2010; 
Seeman et al., 2003). These findings may be related to the support clients receive from 
religion. For example, a qualitative study of Blacks with HTN noted participants were 
highly committed to taking their antihypertensive medications, and their religious beliefs 
served as a protective mechanism to manage stress, exert control over HTN management, 
and increase their ability to cope with having HTN (C. M. Brown, 2000). However, no 
studies were found that explored if adherence to religious activity is associated with 
adherence to the prescribed treatment regimen. A study of this nature may help clarify the 
true nature of a client‘s claim to religiosity or spirituality versus an affiliation with a 
religious group that serves as a social club. Because Blacks have a strong connection to 
the church and are deemed the most religiously devout group in the United States (Vu, 
2009, February), it seems plausible that clients who are faithful in their religious practices 
may be amenable to develop consistent adherence practices to the health care regimen for 
adequate BP control. 
Conversely, if a client is not truly adherent to their religious practice, this may be 
evident in other areas of their lives. Yet, there is an underlining assumption that reported 
adherence to religious activity equates to adherence to other activities. Because religious 
principles and medication adherence are both predicated on the multifaceted nature of 
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human behavior that is impacted by social, psychological, physical, and environmental 
stimuli, oftentimes the rationale and mechanisms that drive free choice are not easily 
understood, predicted, or responsive to change. This may provide an explanation why 
spirituality is rarely recognized or encouraged by health care providers even though they 
claim to provide holistic health care (Black et al., 2006). It is imperative that appropriate 
assessment methods, such as longitudinal studies, are developed to capture an accurate 
depiction of religiosity and spirituality over time to uncover predictors of adherence that 
can be conveyed to other activities. Once mechanisms are devised to measure religious 
fidelity, the true impact of religion in other areas such as medication adherence may be 
determined.    
Previous health care experience. 
Family history of HTN. Those with a family history of HTN may have 
experiences that facilitated adherence to medications. However, when examining the 
relation between adherence to antihypertensive medication and family history in this 
study, the relation between these variables was not significant. These results suggest that 
family history does not necessarily have an effect on antihypertensive medication 
adherence. Almost all of the participants in this study had a family history of HTN, thus 
little variability in this sample. Family history is a well-known nonmodifiable risk factor 
for HTN, however, gene research to discover appropriate treatment for HTN has had 
limited success (Arnett, 2000; Ferdinand & Welch, 2007). These results are similar to an 
internet-based research study of Blacks with HTN ("The pressure is on", 2009) that found 
three out of four (75%) were aware of a family member with HTN, but three out of five 
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(60%) with this knowledge choose not to engage in preventive health behaviors before 
their own diagnosis of HTN. When aware of a family history of HTN, men (46%) were 
more likely than women (38%) to make an effort to control their BP before their own 
diagnosis of HTN. Black women with HTN reported they did not give their health 
adequate attention and were less likely to be proactive about their health than men. These 
results indicate that health does not take precedence over other life issues until a serious 
health calamity occurs, especially for Black women. This laissez-faire attitude of Black 
women in relation to their health deserves further exploration. 
Although the risk for HTN is greater for Blacks, those who develop HTN can 
effectively manage it by participating in risk reduction behaviors such as physical activity 
and diet, along with adherence to antihypertensive medication therapy (Douglas et al., 
2003). Although it is not fully understood why Blacks, particularly Black women, have 
not readily participated in risk reduction behaviors to manage and prevent HTN 
(Benjamin et al., 2005; Smith et al., 2005; Webb & Gonzalez, 2006), it seems plausible 
that high risk behaviors have been perpetuated through family history from one 
generation to the next.  
One method used by Blacks to preserve family behaviors is oral cultural 
traditions. Oral traditions, while common to West African literary and cultural 
expressions, were rooted in slavery as a mechanism to educate, enlighten minds, and free 
souls because reading, writing, and speaking in native languages were forbidden (Papa, 
Gerber, & Mohamed, 2008). In a qualitative study of Black women with HIV (Bueno, 
2009), self-talk, a form of oral culture was practiced to promote successful adherence to 
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the medication regimen. Self-talk aided in building confidence, self-esteem, and in the 
adoption of healthy practices and positive behavior change. The study also noted that 
self-talk could hinder health promotion if it was stimulated by fear, negativism, and 
criticism. Thus, Black families could unknowingly use oral traditions to perpetuate 
negative health practices. 
Because Black women with HTN may interpret their lives as busy with no time 
for self and always putting the needs of family first, they may use the ―busy life‖ and 
feeling ―stressed out‖ as a camouflage for depressive feelings of hopelessness and 
despair. Thus, neglecting self-care needs with an ―it does not matter‖ or ―it‘s all in God‘s 
hands‖ attitude is not easily understood. Wexler, Elton, Pleister, & Feldman (2009) 
describe this behavior as fatalistic in nature whereby many Blacks tend to believe that 
HTN is inevitable, so why do anything about it. Fatalistic attitudes about HTN are 
alarming and could be rooted in oral family traditions. Similarly, in a study of cancer 
fatalism, Powe and Finnie (2003) reported that as families experience cancer diagnosis 
and death over time, fatalism is reinforced and perpetuated like a self-fulfilling prophecy. 
Those diagnosed with cancer direct their efforts toward daily survival rather than healthy 
behaviors, especially if asymptomatic, and by the time symptoms manifest, treatment 
options are limited and the prognosis is poor. To the client, fatalism is viewed as a 
rational behavior because their interpretation of reality is that the treatment regimen is not 
beneficial. Black women with high cancer fatalism also had high perceptions of 
spirituality that are believed to serve as a coping strategy. The parallels between cancer 
fatalism and HTN fatalism warrants further study. Fatalism could present a major 
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challenge to the management of HTN because of the client‘s reluctance to fully adhere to 
the treatment regimen, and nonadherence may contribute to a myriad of subsequent 
health problems for Blacks, especially Black women. 
Comorbidities. Hypertension is associated with a number of cardiovascular 
diseases (CVD) such as coronary artery disease, stroke, and heart failure, as well as other 
comorbidities such as kidney disease, diabetes, and metabolic syndrome (Wong et al., 
2007). In terms of morbidity and mortality, HTN and other CVD comorbidities are 
considered to be serious conditions (Headen, Manton, & Woodbury, 2004). One study 
(Headen et al., 2004) suggests that initiatives to reduce racial health disparities may be 
more successful if the focus were targeted to disease clusters rather than single disease 
states, especially CVD related comorbidities. For Blacks, multiple CVD comorbidities 
are usually the result of multiple risk factors (Roger et al., 2011). Thus, better monitoring 
and aggressive management of CVD risk factors, such as obesity and physical inactivity, 
is indicated especially for Black women with HTN. 
The presence of HTN and comorbidities support the importance of adherence to 
the treatment regimen (Munger et al., 2007) to better control and manage disease 
processes. While over 65% of clients with HTN require two or more antihypertensive 
medications to achieve adequate BP control, the diagnosis of one or more comorbidities 
also requires further medication, thus more costs (Chobanian et al., 2004; Munger et al., 
2007). In addition, older age is associated with less income and more comorbidities. The 
costs of medications may be a burden for clients with CVD comorbidities because co-
payments are required for those enrolled in health insurance plans and government 
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sponsored programs such as Medicaid or Medicare. Although these co-payments seem 
modest, they quickly become costly as the number of health care provider visits and 
medications increase. One study found that the presence of CVD comorbidities in Black 
clients with Medicaid was associated with not filling antihypertensive prescription 
medications (Lagu et al., 2009). Thus, examining both the number of comorbidities and 
the number of medications is important when exploring adherence. 
According to Munger et al. (2007), those with HTN have one or more 
comorbidities that require additional medications. Consistent with this finding, clients in 
the current study had an average of three comorbidities. As comorbidities increase, 
clients tend to get sicker and the likelihood of taking prescribed medications may 
decrease. Excluding medication cost factors, sicker clients may select only those 
medications that allow them a reasonable ability to function and feel better. However, 
when examining the relationship between comorbidities and medication adherence in the 
current study, there was no significant association between the variables.   
Oftentimes, the effects of CVD comorbidities and related comorbidities present 
major problems for clients that often go unnoticed by health care providers. For instance, 
many clients with CVD comorbidities have poorer health and quality of life, physical 
inactivity, overweight/obesity, mental impairment (e.g. depression and anxiety), physical 
impairment, disability, decreased capacity to work, polypharmacy, excessive medical 
services use, higher rates of hospitalization, and increased communication with multiple 
health care providers, health care costs, and risk for death ("Cardiovascular disability", 
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2010). These challenges may contribute to nonadherence to the treatment regimen as the 
client struggles to maintain an adequate quality of life.  
Number of medications. Because most clients with HTN require two or more 
antihypertensive medications for adequate BP control (Chobanian et al., 2004), health 
care providers should pay close attention to the total number of medications a client is 
prescribed. Increased medication use, or polypharmacy, is one issue that may affect 
medication adherence. With polypharmacy, medication interactions may cause untoward 
side effects (Moss & Crane, 2010; West et al., 2010). In addition, many clients may have 
difficulty organizing complex medication regimens. Also, polypharmacy could create a 
substantial cost burden (Munger et al., 2007). 
Because multiple antihypertensive medications and multiple doses are often 
required, fixed-dose combinations (two or different medicine classifications in one tablet 
or pill form) aid adherence (Chobanian et al., 2004). Gradman et al. (2010) reported that 
combination medications can be advantageous in leading to better adherence whereby 
two pills are replaced with one, lower dosage minimizes adverse effects, and less time is 
required to achieve adequate BP control. However, cost of fixed-dose combinations may 
be an issue that affects adherence because many third party payers will either not pay for 
combination medications that are not available in the generic form or substantially 
increase the copay (Chobanian et al., 2004; Gradman et al., 2010; Pitt, 2004). Disputes 
over the more expensive fixed-dose combinations may become a future policy issue. 
In the current study, clients took an average of five medications. Both the 
univariable predictors and the optimal predictive model revealed that participants who 
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took five to seven medications were more likely to be adherent to their medication 
regimen, but a significant linear trend was not observed for either of the predictors. This 
medication adherence finding was not consistent with the literature that purports fewer 
medications equate with better adherence (Gradman et al., 2010; Munger et al., 2007). 
Perhaps those with a higher number of medications in this study perceived themselves as 
sicker and were more adherent. Further, the increased number of medications may have 
serendipitously contributed to frequent visits to the health care provider that fostered 
better communication, trust, and engagement in self-care/medication adherence.    
Clients tend to be more adherent to their antihypertensive medications when they 
are actively engaged in their own care. Because random office visits may be the client‘s 
only BP measuring tool, they may feel disconnected and identify less with their HTN 
diagnosis (Friedewald et al., 2010). To facilitate active participation of clients in their 
own care, Friedewald et al. (2010) described a technique used in their practice that is 
worthy of summation. Client education is first used to help clients understand their HTN 
diagnosis and how medications work in their body to control BP. Because education 
alone does not increase adherence to antihypertensive medications, clients are made 
active participants in their care to assist them in taking ownership of their BP through 
self-monitoring. Initially, clients are taught how to use BP monitoring equipment in the 
office while comparing their results with the office equipment. As clients take their own 
BP as prescribed, they electronically transmit the results to the health care provider or 
keep the results in a BP diary that is brought to office during visits. These activities serve 
to keep the client actively involved in their BP care as they experience firsthand how 
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their BP fluctuates with stress, emotions, time of day, and diets high in sodium and fat. 
Although this method of actively involving the client in BP self-care may be time 
consuming initially, the end result of adequate BP control is rewarding. This method may 
not work for all clients, but it does create an atmosphere where the client owns their 
diagnoses of HTN and works to maintain BP control. Further research to verify how 
medication adherence is affected by this intervention is needed.      
Blood pressure. According to Friedewald et al. (2010), Blacks tend to experience 
a longer duration of the hemodynamic stresses of HTN long before they meet the JNC 7 
criteria for HTN. The authors contend that it is the long duration of HTN that contribute 
to higher mortality rates in Blacks when compared to Whites. Friedewald, et al. (2010) 
concur with the recommendation of the International Society on Hypertension in Blacks 
(ISHIB) (Flack et al., 2010) to lower the target BP from less than 140/90 to less 
than135/85 for Black clients with uncomplicated HTN (e.g. no target organ damage or 
CVD) and continue with the JNC 7 criteria of less than 130/80 for Black clients with 
complicated HTN. However, the complications to monitor have expanded from those 
only with diabetes or chronic kidney disease to include those with diabetes, prediabetes, 
high Framingham risk, left ventricular hypertrophy, metabolic syndrome, or glomerular 
filtration rate <60. Flack, et al. (2010) report that these BP recommendations followed an 
extensive review of clinical trials and treatment guidelines. The ISHIB recommendations 
were criticized by Wright et al. (2010) who claimed that sufficient evidence was not 
available to support the lower BP treatment goals. This lack of clarity is of concern 
because no consistent recommendations exist for Blacks.  
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Currently Blacks, especially Black women, have the highest rates of HTN in the 
world (Roger et al., 2011). Lowering the BP in Blacks requires a multifaceted approach 
and the guidelines from both JNC 7 and ISHIB warrant an aggressive health focus at the 
client, medical, and community levels to combat this vexing health problem. At the time 
of this study, over 40% of the participants were hypertensive, despite being prescribed 
and filling antihypertensive medications. 
Of those study participants who claimed total adherence to their antihypertensive 
medications, over one-third had HTN. These results may be indicative of unknown 
factors that could contribute to increases in BP. Another consideration is that participants 
may not have been completely truthful in their claim of total adherence to their 
antihypertensive medications. No matter what the cause, HTN in over one-third (35%) of 
those claiming total adherence to their antihypertensive medications is alarming. 
Similarity, over one-third (38%) of those study participants who reported nonadherence 
to their antihypertensive medications experienced HTN. This may suggest that many in 
the nonadherent group were engaging in a partial level of adherence to their 
antihypertensive medications. Of great concern is that over 40% of all participants in this 
study were not adequately controlled with their current antihypertensive medications. 
These data are similar to the 45.7% prevalence rate of HTN among Black women 
according to the American Heart Association statistics (Roger et al., 2011). If the 
suggested ISHIB recommendations for HTN were followed, the prevalence rate of HTN 
in Black women would be considerable higher. The results of this study add support to 
the JNC 7 statement that HTN will only be controlled if clients are motivated to adhere to 
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the treatment plan (Chobanian et al., 2004). Hence, further investigation into other areas 
such as the psychological impact of fatalism may be in order. 
Body mass index. Body mass index is commonly used to assess obesity that is 
caused by an energy imbalance ("Overweight and obesity", n.d.). This energy imbalance 
occurs when the amount of ―energy in‖ is not balanced with the amount of ―energy out‖ 
of the body. For instance, excess caloric intake from food and drinks along with physical 
inactivity over time will result in overweight/obesity ("Overweight and obesity", n.d.).  
It is well documented that Black women (79.6%) have the highest prevalence of 
overweight/obesity when compared to White (57.5%) and Hispanic (74.1%) women 
(Flack et al., 2010; Roger et al., 2011). Black women (24.1%) also have the lowest 
prevalence of regular leisure-time physical activity as compared to White (36.2%) and 
Hispanic (25.9) women (Roger et al., 2011). This lack of energy expenditure is reflected 
in higher BMIs and larger waist circumferences both of which are predictors of obesity-
related health risk, such as CVD (Roger et al., 2011). The current study findings of this 
Black female sample are consistent with the literature (Roger et al., 2011), whereby the 
majority were overweight or obese with a waist circumference greater than or equal to 88 
cm. Study findings indicated that there was no statistically significant association 
between BMI and medication adherence. This result suggests that BMI and medication 
adherence are not related concepts although antihypertensive medications are more 
effective with lifestyle modifications such as weight control. Lack of weight control may 
be indicative of lack of control in other aspects of life. This perception may create bias 
toward overweight/obese clients. In fact, clients with higher BMIs were less likely to be 
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perceived as adherent to medications by their health care providers (Huizinga, Bleich, 
Beach, Clark, & Cooper, 2010). Perceived discrimination because of physical 
characteristics toward overweight/obese clients is similar to prejudices held against 
women due to race or gender. In comparison to Blacks, perceptions of this nature may be 
a reality as evidenced by disparate health care. Therefore, this issue deserves further 
exploration.    
Environmental resources. 
Income. The cost of medications has been reported as a frequent barrier to 
medication adherence, especially for low income clients. Even low prescription 
copayments can be problematic for Medicare and Medicaid recipients (Munger et al., 
2007). One study (Applegate et al., 2000) found that the cost of antihypertensive 
medications was the primary reason for nonadherence to the treatment regimen, and the 
initiation of free medication and health care was significantly related to BP control.  
Contrary to popular opinion, Blacks are thought to value other items, such as 
cellular telephones, as more affordable than antihypertensive medications. Many are not 
aware that cellular telephones are essentially free to low-income consumers through a 
federal program that subsidizes providers to supply up to 250 free minutes of cellular 
telephone use monthly. The Federal Communications Commission‘s Lifeline Assistance 
and Link-Up program was initiated in 1996 to provide discounts for landline telephones 
and upgraded to mobile telephones during the G. W. Bush‘s administration (Free 
government cell phones, 2011). Biased information concerning the client‘s use or misuse 
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of economic resources that could aid adherence to the treatment regimen may contribute 
to stereotypes that may ultimately influence the quality of health care delivered.   
When clients cannot afford to purchase medications, it is not an uncommon 
practice to alter the medication dosage or schedule to make medications last a longer 
period of time. Low income and high out of pocket cost contribute to this behavior 
(Steinman, Sands, & Covinsky, 2001). According to a study conducted by Steinman, et 
al.(2001), elderly clients, particularly minorities, engaged in medication restriction 
behaviors when they lacked health insurance. 
This study found no statistically significant association between income and 
medication adherence. Over 75% of participants in this study reported they could afford 
their medications all of the time. Only one participant stated they could not afford any of 
their medications. Interestingly, nonadherence to antihypertensive medications was noted 
among one fifth of participants who reported income levels ranging from $45,000 to an 
excess of $100,000. Despite adequate resources participants were nonadherent to their 
antihypertensive medications. Thus, a sufficient income level with the ability to afford 
medications was not an assurance of medication adherence in this sample. Nonadherence 
was also noted in a randomized controlled intervention study (Martin et al., 2011). A 
population of predominately low income Black clients (95%) living in a rural setting 
were nonadherent to medication-taking even though free antihypertensive medications 
were provided. Although individual-level factors, such as confidence building and 
modification of beliefs and behaviors were implemented, the authors noted this was not 
enough to improve adherence to antihypertensive medications. The authors concluded 
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that there are factors other than the ability to afford medications that influence medication 
adherence behaviors. Barriers cited to nonadherence were forgetfulness and 
transportation. This study suggests that health care providers need to assess individual 
client dynamics to determine the factors that contribute medication adherence.  
Type of health coverage. For those who are employed, the type of health care 
coverage is primarily limited to the policy offered by employers. One type of plan, high-
deductible health plan, attracts those who are young, healthy, and low-cost users. Clients 
who are older and sicker generally choose the traditional plans that become more 
expensive with long term use or the high-deductible health plan resulting in less care 
initially, then higher morbidity and increased overall health care costs later (Waters, 
Chang, Cecil, Kasteridis, & Mirvis, 2011). Government health programs, such as 
Medicaid and Medicare, were created primarily to cover single parent families and the 
elderly. However, services in both of these programs have expanded to provide indigent 
care (Kovner & Knickman, 2008). People who are uninsured generally rely on free 
clinics, health departments, and hospital emergency departments for health care (Kovner 
& Knickman, 2008) and may be less adherent to a medication regimen.  
In the current study, there was no statistically significant association between type 
of health coverage and medication adherence. Study results indicated that over 80% of 
participants had health insurance through employers or were covered through health 
programs such as Medicaid and Medicare. The economic recession in the United States 
affected employment opportunities for 15% of the participants in this study. If 
government health plans were nonexistent, one-fourth of this sample would not have had 
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a health care plan. This would have increased the number of uninsured persons and 
increased the burden of indigent health care to emergency departments.  
Consumer expenditures for health care in the form of insurance premiums, co-
payments, and out-of-pocket cash have increased immensely with advances in medical 
technology and the treatment of chronic diseases, such as HTN. Medications are one of 
the primary treatments for chronic diseases and the costs continue to escalate. In one 
study (Domino et al., 2011), Medicaid policy changes restricted medication refills to a 
30-day supply and increased the co-pay for brand medications. The effects of these policy 
changes 18 months later revealed a substantial decrease in medication adherence in 
clients with chronic diseases. The most pronounced barrier to adherence was frequent 
trips to the pharmacy for refills, not cost of medications. Although these policy changes 
resulted in government cost savings, the long-term clinical effects of medication 
nonadherence with worsening disease states requiring increased hospitalizations have not 
yet been realized.    
Elements of Client Singularity: Dynamic Variables 
Intrinsic motivation. 
Reactance. Because treatment of HTN involves lifestyle changes such as taking 
medications, altering the diet, and increasing physical activity, personal freedoms are 
impacted. Clients may be motivated to preserve those freedoms (Fogarty, 1997) by not 
adhering to the treatment regimen. Because of their historical legacy of slavery and racial 
discrimination, Blacks may view freedoms differently than other races and make greater 
efforts to reserve those freedoms. For instance, when a Black woman with HTN is told 
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she must adhere to the medication regimen, she may choose to preserve her freedom and 
do the opposite of what she is told to do. This behavior is consistent with psychological 
reactance (J. W.  Brehm, 1966). Studies (Seemann et al., 2004; Woller et al., 2007) 
indicated that Blacks have higher levels of reactance than Whites in the areas of distrust, 
stress, hostility, and depressive symptoms. In addition, men were noted to have higher 
reactance scores than women possibly due to women‘s socialization to be more 
submissive. Thus, reactance may be an intrinsic variable associated with medication 
adherence. 
The relationship between reactance and medication adherence was not statistically 
significant in this study. One explanation for the lack of reactant behaviors was that the 
design of the tool may not have captured the intrinsic motivation that Black women 
possess due to their unique psychological complexities. Although the reactance tool was 
designed to identify clients who may need additional help in adhering to the treatment 
regimen, its use with Black women was not previously established. No known studies 
have investigated reactant behaviors in Black women as related to medication adherence. 
Because very little is known about the psychology make-up of Black women and the 
challenges they face in various aspects of their lives, they are oftentimes misjudged, 
misunderstood, and even labeled as mythical creatures (Jones & Shorter-Gooden, 2003). 
Behind the tough appearing façade of many Black women lurks the trauma of racism, 
sexism, and classism with resultant psychological and physiological stressors that 
manifest in diseases such as HTN. Although this tool has merit, further development and 
research are needed to capture psychological reactance in Black women.  
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Another explanation for the lack of reactant behaviors in this study is the older 
age of participants (M = 47.8) as compared to previous studies using younger men and 
women participants (M = 21.9 – 23.6) (Seemann et al., 2004; Woller et al., 2007). In the 
current study, no significant correlations were found in the reactance scores of younger 
women or older women. Only 6% (n=5) of the women in this study were aged 30 or less. 
A study conducted by Hong et al. (Hong, Giannakopoulos, Laing, & Williams, 1994) that 
included men and women aged 18-40, found that younger people displayed higher 
reactance levels than older people. Hong et al. (1994) concluded that maturity and life 
experiences may decrease motivations to preserve personal freedoms, thus decreasing 
reactant behaviors. Studies focused on refining the instrument and including increased 
numbers of younger women may provide clarity on the role of reactance to medication 
adherence. 
Cognitive appraisal. 
Hypertension knowledge. According to the American Heart Association statistics 
(Roger et al., 2011), the overall percentages of those aware of and treated for HTN is 
about 80% and the percentages were higher among Blacks than Whites. Low scores on 
the 12-item High BP Prevention IQ questionnaire (HBPPIQ) suggest several 
misconceptions about HTN. Almost all of the participants in this study believed stress 
causes HTN, and the vast majority thought that HTN has symptoms. In addition, over 
two-thirds believed that there is a cure for HTN, and over half held that a person has to 
exercise vigorously every day to improve their BP and heart health. Also, over half 
thought they would get HTN if their parents were diagnosed with HTN. Based on the 
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current study of Black women with HTN, increased awareness was not associated with a 
better knowledge of HTN as reflected in the low HTN knowledge scores.  
Low health literacy may be one explanation for the low HBPPIQ scores, although 
health literacy was not assessed in the current study. Those who had not completed a high 
school education could have contributed to the low HBPPIQ scores. However, no 
statistically significant correlations were found between education and HTN knowledge. 
Nevertheless, the participants‘ low HBPPIQ scores indicate the need for further education 
concerning HTN to increase knowledge and contribute to better medication adherence. 
Even though knowledge in itself is not enough to ensure adherence, it is necessary for 
adherence to occur (Pascucci et al., 2010).  
Kim et al. (2007) found that intentional nonadherence to antihypertensive 
medication regimens in middle-aged Korean Americans with HTN was significantly 
associated with a lack of HTN knowledge. In contrast, a Cochrane review concluded that 
education alone was not associated with large BP reductions in clients on prescribed 
medications (Glynn et al., 2010). Therefore, in addition to education, interventions to 
affect HTN in Black women may need to be multifaceted and inclusive of strategies that 
include pertinent aspects of the client‘s physiological, psychological, sociodemographic, 
and environmental characteristics (Cox, Sullivan, & Roghmann, 1984) along with the 
inclusion of the client as an active participant in the treatment regimen.  
Self-care of HTN. Self-care knowledge is educational information a client has 
learned to independently take care of their personal needs. According to Becker (1985), 
clients who are motivated to adhere to the treatment regimen must have adequate 
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knowledge to succeed. Riegel, Lee, Dickson, and Carlson (2009) developed a model of 
self-care for HTN. This model describes the client‘s naturalistic decisions that reflect his 
or her choice of behaviors in self-care maintenance and self-care management. The client 
engages in self-care between visits to their health care provider. Maintenance refers to the 
physiological stability of BP that is achieved with routine activities such as medication 
adherence, eating a diet rich in fruits and vegetables, participating in physical activity, 
and regular check-ups with the health care provider. Management differs in that it refers 
to recognizing, responding, making decisions about appropriate treatment, implementing 
the treatments, and evaluating the response to the treatment. The goal of management is 
adequate BP control. Self-care confidence, though not part of the model, is the ability to 
perform a task comfortably to achieve the desired outcome.  
Of the self-care of HTN subscales, only the self-care maintenance and self-care 
confidence subscales were significant univariable predictors of medication adherence 
suggesting that participants were likely to be adherent to antihypertensive medications. 
The management subscale not a significant univariable predictor of medication 
adherence.  
Riegel, et al. (2009) found that clients who had above-average scores (≥70) on the 
management subscale, indicating self-care, had a lower risk of an adverse health event 
during follow-up than those with below-average scores (<70). However, the authors 
noted that benefits of self-care, such as lower health care costs, effective relationships 
with health care providers, and client satisfaction may be evident in some clients with 
below-average scores on the subscales. In the current study, only a small percentage of 
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participants achieved a cut-off score of 70 or greater on the Self-Care of HTN Index 
subscales to indicate self-care adequacy; maintenance (3.8%), management (11.8%), and 
confidence (28.8%). These low self-care scores may be reflective of low HTN knowledge 
scores previously discussed. While knowledge is nice, it is not sufficient evidence of 
medication adherence. Therefore avenues to augment HTN knowledge may include BP 
self-monitoring and participation in HTN self-help and support groups. 
Clients who possess knowledge, experience, and skill of their disease process are 
expertly engaged in self-care (Riegel et al., 2009). One factor that may enhance the self-
care of HTN model is motivation. While it is advantageous for client‘s to have 
knowledge, experience, and skill to conduct self-care, if the client is not motivated to 
adhere to the treatment regimen, they are unlikely to improve (Becker, 1985).  
Trust in health care provider. The literature indicates that many Black clients 
generally distrust White health care providers because of their historical legacy of slavery 
and oppression that contributed to perceptions of injustices and discriminatory 
experiences in various health care situations (Gamble, 1997; Spillers, 1987; "Unequal 
treatment", 2002; Washington, 2006). This lack of trust in White health care providers 
may result in a lack of adherence to the treatment regimen (Greer, 2010). Consequently, 
many Black clients may have a preference for care and treatment from Black health care 
providers (Flack et al., 2010; Greer, 2010; B. D. Smedley et al., 2003; Watkins & Terrell, 
1988). However, the scarcity of Black health care providers is concerning and limits the 
Black clients‘ inclination to choose a provider based on race. Also, inappropriate cultural 
competence and awareness to treat the holistic needs of Black clients by health care 
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providers of other races and ethnicities may further complicate the trust issue and 
medication adherence outcomes (Barksdale, 2009; Yancy et al., 2005).  
The optimal predictive model in this study revealed that the dynamic variable that 
had a statistically significant relationship with medication adherence was trust. As trust in 
the health care provider increased, adherence to medications increased. That is, 
participants who reported the most trust in their health care providers were more willing 
to adhere to the prescribed treatment regimen. This finding is congruent to expectations 
that trust promotes better medication adherence (Benkert et al., 2009; Schoenthaler, 
Chaplin, et al., 2009). Similarly, another study (Nguyen et al., 2009) that used these same 
instruments to measure trust and medication adherence as did the current study found that 
higher adherence was associated with greater trust in the health care provider in a sample 
of Black and Whites with inflammatory bowel disease (IBO). Because the sex of 
participants in the study was not reported, it is unclear whether Black women were 
included. Further, because IBO has symptoms and HTN is silent, this may be a major 
difference between these two diagnostic groups.  
Although the findings of the current study support currently held beliefs regarding 
trust and medication adherence, there is reason to consider an alternative viewpoint for 
clients who may not trust their health care providers. In the age of time-constrained office 
visits, health care providers may tend to engage Black clients with HTN in chit-chat 
instead of meaningful dialogue relative to their health status. Clients who are distrustful 
may recognize that their health needs are not satisfied when they are left with superficial 
directives that are virtually meaningless and impossible to follow. Over time, the clients 
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become symptomatic and gain the label of being nonadherent to the treatment regimen 
that they may have had no knowledge. In essence, health care providers may not be 
providing Black clients with the health care information and services necessary to 
promote healthy lifestyle changes, thus increasing distrust of the health care provider. 
Although medications are the mainstay of HTN therapy (Chobanian et al., 2004), 
other treatment strategies may be necessary to maintain trust and adherence to the 
treatment regimen. According to Cox, Sullivan, and Roghmann (1984), multifaceted 
interventions to manage health problems are required from health care providers. These 
interventions include combining the client‘s physiological, psychological, 
sociodemographic, and environmental characteristics to achieve the desired health 
outcome, such as adherence to antihypertensive medication. Cox (2010, August 4) 
contends that clients must be involved as participants in the self-care of their health and 
initially, ample time must be spent to clear up misperceptions, misunderstandings, and 
misknowledge. Barksdale (2009) concurs and recommends a client-centered approach to 
delivering health care. Thus, increasing client knowledge, involvement in the treatment 
process, and devising interventions pertinent to the client‘s needs may be vital to 
establishing trust and maintaining medication adherence.      
Coping. Coping is the way an individual uses thoughts and actions to deal with 
stress. Stress on the other hand refers to how the body reacts to internal and external 
experiences. All people experience a measure of stress. Black women, unlike other 
racial/ethnic groups, are confronted with the triple jeopardy of racism, sexism, and 
classism that may overtax coping mechanisms and contribute to insurmountable 
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psychological and physiological stressors (Beal, 1969; Jones & Shorter-Gooden, 2003). 
Empirical evidence suggests that persistent stress in the absence of adequate coping 
mechanisms may predispose an individual to chronic diseases such as HTN (Lehman et 
al., 2009; B. McEwen & Seeman, 1999; B. S. McEwen, 2005; Schneider et al., 2001). 
The John Henryism hypothesis predicts that low socioeconomic status (SES) clients with 
chronic psychosocial, economic, and environmental stressors who continuously engage in 
active coping through hard work will increase their likelihood of developing sustained 
physiological reactions over time that contribute to HTN (Bennett et al., 2004; James, 
1996). It is well known that when people actively cope with difficult stressors in the 
environment, the body experiences a recurrent sympathetic arousal that leads to an 
elevated BP. With John Henryism, those who believe they can master or actively cope 
with difficult or prolonged psychosocial or environmental stressors by trying to overcome 
the stressor with inadequate coping strategies are at greater risk for chronic diseases such 
as HTN than those who are more reserved about stressors. When John Henryism active 
coping is repeatedly elevated, an inverse relationship exists between SES and BP 
whereby SES is decreased and BP is increased (James et al., 1987). 
The variables frequently used to examine SES are wealth related (education, 
income, and health insurance). In the current study, 16.3% of this sample had less than a 
high school education, about a third of the participants lived below the federal poverty 
level, and only 17.5% were without health care coverage. In addition, 18.8% reported 
inadequate finances or unemployment as a stressor. Almost one-third of this sample was 
poverty stricken and almost half had HTN despite having prescribed antihypertensive 
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medications. The John Henry inverse relationship between low SES (income) and high 
BP was true for almost half of the study participants, and the High John Henry scores 
above the median (>50) were noted in those whose income was less that the poverty 
level. Further, 21% of those below the poverty level reported total medication adherence 
with a perfect Hill-Bone Compliance score. In this study, coping was not significantly 
related to medication adherence.  
Other studies found no relationship between coping and HTN (Jackson & Adams-
Campbell, 1994; James, Keenan, Strogatz, Browning, & Garett, 1992). In contrast, two 
studies showed that coping was associated with mean arterial changes (R. Clark, Adams, 
& Clark, 2001) and increased BP (James et al., 1987). According to James (1992), the 
inverse association between coping and high BP is more apparent with the presence of a 
low SES which signifies increased psychosocial stressors that overwhelm coping 
mechanism. In a study conducted by Shorter-Gooden (2004) on mechanisms to identify 
coping strategies in Black women, results indicated that those who were resistant to the 
damaging effects of stress-related health consequences tended to engage in various 
coping strategies, such as spirituality, social support, and valuing oneself. In the current 
study, results suggest that the low SES of some participants was not a persistent stressor 
that taxed coping resources. 
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Affective response. 
Perceived racism/discrimination. Research findings note that perceptions of 
racism/discrimination experienced by many Blacks in health care settings is related to 
disparate care for diseases, procedures, and pharmacological care, especially as related to 
CVD ("Unequal treatment", 2002). Behavioral and emotional responses to 
racism/discrimination is associated with an elevated BP in Blacks (Armstead et al., 1989; 
T. T. Lewis et al., 2009), including less nocturnal systolic BP and diastolic BP dipping, 
indicating a consistently increased BP (Tomfohr et al., 2010). In contrast, several studies 
including the current study, found no correlation between BP and perceived 
racism/discrimination in Blacks (Barksdale et al., 2009; C. Brown et al., 2006; S. K. 
Davis & Quarells, 2005; Peters, 2004, 2006).  
The age of participants in the current study may have been an influencing factor 
on their perceptions of racism/discrimination. Since the average age of the participants 
was 47.8, around 63% of the participants were around the age of 10 when the Civil 
Rights era ended in 1968. Therefore, many participants were not directly exposed to the 
harsh realities of racism/discrimination and may only have experienced subdued forms of 
racism/discrimination. However, since the election of the nation‘s first Black President, 
―silent racism‖ has evolved (Rossing, 2011, p. 429). The term racism has become 
distorted and downplayed, especially in the political arena, because it signifies racial 
disunity. Therefore, any racist attacks on the President or other people of color are 
virtually ignored in the mainstream public discourse (Rossing, 2011). These events could 
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have a major impact on the health status of racial/minority groups with a potential 
increase in stress related illnesses, such as HTN.  
In the current study, perceived racism/discrimination was not related to 
medication nonadherence. In contrast, several qualitative studies found that perceived 
racism/discrimination was identified as a factor in nonadherence to antihypertensive 
medications (L. M. Lewis et al., 2010; Lukoschek, 2003; Webb & Gonzalez, 2006). 
Clients who feel they are treated unfairly may respond with anger and hostility and be 
less likely to follow the health care providers‘ treatment advice. Consequently, the impact 
of racism/discrimination may reflect mistrust and rejection of health care providers and 
services offered, contributing to poor medication adherence and subsequent poor health 
outcomes (Chakraborty, King, Leavey, & McKenzie, 2010).  
Depression. Depression in Black women is not fully understood (Read & 
Gorman, 2007) and may be difficult to detect (Jones & Shorter-Gooden, 2003). 
Typically, Black women deny depressive symptoms (Duckwork, 2009) and describe 
depression differently, such as feeling stressed or tired (Jones & Shorter-Gooden, 2003). 
Therefore, treatment for depression is either not readily sought by Black women, or 
depression is oftentimes misdiagnosed (Duckwork, 2009). Therefore, capturing the true 
clinical picture and prevalence of depression in Black women may be elusive. 
The relationship between depression and HTN is not clear. The results of one 
study found that depression was related to higher diastolic BP and stress in Black women 
(Artinian et al., 2006). Hypertension was associated with a greater risk of depression in 
Canadian men, but not women (Patten, 2001). In contrast, another study (M. T. Kim et 
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al., 2003) noted that depression was not significantly related to BP in Black men, 
although medication nonadherence was associated with increased systolic BP.  
Medication adherence is also associated with depression and HTN. One study 
(Schoenthaler, Chaplin, et al., 2009) of Blacks who have HTN found that poor 
medication adherence was associated with depressive symptoms and younger age. 
Another study in clients with HTN noted that increases in depressive symptoms were 
associated with lower odds of antihypertensive medication adherence (Wang et al., 2002). 
A qualitative study (Fongwa et al., 2008) including those with HTN noted that depressed 
clients ruminated about things they could not change and failed to follow the treatment  
regimen including medication adherence. These studies clearly show that depression is 
associated with medication adherence in clients with HTN. In the current study, as 
medication adherence decreased, depression increased. Depression was a significant 
univariable predictor of medication adherence. Consistent with this finding, other studies 
concur that poor medication adherence is associated with depression in clients with HTN 
(Fongwa et al., 2008; Read & Gorman, 2007; Schoenthaler, Chaplin, et al., 2009; Wang 
et al., 2002). Despite the association of depression and medication adherence, depression 
was not in the optimal predictive model. 
Implications for Nursing 
Hypertension is rampant among Blacks, especially Black women. The effects of 
HTN are noted earlier in the life of Blacks when compared to Whites and other 
racial/ethnic groups. Therefore, education of young Black elementary and middle school 
children about the devastating effects of HTN is imperative. In addition, HTN education 
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and screening in pre-adolescent youth will assist in making young Blacks cognizant of 
HTN, its risk factors, and the importance of lifestyle modifications. Targeting this 
population may help break the cycle of cultural practices that negatively impact HTN. 
Nursing is in a pivotal role to implement these primary prevention strategies.  
Nurses must get involved in organizations, scientific study groups, and other 
mechanisms to encourage resources to fully understand HTN in Blacks, especially Black 
women. Nurses must lead in advocating for awareness of HTN which should be as 
important as breast cancer awareness and the Go Red for Women campaign. It is vital to 
actively engage organizations, such as the American Heart Association, in the education 
of Black youth. Interventions aimed at Black at-risk youth may help to prevent the long 
term effects of HTN that contribute to increased morbidity, disability, and mortality. 
Equally important is the necessity for research to define the early age that HTN risk is 
most likely to be noted in Blacks. Without clear direction in the incidence of HTN, 
healthcare providers may miss opportunities to screen for HTN due to their lack of 
awareness.   
Depression in Black women is oftentimes difficult to detect because many have 
been socialized to appear strong, tough, and confident even when falling apart on the 
inside. More psychometrically sound assessment and screening tools are needed that 
target depression in Black women. Because Black women tend to report they are stressed 
and cannot name their feeling as depression, help sought from health care providers is 
usually futile as it addresses stress, not depression. As a result, Black women are 
oftentimes misdiagnosed. Frustration develops from a lack of sensitivity to their needs 
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and fatalistic attitudes may evolve that hinder their ability to follow the treatment 
regimen. Oftentimes depression in the Black community is viewed as a weakness and 
thought to be overcome by reliance on prayer, family, and friends. Support from 
policymakers is needed for public education programs to aid in dispelling long held 
beliefs about depression in Black women. Nurses must be diligent in assessing clinical 
factors, such as depression and fatalism, and in conducting research to identify other 
factors that may be associated with nonadherence to antihypertensive medications. 
Increased number of prescribed medications was related to adherence to 
antihypertensive medications in this study. Participants taking five to seven prescribed 
medications were likely to be adherent. During assessments, nurses should not only ask 
clients to name their prescribed medications, but should rate the effect that prescribed 
medications have on the client‘s daily lives. This evaluation may help nurses determine 
risk for antihypertensive medication nonadherence.  
Currently, a critical need exists for research strategies to improve adherence in 
Black women with HTN. Because HTN occurs earlier in life for Blacks, the likelihood of 
HTN-related complications may contribute to increased hospitalization and health care 
costs. According to a recent study (Abel, Crane, Efird, & Sherer, 2011, February) on 
predictors of readmission rates in heart failure clients, data revealed that the higher the 
number of comorbidities, the greater the risk of readmission. With the economic 
recession in the United States, policymakers are penalizing hospitals with excessive 
readmission rates in an effort to curve health care costs and decrease government 
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spending. Developing and targeting interventions to those with more comorbidities may 
be important in controlling risking health care costs. 
Nurses are in a unique position to impact the health care system at the local, state, 
and national level in the achievement of positive health care outcomes for clients with 
chronic illnesses such as HTN. The current study suggested that Black women with HTN 
who tend to trust their health care provider are willing to adhere to the prescribed 
antihypertensive medications. This finding is congruent with previous research (Benkert 
et al., 2009; Schoenthaler, Chaplin, et al., 2009) that trust promotes medication 
adherence. As trusted professionals, nurses have experienced success in the control of 
HTN through nurse managed clinics. This places nurses in a unique position to take the 
lead in managing care of clients, especially Black women with HTN. Research studies 
found that client education and management by nurses improves clients‘ treatment 
adherence, self-care, clinical outcome, and medical costs (Albert, 2008; Greveson, 2008; 
Velez, Rahko, & Westerfeldt, 2008). In addition, nurse directed intervention programs 
are pivotal assets for improving disease management, client and family education, 
adherence (with clients as decision-makers in the treatment process), and long term 
follow-up post discharge. Because nurses have demonstrated success in improving 
adherence to the treatment regimen, the health care reform bill (Patient Protection and 
Affordable Care Act 2010) promotes nurse managed clinics and intervention programs to 
manage chronic diseases and long term medication adherence. Continuing to advocate for 
nurse led programs as well as clearly disseminating the outcomes of nurse managed 
clinics are essential in improving the health of Black women with HTN.   
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Recommendations for Future Research 
There are gaps in the literature related to factors that contribute to HTN in Black 
women as well as gaps in knowledge on how to increase adherence to the 
antihypertensive medication and treatment regimen. The unanswered question remains: 
Why are Black women disproportionately affected by HTN? Although medication 
adherence research in clients with HTN has been in existence for more than 30 years 
(Hill et al., 2010), a paucity of research has been dedicated to medication adherence from 
a Black woman‘s perspective. In fact, only one qualitative study was found in the 
literature (Fongwa et al., 2008) that specifically addressed adherence factors in Black 
women. Thus, further studies focusing on Black women with HTN of various ages are 
essential in developing knowledge important in decreasing disparity in HTN and 
associated outcomes. 
This study supports current literature that increased trust in the health care 
provider is associated with adherence to the medication treatment regimen. This finding 
is noteworthy because Black women who trust their health care providers are more likely 
to follow their treatment advice. It is important that health care providers spend adequate 
time cultivating relationships with Black women to discern reasons for the high 
prevalence of HTN in this population. The unknown factors that continue to frame 
inadequate BP control are disturbing because subsequent heart and kidney damage 
contribute to increased morbidity, disability, and mortality. Hence, the causes of these 
disastrous effects of HTN in Black women deserve further study. Both quantitative and 
qualitative studies may provide data to explore and explain these unknown factors. 
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A paucity of measurement instruments exist that are specific to Black women. 
Many Blacks have unique psychosocial, cultural, and environmental factors that are not 
homogenous with other racial/ethnic groups. Therefore, further examination of the 
psychometric properties of instruments used primarily in other racial/ethnic groups is 
needed prior to use in Blacks. In addition, instrument development for specific use in 
Blacks, especially Black women, is warranted.       
Longitudinal research studies on Black women with HTN are warranted to 
capture dynamic factors that may contribute to HTN and medication adherence. Another 
topic for further research is the impact of perceived racism/discrimination on medication 
adherence in Black women with HTN. Several qualitative studies have alluded to this 
topic, but no known studies have fully examined this issue. In addition, there are no 
known conceptual frameworks or models that consistently explain or predict medication 
adherence. Because nurses interface with clients at all levels of care, nurses are in a good 
position to develop a model of adherence. Lastly, future research must impact public 
policy with sustainable and reproducible methods that reduce the HTN disparity and 
improve medication adherence outcomes in Black women. Research in these areas is 
desperately needed to help reduce the burden of HTN in Black women.   
Summary 
The purposes of this study were to describe the differences in adherent and 
nonadherent Black women who have HTN and examine issues that influence medication 
adherence. In addition, this study explored the relationship between reactant behaviors 
and medication adherence. The study results did not show a difference between Black 
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women who adhere to antihypertensive medications and those who do not adhere. Also, 
there was no relationship between reactant behaviors and medication adherence. 
However, in the optimal predictive model, age and trust in the health care provider had 
the greatest influence on medication adherence. Therefore it is important to target those 
in the 40-49 age group and individuals who take five to seven medications. Further, the 
client-health care provider relationship should foster trust, actively involve the client in 
decision-making, and support the client in the adherence process. Future research should 
continue to identify factors that influence adherence to the treatment regimen and develop 
interventions that facilitate the client‘s ability to better manage their HTN and maintain 
BP control, especially for Black women with HTN. 
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APPENDIX D 
 
DEMOGRAPHIC HEALTH DATA COLLECTION TOOL 
 
I‘d like to ask you some questions about your health and different things that may affect 
your health, especially your blood pressure. I am going to read several statements to you, 
and after I read each statement, I want you to answer as honestly as you can with the one 
answer that best describes you. It is important that you give honest answers based on your 
health status and not answer how you think I may want you to respond. 
1. Ethnicity:  a. _____ African American 
   b. _____ Central American 
   c. _____ South American 
   d. _____ Caribbean Countries 
   e. _____ Africa 
   f. _____ Biracial 
   g. _____ Other 
 
2. Age on last birthday: _____________________ 
 
3. Current Marital Status:  a. _____ Single (never married)  
     b. _____ Married  
     c. _____ Separated  
     d. _____ Divorced 
     e. _____ Widowed  
     f. _____ Other  
 
4. Education:  a. _____ Less than 12th grade- list grade completed ______ 
   b. _____ 12
th
 Grade, No Diploma  
   c. _____ High School Graduate  
   d. _____ GED or Equivalent  
   e. _____ Some Community College  
   f. _____ Graduated Community College  
   g. _____ Some 4-year College   
   h. _____ Graduated 4-year College  
   i. _____ Some graduate school  
   j. _____ Completed graduate school  
   k. _____ Other 
 
5. Are you currently attending school? a. _____ Full-time student 
b. _____ Part-time student 
c. _____ Not a student 
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6. Current Occupation: __________________________  
a. _____ Full-time 
b. _____ Part-Time  
c. _____ Not employed/unemployed 
d. _____ Disability 
e. _____ Other 
 
7. Retired: a. _____ Yes,   
b. ____ Pensioner  
c. Position before retired _______________ 
d. _____ No 
 
8. Annual Household Income: 
a. ____Less than $10,000 
b. ____$10,000 to $14,999 
c. ____$15,000 to $19,999 
d. ____$20,000 to $24,999 
e. ____$25,000 to $34,999 
f. ____$35,000 to $44,999 
g. ____$45,000 to $54,999 
h. ____$55,000 to $64,999 
i. ____$65,000 to $74,999 
j. ____$75,000 to $99,999 
k. ____$100,000 and Over 
l. ____Below $30,000 
m. ____Above $30,000 
n. ____ Refused 
 
9. _____ Number of years with High Blood Pressure 
 
10. Family History of High Blood Pressure  
a. _____ Yes 
b. _____ Mother 
c. _____ Father 
d. _____ Sibling ____ # of siblings 
e. _____ Grandparents ____ # grandparents 
f. _____ No 
g. _____ Unsure 
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11. 1st Blood Pressure (5 minutes after arrival) 
 
 
12. 2nd Blood Pressure (one minute between measurements) 
 
 
13. Weight 
 
 
14. Height 
 
 
15. Waist Circumference 
 
 
  
 
 
16. Medical problems/ 
Comorbidities: 
Self Mother Father Grand- 
parents 
Siblings Other: 
Aunt/Uncle 
a. Hypertension/high 
blood pressure 
      
b. Irregular heartbeat        
c. Heart attack 
(Myocardial 
infarction) 
      
d. Heart failure       
e. Peripheral vascular 
disease 
      
f. Stroke 
(Cerebrovascular 
disease) 
      
g. Lung disease: Type:       
h. Diabetes       
i. Ulcer disease       
j. Liver disease       
k. Kidney disease: Type:       
l. Cancer: Type:       
m. Depression       
n. Other: 
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The researcher will need to inspect all prescribed and over-the-counter medications used 
during the past two weeks preceding the interview. 
17. Current Medications NO YES Drug/Dose/Number of times taken each day 
a. Antihypertensive (to 
lower blood pressure 
   
b. Cholesterol     
c. Angina/chest pain    
d. Regulate heartbeat    
e. Aspirin    
f. Water pill/Diuretic    
g. Insulin or oral 
diabetic pill 
   
h. Arthritis    
i. Thyroid pill    
j. Stomach pill    
k. Nerve pill    
l. Hormone pill    
m. Vitamin    
n. Herbal products 
 
   
o. Other medications: 
 
 
 
 
 
   
 
 
18. What is the worst side effect you have experienced from taking blood pressure 
medication?_______________________________________________________ 
a. _____ Does not apply 
 
19. Name one thing that keeps you from taking your blood pressure medication the 
way your health care provider/doctor told you to take it 
_________________________________________________________________ 
a. _____ Does not apply 
 
20. Do you have everything you need to take good care of your high blood pressure? 
a. _____ Yes 
b. _____ No, if not, name one thing that will improve your blood pressure 
management ___________________________________________________ 
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21. Does your high blood pressure affect your ability to do every day activities? 
a. _____ Yes 
b. _____ No 
 
22. Who do you talk to about your high blood pressure? (check all that apply): 
a. _____ Spouse 
b. _____ Children 
c. _____ Family member 
d. _____ Friend 
e. _____ Health care provider 
f. _____ Other, ________________________________________ 
 
23. Do you currently smoke, dip, or chew tobacco? 
a. _____ Yes,  
b. Number of cigarettes you presently smoke per day _____  
c. No of times for dip or chew _____ 
d. _____ No 
 
24. Have you ever smoked, dipped, or chewed tobacco? 
a. _____ Yes; _____ How many years  
b. _____ No 
 
25. Do you or did you live around people who smoke(d) every day? 
a. _____ Yes 
b. _____ No  
 
26. Do you drink alcohol? 
a. _____ Yes 
b. _____ No 
 
27. Do you use illicit drugs? 
a. _____ Yes 
b. _____ No 
 
28. Has your health care provider/doctor put you on a special diet? 
a. _____ Yes, type 
____________________________________________________ 
b. _____ No 
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29. Do you engage in physical activity such as walking for at least 30 minutes each 
week? 
a. _____ Yes, how often? 
b. _____ 1 day per week 
c. _____ 2-3 days per week 
d. _____ 4-5 days per week 
e. _____ 6-7 days per week 
f. _____ No 
 
30. Type of Health coverage (check all that apply):  
a. _____ Health Insurance 
b. _____ Through Work 
c. _____ Self-pay 
d. _____ Medicare  
e. _____ Medicaid  
f. _____ No Health Insurance 
g. _____ Free Clinics 
h. _____Other, list _________________________________   
 
31. Are the total costs of your medications 
a. _____ Covered by your health care plan 
b. _____ Partially covered with a co-pay 
c. _____ Paid for by you 
d. _____ Provided free through clinic or drug program 
 
32. Are you able to afford  
a. _____ All of your medications 
b. _____ 75% of your medications 
c. _____ 50% of your medications 
d. _____ 25% of your medications 
e. _____ None of your medications 
 
33. If you are not able to afford all of your medications, how do you decide which 
medications are most important for you to get?  
a. ______________________________________________________  
b. ______Does not apply  
 
34. What pharmacy do you usually use? 
_________________________________________________________ 
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35. Why did you choose this pharmacy? (check all that apply) 
a. _____ Close to your home 
b. _____ Convenient (such as has a grocery store) 
c. _____ Low prices 
d. _____ Hours open for business 
 
36. Where do you usually go to see your health care provider? 
a. _____ Private office 
b. _____ Emergency room 
c. _____ Health department 
d. _____ Free clinic 
e. _____ Other, List _____________________________________ 
 
37. Family size:  
a. _____  # of persons living in your household, including self 
b. _____  Children < 18 years of age 
c. _____  #Adults > 50 years of age, including self  
 
38. Are you responsible for the care of a person who is 
a. _____ Disabled  
b. _____ Handicapped 
c. _____ Mentally challenged 
d. _____ Elderly person  
e. _____ Other, list ______________________________________ 
f. If yes, how many hours a day ____________   
g. _____  No, I am not responsible. 
 
39. In the past year, have you experienced any stressful events (check all that apply): 
a. _____  Death 
b. _____  Job Change 
c. _____  Marriage 
d. _____  Divorce 
e. _____  Personal Injury 
f. _____  Illnesses 
g. _____  Unemployment 
h. _____  Other:  ________________________________________________ 
 
40. Residential setting:   
a. _____ Primarily Black neighborhood       
b. _____ Primarily White neighborhood 
c. _____ Mixed, list _____________________________________ 
d. ____Other, list ______________________________________ 
 
41. Zip Code:  ____________________________________________ 
 
240 
 
42. Housing/Living Arrangements (check all that apply):   
a. _____  Live Alone 
b. _____Living with Family/Friends 
c. _____Not Living with Family/Friends 
 d.   _____ Apartment 
 e.   _____ House 
 f.   _____ Other 
 
43. How do you travel:  
a. _____ Private car 
b. _____ Rely on Family/Friends 
 c. _____ Public Transportation 
 d. _____ Other, list _____________________________ 
 
44. Do you believe that God exists? 
_____ Yes 
_____ No 
 
45. Religious Denomination or Spiritual Beliefs: 
_____________________________________________ 
 
46. Do you belong to a Church, religious group, or other place of worship as a 
member? 
a. _____ Yes 
b. _____ No 
 
47. How often did you attend Church, religious services, or other place of worship 
this past year? 
a. _____ More than once a week 
b. _____ Every week 
c. _____ Twice a month 
d. _____ Once a month 
e. _____ Once or twice a year 
f. _____ Never 
g. _____ Other, list ______________________________ 
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48. Do you pray? 
a. _____ No 
b. _____ Yes, how often? 
c. _____ More than once a day 
d. _____ Once a day 
e. _____ Once per week 
f. _____ At least twice month 
g. _____ A few times a year 
h. _____Other, list ______________________________ 
 
49. Do you read the Bible or other religious material? 
a. _____No 
b. _____Yes, how often? 
c. _____ More than once a day 
d. _____ Daily 
e. _____ Weekly 
f. _____ Monthly 
g. _____ Other, list ______________________________ 
 
50. How strong are your spiritual beliefs? 
a. _____ Weak 
b. _____ Somewhat weak 
c. _____ Somewhat strong 
d. _____ Strong 
 
51. Do you believe spiritual health is as important as physical health? 
a. _____ Yes 
b. _____ No 
 
52. How do you rate your physical health? 
a. _____ Poor 
b. _____ Fair 
c. _____ Good 
d. _____ Very good 
e. _____ Excellent 
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APPENDIX E 
 
HILL-BONE COMPLIANCE TO HIGH BLOOD PRESSURE THERAPY SCALE 
(HILL-BONE CHBPTS) 
 
 None 
of 
the 
time 
 
Some 
of 
the 
time 
 
Most 
of 
the 
time 
 
All 
of 
the 
time 
 
1. How often do you forget to take your HBP 
medicine? 
1 2 3 4 
2. How often do you decide not to take your HBP 
medicine? 
1 2 3 4 
3. How often do you eat salty food? 1 2 3 4 
4. How often do you shake salt on your food before 
you eat it? 
1 2 3 4 
5. How often do you eat fast food? 1 2 3 4 
6. *How often do you make the next appointment 
before you leave the doctor's office?  
1 2 3 4 
7. How often do you miss scheduled appointments? 1 2 3 4 
8. How often do you forget to get prescriptions 
filled? 
1 2 3 4 
9. How often do you run out of HBP pills? 1 2 3 4 
10. How often do you skip your HBP medicine before 
you go to the doctor? 
1 2 3 4 
11. How often do you miss taking your HBP pills 
when you feel better? 
1 2 3 4 
12. How often do you miss taking your HBP pills 
when you feel sick? 
1 2 3 4 
13. How often do you take someone else's HBP pills? 1 2 3 4 
14. How often do you miss taking your HBP pills 
when you are careless? 
 
1 2 3 4 
*=Reverse score before analysis 
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Willie Abel <wmabel@uncg.edu>  
 
Hill-Bone Compliance to High Blood Pressure Therapy 
Scale (Hill-Bone CHBPTS) 
 
Willie Abel <wmabel@uncg.edu>  Wed, Nov 3, 2010 at 5:02 PM  
To: mkim@son.jhmi.edu  
Dr. Kim, 
  
My name is Willie Mae Abel. I am PhD student in Nursing at The University of 
North Carolina at Greensboro. I will be conducting a non-funded research study on 
issues influencing adherence among Black women with hypertension on a sample 
size of 140 study participants during spring semester 2011.     
  
I am requesting permission to use the Hill-Bone Compliance to High Blood Pressure 
Therapy Scale. I believe this tool will provide valuable information to measure 
medication-taking behavior among Black women with hypertension.   
  
I look forward to hearing from you and I appreciate your prompt response. 
  
Willie Mae Abel, MSN, RN, ACNS-BC 
PhD Student, School of Nursing 
The University of North Carolina at Greensboro  
Phone: 704-638-0693 
Fax: 704-636-1612 
Email: wmabel@uncg.edu 
 
 
 
Kim, Miyong <mkim@son.jhmi.edu>  Wed, Nov 3, 2010 at 5:08 PM  
To: Willie Abel <wmabel@uncg.edu>  
Cc: "Hill, Martha N." <mnhill@son.jhmi.edu>  
Dear Willie, 
 
On behalf of Dr. Hill, the original developer of the scale, I give you a permission to 
use the tool. Please kindly let us know your study results after the study. 
Best wishes of your research, 
 
Miyong- 
  
 
244 
Miyong Kim RN, Ph.D, FAAN  
Professor and Chair 
Department of Health Systems and Outcomes 
School of Nursing  
Johns Hopkins University  
525 North Wolfe Street  
Baltimore, Maryland 21205-2110  
Tel: 410-614-1443  
Fax: 410-502-5481  
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APPENDIX F 
 
THERAPEUTIC REACTANCE SCALE (TRS) 
 
 Strongly 
Disagree 
 
Disagree 
 
Agree 
 
Strongly 
Agree 
 
1. If I receive a lukewarm dish at a 
restaurant, I make an attempt to let 
that be known. 
 1 2 3 4 
2. I resent authority figures who try to 
tell me what to do. 
1 2 3 4 
3. I find that I often have to question 
authority. 
1 2 3 4 
4. I enjoy seeing someone else do 
something that neither of us supposed 
to do. 
1 2 3 4 
5. I have a strong desire to maintain my 
personal freedom. 
1 2 3 4 
6. I enjoy playing "Devil's Advocate" 
whenever I can. 
1 2 3 4 
7. *In discussions, I am easily 
persuaded by others. 
1 2 3 4 
8. Nothing turns me on as much as a 
good argument! 
1 2 3 4 
9. It would be better to have more 
freedom to do what I want on a job. 
1 2 3 4 
10. If I am told what to do, I often do the 
opposite. 
1 2 3 4 
11. *I am sometimes afraid to disagree 
with others. 
1 2 3 4 
12. It really bothers me when police 
officers tell people what to do. 
1 2 3 4 
13. *It does not upset me to change my 
plans because someone in the group 
wants to do something else. 
1 2 3 4 
14. *I don't mind other people telling me 
what to do. 
1 2 3 4 
15. I enjoy debates with other people. 1 2 3 4 
16. If someone asks a favor of me, I will 
think twice about what this person is 
really after. 
 
1 2 3 4 
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 Strongly 
Disagree 
 
Disagree 
 
Agree 
 
Strongly 
Agree 
 
17. I am not very tolerant of others‘ 
attempts to persuade me. 
1 2 3 4 
18. *I often follow the suggestions of 
others. 
1 2 3 4 
19. I am relatively opinionated. 1 2 3 4 
20. It is important to me to be in a 
powerful position relative to others. 
1 2 3 4 
21. *I am very open to solutions to my 
problems from others. 
1 2 3 4 
22. I enjoy ―showing up‖ people who 
think they are right. 
1 2 3 4 
23. I consider myself more competitive 
than cooperative. 
1 2 3 4 
24. *I do not mind doing something for 
someone even when I don‘t know 
why I am doing it. 
1 2 3 4 
25. *I usually go along with others‘ 
advice. 
1 2 3 4 
26. I feel it is better to stand up for what I 
believe than to be silent. 
1 2 3 4 
27. I am very stubborn and set in my 
ways. 
1 2 3 4 
28. *It is very important for me to get 
along well with the people I work 
with. 
 
1 2 3 4 
*=Reverse score before analysis 
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Willie Abel <wmabel@uncg.edu>  
 
Therapeutic Reactance Scale (TRS) 
 
Willie Abel <wmabel@uncg.edu>  Wed, Jun 2, 2010 at 5:28 PM  
To: edowd@kent.edu  
Dr. Dowd, 
  
My name is Willie Mae Abel. I am PhD student in Nursing at The University of 
North Carolina at Greensboro. I will be conducting a non-funded research study on 
issues influencing adherence among African American women with hypertension on 
a sample size of 60 study participants during fall semester 2010.     
  
I am requesting permission to use the Therapeutic Reactance Scale (TRS). I believe 
this tool will provide valuable information to assess the impact of psychological 
reactance on compliance with medication adherence among African American 
women with hypertension.   
  
I look forward to hearing from you and I appreciate your prompt response. 
  
Willie Mae Abel, MSN, RN, ACNS-BC 
PhD Student, School of Nursing 
The University of North Carolina at Greensboro  
Phone: 704-638-0693 
Fax: 704-636-1612 
Email: wmabel@uncg.edu 
 
 
DOWD, E THOMAS <edowd@kent.edu>  Sun, Jun 6, 2010 at 2:36 PM  
To: Willie Abel <wmabel@uncg.edu>  
Yes, you have my permission to use the scale. It is in the Summer 1991 issue of the 
Journal of Counseling and Development, along with scoring and reliability data. I 
can, if you wish, provide you with additional references on research using the scale.  
Tom  
 
E. Thomas Dowd, Ph.D., ABPP, DSNAP 
Board Certified in Cognitive & Behavioral Psychology and Counseling Psychology 
Professor Emeritus, Department of Psychology,  
Kent State University  
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Kent, Ohio 44242, USA 
phone - 330.672.7664, Fax - 330.672.3786 
Professor, Postdoctoral International Institute for Advanced Studies of 
Psychotherapy and Applied Mental Health, Babes-Bolayi University, Cluj Napoca, 
Romania 
Vice President, American Board of Cognitive & Behavioral Psychology 
President, American Academy of Cognitive & Behavioral Psychology 
Secretary/Treasurer and Cognitive & Behavioral Psychology representative, Council 
of Specialties 
International Editor, Journal of Cognitive Psychotherapy 
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APPENDIX G 
 
HIGH BLOOD PRESSURE PREVENTION IQ (HBPPIQ) 
 
Test your knowledge of high blood pressure with the following questions.  
Circle each true or false.  
1. There is nothing you can do to prevent high blood pressure. True False 
 
2. If your mother or father has high blood pressure, you‘ll get it. True False 
 
3. Young adults don‘t get high blood pressure. True False 
 
4. High blood pressure has no symptoms. True False 
 
5. Stress causes high blood pressure. True False 
 
6. High blood pressure is not life threatening. True False 
 
7. Blood pressure is high when it‘s at or over 140 mm Hg / 90 mm 
Hg. 
True False 
 
8. If you‘re overweight, you are two to six times more likely to 
develop high blood pressure. 
True False 
 
 
9. You have to exercise vigorously every day to improve your blood 
pressure and heart health. 
True False 
 
 
10. Americans eat two to three times more salt and sodium than they 
need. 
True False 
 
11. Drinking alcohol lowers blood pressure. True False 
 
12. High blood pressure has no cure. 
 
True False 
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HIGH BLOOD PRESSURE PREVENTION IQ (HBPPIQ) 
 
Answers 
1. F 
2. F 
3. F 
4. T 
5. F 
6. F 
7. T 
8. T 
9. F 
10. T 
11. F 
12. T 
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The High Blood Pressure Prevention IQ (HBPPIQ) is published by the National Heart, 
Lung, and Blood Institute and is in the public domain. No further permission is required 
to reproduce or reprint the information in whole or in part.  
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APPENDIX H 
 
SELF-CARE OF HYPERTENSION INDEX (SCHI) 
 
All answers are confidential. 
 
Think about how you have been feeling in the last month.  
 
SECTION A: 
 
Listed below are common instructions given to persons with high blood pressure. How 
routinely do you do the following? 
 
  
 
Never 
or  
rarely 
Sometimes 
Frequently 
Always 
or daily 
1.Check your blood pressure?  1 2 3 4 
2.Eat a diet rich in fruits and 
vegetables? 
 1 2 3 4 
3.Do some physical activity?  1 2 3 4 
4.Keep doctor or nurse 
appointments? 
 1 2 3 4 
5.Eat a low salt diet?  1 2 3 4 
6.Exercise for 30 minutes?  1 2 3 4 
7.Take your medicines?  1 2 3 4 
8.Ask for low salt items when 
eating out or visiting others? 
 1 2 3 4 
9.Use a system (pill box, 
reminders) to help you 
remember your medicines? 
 1 2 3 4 
10. Limit your alcohol intake  1 2 3 4 
11.  Eat a diet low in saturated fat 
and cholesterol? 
 1 2 3 4 
12. Try to lose weight or control 
your body weight?  
 
 1 2 3 4 
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SECTION B: 
Many patients have difficulty controlling their blood pressure.  
In the past month, has your blood pressure gotten out of control, even briefly? Circle one. 
0) No 
1) Yes 
 
13. If you had trouble controlling your blood pressure in the past month…  
(circle one number) 
 Have 
not had 
these 
I did not 
recognize 
it 
Not 
Quickly 
 
 
Some 
  what    
Quickly 
Quickly  Very 
Quickly 
How quickly did you 
recognize that your 
blood pressure was 
elevated? 
 
N/A 0 1  2 3  4 
 
Listed below are remedies that people will use to control their blood pressure. If your 
blood pressure goes up, how likely are you to try one of these remedies? 
(circle one number for each remedy) 
 Not 
Likely 
Somewhat 
Likely 
 Likely  
 
Very  
Likely 
14. Reduce the salt in your diet 1 2  3  4 
15. Reduce your stress level 1 2  3  4 
16. Take an extra blood pressure 
pill 
1 2  3  4 
17. Call your doctor or nurse for 
guidance 
 
1 2  3  4 
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18. Think of a remedy you tried the last time your blood pressure was up,  
 
(circle one number) 
  
 
 
I did not  
try  
anything 
Not 
Sure 
Somewhat 
Sure 
 Sure  Very 
Sure 
How sure were you that 
the remedy helped or did 
not help? 
 
 0 1 2  3  4 
 
 
 
SECTION C:  
In general, how confident are you that you can:  
 Not 
Confident 
Somewhat 
Confident 
Very 
Confident 
Extremely 
Confident 
19. Keep your blood pressure in 
control? 
1 2 3 4 
20. Follow the treatment advice 
you have been given? 
1 2 3 4 
21. Evaluate the importance of 
your blood pressure changes? 
1 2 3 4 
22. Recognize changes in your 
health if they occur? 
1 2 3 4 
23. Do something that will lower 
your blood pressure? 
1 2 3 4 
24. Evaluate how well a remedy 
works? 
 
1 2 3 4 
 
 
 
 
 
 
 
 
255 
 
 
Willie Abel <wmabel@uncg.edu>  
 
Self-Care of Hypertension Index (SCHI) 
 
Willie Abel <wmabel@uncg.edu>  Mon, Nov 22, 2010 at 11:43 PM  
To: vdickson@nyu.edu  
Dr. Dickson, 
  
It was nice meet you at the AHA Scientific Session in Chicago. Dr. Patricia Crane, 
my advisor introduced us.  
 
I will be conducting a non-funded research study on issues influencing medication 
adherence among Black women with hypertension on a sample size of approximately 
80 study participants during spring semester 2011.      
  
You mentioned that you are seeking researchers to conduct psychometric testing on 
your adherence instrument and hypertension index. I would love to examine those 
tools before finalizing my dissertation methods.  
  
I look forward to hearing from you and I appreciate your prompt response. 
  
Willie Mae Abel, MSN, RN, ACNS-BC 
PhD Student, School of Nursing 
The University of North Carolina at Greensboro  
Phone: 704-638-0693 
Fax: 704-636-1612 
Email: wmabel@uncg.edu 
 
 
vd30@nyu.edu <vd30@nyu.edu>  Tue, Nov 23, 2010 at 9:50 AM  
Reply-To: vd30@nyu.edu  
To: Willie Abel <wmabel@uncg.edu>, briegel@nursing.upenn.edu  
Hi Willie - it was great to meet you at AHA! I am traveling so will send you info later 
this week. Also I am copying Dr. Riegel as the instrument and conceptual model is 
posted on her Self-Care website. 
 
Dr. Riegel- Willie Mae is a student of Tricia Crane's and I told her about the SC-HI.  
 
V 
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Sent from my Verizon Wireless BlackBerry 
 
 
 
 
 
Riegel, Barbara <briegel@nursing.upenn.edu>  Tue, Nov 23, 2010 at 10:18 AM  
To: "vd30@nyu.edu" <vd30@nyu.edu>, Willie Abel <wmabel@uncg.edu>  
Hi Willie Mae, we would love to have you test the Self-Care of Hypertension Index. 
It‘s not posted on the website because validity has not yet been demonstrated; we 
need more data to accomplish that. 
Our usual approach is to offer co-authorship for anyone providing complete and 
usable data on a minimum of 50 subjects. If that sounds like something you are 
interested in please let me know.  
I will attach the article describing the self-care of heart failure index; the SC-HI was 
developed on the same model. Barbara 
Dr. Barbara Riegel 
Professor, University of Pennsylvania  
NewCourtland Center for Transitions and Health 
School of Nursing, Claire M. Fagin Hall 
418 Curie Boulevard 
Philadelphia, PA 19104-4217 
briegel@nursing.upenn.edu 
215-898-9927 Phone 
240-282-7707 eFax 
Editor, The Journal of Cardiovascular Nursing  
http://journals.lww.com/jcnjournal/pages/default.aspx     
Guest Professor, Linköpings Universitet, Linköping, Sweden 
http://www.self-careofheartfailureindex.com/ 
 
   
 
SCHFI_2009 update.pdf 
678K  
 
 
 
 
[Quoted text hidden] 
 
 
Victoria Vaughan Dickson <vdickson@nyu.edu>  Wed, Nov 24, 2010 at 2:03 PM  
To: Willie Abel <wmabel@uncg.edu>  
Hi Willie Mae - Are you interested in using the SC-HI (self-care of hypertension 
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index) for your work? If so, please let me know and I will send you a copy. I know 
Dr. Riegel sent you one of the papers; and now that I am back and re-connected...I 
would be happy to schedule some time to talk with you and Dr. Crane about the 
instrument. Thanks much! 
 
Victoria Vaughan Dickson, PhD, CRNP 
Assistant Professor 
Brookdale Leadership in Aging Fellow 
New York University 
College of Nursing 
726 Broadway, 10th Floor 
New York, NY 
212-992-9426 (phone) 
212-995-4679 (fax) 
vdickson@nyu.edu 
 
 
Willie Abel <wmabel@uncg.edu>  Fri, Nov 26, 2010 at 3:13 PM  
To: Victoria Vaughan Dickson <vdickson@nyu.edu>  
Cc: Patricia Crane <patriciab.crane@gmail.com>  
Dr. Dickson, 
 
I read the article on an update of the SCHFI. Dr. Riegel mentioned that the HTN 
index was developed on the same model. Since HTN is often silent, I am trying to 
visualize the symptom recognition piece of the model. My outcome variable is 
medication adherence. In looking at the SCHFI, it looks as if adherence is part of all 
three self-care items, maintenance, management, and confidence.  
 
Before I give a definite yes, is it possible for us to view the HTN index to ensure that 
it is a good fit for my study? After reviewing it, then we can discuss the specifics with 
you. 
 
Thanks and I look forward to hearing from you.  
 
Willie Mae Abel, MSN, RN, ACNS-BC 
PhD Student, School of Nursing 
The University of North Carolina at Greensboro 
 
 
Victoria Vaughan Dickson <vdickson@nyu.edu>  Fri, Nov 26, 2010 at 5:54 PM  
To: Willie Abel <wmabel@uncg.edu>  
Cc: Patricia Crane <patriciab.crane@gmail.com>  
Hi Willie Mae - 
Attached is the Self-Care of Hypertension Index - So far we have pretty good 
Cronbach‘s alpha for the scales. Scoring is transformation to a scale of 1 to 100 for 
 
258 
each subscale. If you are interested in using this and helping us test it, let me know! 
Thanks - Hope you had a great Thanksgiving. 
Vicky 
 
Victoria Vaughan Dickson, PhD, CRNP 
Assistant Professor 
Brookdale Leadership in Aging Fellow 
New York University 
College of Nursing 
726 Broadway, 10th Floor 
New York, NY 
212-992-9426 (phone) 
212-995-4679 (fax) 
vdickson@nyu.edu 
 
 
  
SCH-HI_version1_4-21-09.doc 
61K  
 
 
 
 
 
Willie Abel <wmabel@uncg.edu>  Sat, Dec 4, 2010 at 5:05 PM  
To: Victoria Vaughan Dickson <vdickson@nyu.edu>  
Bcc: Patricia Crane <patriciab.crane@gmail.com>  
Dr. Dickson, 
 
I met with Dr. Crane and I would like to use the HTN index in my dissertation. You 
mentioned that you have good Cronbach's alpha for the scales. I would like to 
summarize any instrumentation results you have thus far for my methods section. 
 
Thanks and I look forward to working with you. 
 
Willie Mae Abel, MSN, RN, ACNS-BC 
PhD Student, School of Nursing 
The University of North Carolina at Greensboro 
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APPENDIX I 
 
TRUST IN PHYSICIAN SCALE (TPS) 
 
Each item below is a statement with which you may agree or disagree. Beside each 
statement is a scale that ranges from strongly agree to strongly disagree. For each item 
please circle the number that represents the extent to which you agree or disagree with 
the statement. Please make sure that you answer every item and that you circle only one 
number per item. It is important that you answer according to what you actually believe 
and not according to how you feel you should believe or how you think I may want you 
to respond. 
 Strongly 
Disagree 
 
Disagree 
 
Neutral Agree Strongly 
Agree 
1. *I doubt that my doctor 
really cares about me as a 
person. 
1 2 3 4 5 
2. My doctor is usually 
considerate of my needs 
and puts them first. 
1 2 3 4 5 
3. I trust my doctor so much I 
always try to follow his/her 
advice. 
1 2 3 4 5 
4. If my doctor tell me 
something is so, then it 
must be true. 
1 2 3 4 5 
5. *I sometimes distrust my 
doctor‘s opinion and would 
like a second one. 
1 2 3 4 5 
6. I trust my doctor‘s 
judgments about my 
medical care. 
1 2 3 4 5 
7. *I feel my doctor does not 
do everything he/she should 
for my medical care. 
1 2 3 4 5 
8. I trust my doctor to put my 
medical needs above all 
other considerations when     
treating my medical 
problems. 
1 2 3 4 5 
9. My doctor is a real expert in 
taking care of medical 
problems like mine. 
1 2 3 4 5 
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 Strongly 
Disagree 
 
Disagree 
 
Neutral Agree Strongly 
Agree 
10. I trust my doctor to tell me 
if a mistake was made about 
my treatment. 
 
1 2 3 4 5 
11. *I sometimes worry that my 
doctor may not keep the 
information we discuss 
totally private. 
 
1 2 3 4 5 
*=Reverse score before analysis 
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Willie Abel <wmabel@uncg.edu>  
 
Trust in Physician Scale (TPS) 
 
Willie Abel <wmabel@uncg.edu>  
Wed, June 02, 2010 5:26 PM 
 
To: Anderson, Lynda (CDC/ONDIEH/NCCDPHP) 
Dr. Anderson, 
 
My name is Willie Mae Abel. I am PhD student in Nursing at The University of 
North Carolina at Greensboro. I will be conducting a non-funded research study on 
issues influencing adherence among African American women with hypertension on 
a sample size of 60 study participants during fall semester 2010.     
  
I am requesting permission to use the Trust in Physician Scale (TPS). I believe 
this tool will provide valuable information to measure interpersonal trust in 
primary care providers among African American women with hypertension.   
  
I look forward to hearing from you and I appreciate your prompt response. 
  
Willie Mae Abel, MSN, RN, ACNS-BC 
PhD Student, School of Nursing 
The University of North Carolina at Greensboro  
Phone: 704-638-0693 
Fax: 704-636-1612 
Email: wmabel@uncg.edu 
 
 
Anderson, Lynda (CDC/ONDIEH/NCCDPHP) <laa0@cdc.gov>  
Wed, Jun 2, 2010 at 5:29 
PM  
To: wmabel@uncg.edu  
Cc: "Anderson, Lynda (CDC/ONDIEH/NCCDPHP)" <laa0@cdc.gov>  
I am attaching a copy of the Trust in Physician scale with the instructions that have 
been used in written surveys. If you need me to fax you a copy, please let me know. 
You have my permission to use the Anderson/Dedrick Trust in Physician Scale in 
your research. Please cite the original citation in any work you publish using the 
scale: Anderson, L.A., & Dedrick, R.F. (1990). Development of the trust in physician 
scale: A measure to assess interpersonal trust in patient-physician relationships. 
Psychological Reports, 67, 1091-1100. 
 
 
262 
Please note that this scale was used recently in study of persons with arthritis (see 
Freburger, J.K., Callahan, L.F., Currey, S.S., & Anderson, L.A. (2003). Correlates of 
trust in the rheumatologist among patients with rheumatic disease. Arthritis & 
Rheumatism 49(1):51-58.). Please note another recent publication validating my 
Trust in Physician scale (Thom et al. Stanford Trust Physician Study. Medical Care 
1999; 37(5), 510-17.). 
 
The Trust in Physician Scale is copyrighted with the journal of Psychological Reports 
so if you use the scales in your work, please cite that reference by Anderson, L.A., & 
Dedrick, R.F. (1990). Development of the trust in physician scale: A measure to 
assess interpersonal trust in patient-physician relationships. Psychological Reports, 
67, 1091-1100. 
 
I would be very interested in your findings and I do try to monitor the use and 
findings from studies. If you have any questions, please let me know. 
 
My contact information is at the end of this message.  
 
Lynda 
 
Lynda A. Anderson, PhD 
Director, Health Aging Program 
Division of Adult and Community Health (MS K45) 
National Center for Chronic Disease Prevention and Health Promotion 
Centers for Disease Control and Prevention 
(770) 488-5360 (Healthy Aging Program) 
(770) 488-5998 (Direct line) 
Email: Landerson4@cdc.gov 
Healthy Aging Program: www.cdc.gov/aging 
 
3 attachments 
  
SCALE.DOC 
6K  
 
 
  
freburger article.pdf 
84K  
 
 
  
LA RD Trust in Physician Scale article.pdf 
305K  
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APPENDIX J 
 
THE JOHN HENRYISM ACTIVE COPING SCALE (JHACS) 
 
I‘d like to ask you some questions about how you see yourself right now, today, as a 
woman living and doing things in the real world. I am going to read several statements to 
you, and after I read each statement, I want you to tell me if what I‘ve just said is either 
TRUE or FALSE for you, personally. Then I will ask to what degree (i.e. completely true 
or false, or somewhat true or false).  
 Completely 
False 
Somewhat 
False 
Don‘t 
Know 
Somewhat 
True 
Completely 
True 
1. I‘ve always felt that 
I could make of my 
life pretty much 
what I wanted to 
make of it.  
1 2 3 4 5 
2. Once I make up my 
mind to do 
something, I stay 
with it until the job 
is completely done. 
1 2 3 4 5 
3. I like doing things 
that other people 
thought could not be 
done. 
1 2 3 4 5 
4. When things don‘t 
go the way I want 
them to, that just 
makes me work even 
harder. 
1 2 3 4 5 
5. Sometimes I feel that 
if anything is going 
to be done right, I 
have to do it myself. 
1 2 3 4 5 
6. It‘s not always easy, 
but I manage to find 
a way to do the 
things I really need 
to get done. 
 
1 2 3 4 5 
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 Completely 
False 
Somewhat 
False 
Don‘t 
Know 
Somewhat 
True 
Completely 
True 
7. Very seldom have I 
been disappointed by 
the results of my 
hard work. 
 
1 2 3 4 5 
8. I feel that I am the 
kind of individual 
who stands up for 
what he believes in, 
regardless of the 
consequences. 
1 2 3 4 5 
9. In the past, even 
when things got 
really tough, I never 
lost sight of my 
goals. 
1 2 3 4 5 
10. It‘s important for me 
to be able to do 
things the way I 
want to do them 
rather than the way 
other people want 
me to do them. 
1 2 3 4 5 
11. I don‘t let my 
personal feelings get 
in the way of doing a 
job. 
1 2 3 4 5 
12. Hard work has really 
helped me to get 
ahead in life. 
 
1 2 3 4 5 
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Willie Abel <wmabel@uncg.edu>  
 
John Henryism Scale (JHACS) 
 
Willie Abel <wmabel@uncg.edu>  Wed, Jun 2, 2010 at 5:27 PM  
To: sjames@duke.edu  
Dr. James, 
  
My name is Willie Mae Abel. I am PhD student in Nursing at The University of 
North Carolina at Greensboro. I will be conducting a non-funded research study on 
issues influencing adherence among African American women with hypertension on 
a sample size of 60 study participants during fall semester 2010.     
  
I am requesting permission to use the John Henryism Scale. I believe this tool will 
provide valuable information to measure active coping with psychosocial 
environmental stressors among African American women with hypertension.   
  
I look forward to hearing from you and I appreciate your prompt response. 
  
Willie Mae Abel, MSN, RN, ACNS-BC 
PhD Student, School of Nursing 
The University of North Carolina at Greensboro  
Phone: 704-638-0693 
Fax: 704-636-1612 
Email: wmabel@uncg.edu 
 
 
Sherman James, Ph.D. <sjames@duke.edu>  Wed, Jun 2, 2010 at 5:45 PM  
To: Willie Abel <wmabel@uncg.edu>  
Ms. Abel, 
Per your request, attached is a copy of the JHAC12. Sometimes the pagination suffers 
with the electronic transfer, but I think you‘ll be able to correct that without a 
problem. 
Good luck with your research. 
Best wishes, 
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Sherman James 
Sherman A. James, PhD, FAHA 
Susan B. King Professor of Public Policy  
Duke Sanford School of Public Policy 
Room 213, Box 90245 
Duke University 
Durham, NC 27708-90245 
Tel:  (919) 613-7338 
Fax: (919) 681-8288 
www.sanford.duke.edu 
 
 
  
JHAC12_English_ 2005a.doc 
43K  
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APPENDIX K 
 
INDEX OF RACE-RELATED STRESS-BRIEF VERSION (IRRS-B) 
 
This survey questionnaire is intended to sample some of the experiences that Black 
people have in this country because of their "blackness." There are many experiences that 
a Black person can have in this country because of his/her race. Some events happen just 
once, some more often, while others may happen frequently. Below you will find listed 
some of these experiences; for which you are to indicate those that have happened to you 
or someone very close to you (i.e. a family member or loved one). It is important to note 
that a person can be affected by those events that happen to people close to them; this is 
why you are asked to consider such events as applying to your experiences when you 
complete this questionnaire. Please circle the number on the scale (0 to 4) that 
indicates the reaction you had to the event at the time it happened. Do not leave any 
items blank. If an event has happened more than once refer to the first time it happened. 
If an event did not happen circle 0 and go on to the next item.   
 This 
never 
happened 
to me 
This 
event 
happened, 
but did 
not bother 
me 
This 
event 
happened 
& I was 
slightly 
upset 
This 
event 
happened 
& I was 
upset 
This 
event 
happened 
& I was 
extremely 
upset 
1. You notice that crimes 
committed by White people 
tend to be romanticized, 
whereas the same crime 
committed by a Black person is 
portrayed as savagery, and the 
Black person who committed 
it, as an animal. 
 
0 
 
1 
 
2 
 
3 
 
4 
2. Sales people/clerks did not say 
thank you or show other forms 
of courtesy and respect (i.e. put 
your things in a bag) when you 
shopped at some White/non-
Black owned businesses. 
 
0 
 
1 
 
2 
 
3 
 
4 
3. You notice that when Black 
people are killed by the police 
the media informs the public of 
the Victim‘s criminal record or 
negative information in their 
background, suggesting they 
got what they deserved. 
 
 
0 
 
1 
 
2 
 
3 
 
4 
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 This 
never 
happened 
to me 
This 
event 
happened, 
but did 
not bother 
me 
This 
event 
happened 
& I was 
slightly 
upset 
This 
event 
happened 
& I was 
upset 
This 
event 
happened 
& I was 
extremely 
upset 
4. You have been threatened with 
physical violence by an 
individual or group of 
White/non-Blacks. 
 
0 
 
1 
 
2 
 
3 
 
4 
5. You have observed that White 
kids who commit violent 
crimes are portrayed as "boys 
being boys", while Black kids 
who commit similar crimes are 
wild animals. 
 
0 
 
1 
 
2 
 
3 
 
4 
6. You seldom hear or read 
anything positive about Black 
people on radio, T.V., 
newspapers or in history books. 
 
0 
 
1 
 
2 
 
3 
 
4 
7. While shopping at a store the 
sales clerk assumed that you 
couldn't afford certain items 
(i.e. you were directed toward 
the items on sale). 
 
0 
 
1 
 
2 
 
3 
 
4 
8. You were the victim of a crime 
and the police treated you as if 
you should just accept it as part 
of being Black. 
 
0 
 
1 
 
2 
 
3 
 
4 
9. You were treated with less 
respect and courtesy than 
Whites and other non-Blacks 
while in a store, restaurant, or 
other business establishment. 
 
0 
 
1 
 
2 
 
3 
 
4 
10. You were passed over for an 
important project although you 
were more qualified and 
competent than the White/non-
Black person given the task. 
 
 
0 
 
1 
 
2 
 
3 
 
4 
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 This 
never 
happened 
to me 
This 
event 
happened, 
but did 
not bother 
me 
This 
event 
happened 
& I was 
slightly 
upset 
This 
event 
happened 
& I was 
upset 
This 
event 
happened 
& I was 
extremely 
upset 
11. Whites/non-Blacks have stared 
at you as if you didn't belong in 
the same place with them; 
whether it was a restaurant, 
theater, or other place of 
business. 
 
0 
 
1 
 
2 
 
3 
 
4 
12. You have observed the police 
treat White/non-Blacks with 
more respect and dignity than 
they do Blacks. 
 
0 
 
1 
 
2 
 
3 
 
4 
13. You have been subjected to 
racist jokes by Whites/non-
Blacks in positions of authority 
and you did not protest for fear 
they might have held it against 
you. 
 
0 
 
1 
 
2 
 
3 
 
4 
14. While shopping at a store, or 
when attempting to make a 
purchase you were ignored as if 
you were not a serious 
customer or didn't have any 
money. 
 
0 
 
1 
 
2 
 
3 
 
4 
15. You have observed situations 
where other Blacks were 
treated harshly or unfairly by 
Whites/non-Blacks due to their 
race. 
 
0 
 
1 
 
2 
 
3 
 
4 
16. You have heard reports of 
White people/non-Blacks who 
have committed crimes, and in 
an effort to cover up their deeds 
falsely reported that a Black 
man was responsible for the 
crime. 
 
 
0 
 
1 
 
2 
 
3 
 
4 
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 This 
never 
happened 
to me 
This 
event 
happened, 
but did 
not bother 
me 
This 
event 
happened 
& I was 
slightly 
upset 
This 
event 
happened 
& I was 
upset 
This 
event 
happened 
& I was 
extremely 
upset 
17. You notice that the media plays 
up those stories that cast Blacks 
in negative ways (child 
abusers, rapists, muggers, etc. 
[or as savages] Wild Man of 
96th St., Wolf Pack, etc.), 
usually accompanied by a large 
picture of a Black person 
looking angry or disturbed. 
 
0 
 
1 
 
2 
 
3 
 
4 
18. You have heard racist remarks 
or comments about Black 
people spoken with impunity 
by White public officials or 
other influential White people. 
 
0 
 
1 
 
2 
 
3 
 
4 
19. You have been given more 
work, or the most undesirable 
jobs at your place of 
employment while the 
White/non-Black of equal or 
less seniority and credentials is 
given less work, and more 
desirable tasks. 
 
0 
 
1 
 
2 
 
3 
 
4 
20. You have heard or seen other 
Black people express the desire 
to be White or to have White 
physical characteristics because 
they disliked being Black or 
thought it was ugly. 
 
0 
 
1 
 
2 
 
3 
 
4 
21. White people or other non-
Blacks have treated you as if 
you were unintelligent and 
needed things explained to you 
slowly or numerous times. 
 
0 
 
1 
 
2 
 
3 
 
4 
22. You were refused an apartment 
or other housing; you suspect it 
was because you are Black. 
 
 
0 
 
1 
 
2 
 
3 
 
4 
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Willie Abel <wmabel@uncg.edu>  
 
The Index of Race-Related Stress (IRRS)-Brief Version 
 
Willie Abel <wmabel@uncg.edu>  Mon, Nov 8, 2010 at 1:12 AM  
To: soutsey@vcu.edu  
Dr. Utsey, 
  
My name is Willie Mae Abel. I am PhD student in Nursing at The University of 
North Carolina at Greensboro. I will be conducting a non-funded research study on 
issues influencing medication adherence among African American women with 
hypertension on a sample size of 75 study participants during spring semester 2010.  
   
  
I am requesting permission to use the Index of Race-Related Stress (IRRS)-Brief 
Version Questionnaire. I believe this tool will provide valuable information to 
measure the association between perceived racism and hypertension among African 
American women.   
  
I look forward to hearing from you and I appreciate your prompt response. 
  
Willie Mae Abel, MSN, RN, ACNS-BC 
PhD Student, School of Nursing 
The University of North Carolina at Greensboro  
Phone: 704-638-0693 
Fax: 704-636-1612 
Email: wmabel@uncg.edu 
 
 
Shawn O Utsey/FS/VCU <soutsey@vcu.edu>  Mon, Nov 8, 2010 at 5:49 PM  
To: Willie Abel <wmabel@uncg.edu>  
Greetings,  
 
Yes, you have permission to use the IRRS-B. I have attached a copy of the 
instrument and scoring protocol. Please let me know if you have questions.  
 
Shawn  
 
Shawn O. Utsey, Ph.D., 
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Chair, Department of African American Studies, 
Director, Institute for African American  
Mental Health Research and Training, 
Professor, Department of Psychology 
Virginia Commonwealth University 
(804) 828-1384 
Fax: (804) 828-1665  
2 attachments 
  
irrsshort2.doc 
28K  
 
 
  
SCORING FOR IRRS BRIEF.doc 
20K  
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APPENDIX L 
 
PATIENT HEALTH QUESTIONNAIRE-9 (PHQ-9) 
 
Over the last 2 weeks, how often have you 
been bothered by any of the following 
problems? 
(Use “√” to indicate your answer) 
Not at 
all 
Several 
days 
More 
than half 
the days 
Nearly 
every 
day 
1. Little interest or pleasure in doing 
things 
0 1 2 3 
2. Feeling down, depressed, or hopeless 0 1 2 3 
3. Trouble falling or staying asleep, or 
sleeping too much 
0 1 2 3 
4. Feeling tired or having little energy 0 1 2 3 
5. Poor appetite or overeating 0 1 2 3 
6. Feeling bad about yourself—or that 
you are a failure or have let yourself or 
your family down 
0 1 2 3 
7. Trouble concentrating on things, such 
as reading the newspaper or watching 
television 
0 1 2 3 
8. Moving or speaking so slowly that 
other people could have noticed? Or 
the opposite—being so fidgety or 
restless that you have been moving 
around a lot more than usual 
0 1 2 3 
9. Thoughts that you would be better off 
dead or of hurting yourself in some 
way 
 
0 1 2 3 
 
                           FOR OFFICE CODING             0          + ______   +  ______   +  _____ 
              
___________________________________________________     = Total Score: ______ 
 
If you checked off any problems, how difficult have these problems made it for you to do 
your work, take care of things at home, or get along with other people? 
 
Not difficult at all 
□ 
Somewhat difficult 
□ 
Very difficult 
□ 
Extremely difficult 
□ 
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The Patient Health Questionnaire-9 (PHQ-9) was developed by Drs. Robert L. Spitzer, 
Janet B. W. Williams, Kurt Kroenke and colleagues, with an educational grant from 
Pfizer Inc. No permission is required to reproduce, translate, display, or distribute.  
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APPENDIX M 
 
MARLOWE-CROWNE SOCIAL DESIRABILITY SCALE (M-C 1[10] SDS) 
 
1. I like to gossip at times.  True False 
 
2. There have been occasions when I took advantage of someone. True False 
 
3. I‘m always willing to admit it when I make a mistake. True False 
 
4. I always try to practice what I preach. True False 
 
5. I sometimes try to get even rather than forgive and forget. True False 
 
6. At times I have really insisted on having things my own way. True False 
 
7. There have been occasions when I felt like smashing things. True False 
 
8. I never resent being asked to return a favor. True False 
 
9. I have never been irked when people expressed ideas very 
different from my own. 
True False 
 
 
10. I have never deliberately said something that hurt someone's 
feelings. 
 
True False 
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MARLOWE-CROWNE SOCIAL DESIRABILITY SCALE (M-C 1[10] SDS) 
 
Answers 
1. F 
2. F 
3. T 
4. T 
5. F 
6. F 
7. F 
8. T 
9. T 
10. T 
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Willie Abel <wmabel@uncg.edu>  
 
Marlowe-Crowne Social Desirability Scale (M-C 1[10] 
SDS) 
 
Willie Abel <wmabel@uncg.edu>  Tue, Jan 11, 2011 at 3:20 PM  
To: kgerbasi@niagaracc.suny.edu  
Dr. Gerbasi, 
  
My name is Willie Mae Abel. I am PhD student in Nursing at The University of 
North Carolina at Greensboro. I will be conducting a non-funded research study on 
issues influencing adherence among African American women with hypertension on 
a sample size of 80 study participants during spring semester 2011.  
  
I am requesting permission to use the M-C 1(10) Social Desirability Scale published 
with Robert Strahan in the 1972 article entitled "Short, homogeneous version of the 
Marlow-Crowne Social Desirability Scale" (Journal of Clinical Psychology, 28(2), 
191-193. I believe this tool will provide valuable information to control for social and 
culturally approved response tendencies in conjunction with other self-report 
measures. 
  
I look forward to hearing from you and I appreciate your prompt response. 
 
Willie Mae Abel, MSN, RN, ACNS-BC 
PhD Student, School of Nursing 
The University of North Carolina at Greensboro 
 
 
Kathy Gerbasi <kgerbasi@niagaracc.suny.edu>  Tue, Jan 11, 2011 at 3:25 PM  
To: Willie Abel <wmabel@uncg.edu>  
Dear Willie Mae, 
Of course you may use the MCSDS short form(s). Just be sure to appropriately cite 
the article. Good luck with your research. 
Kathy Gerbasi PhD 
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Professor Psychology Social Science Division  
Niagara County Community College  
Sanborn NY 14132  
kgerbasi@niagaracc.suny.edu  
716-614-6762  
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APPENDIX N 
PERMISSION TO USE COX INTERACTION MODEL OF CLIENT HEALTH 
BEHAVIOR FIGURE  
 
